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GENERAL INTRODUCTION 
Introduction 
Relaxin is a polypeptide hormone produced primarily during pregnancy 
in several mammalian species. Hisaw (1926) receives credit for first 
discovering relaxin while working on the phenomenon of interpublc liga­
ment separation in rodents. Relaxin was overshadowed by progesterone, 
also produced by the corpora lutea, and remained obscure until the advent 
of protein purification and recombinant DNA technology during the last 
half decade. The amino acid sequences of relaxin from pig, rat, tiger 
shark, dogfish shark, and human have since been established. The hormone 
consists of two peptide chains (A and B) joined by disulfide bonds with 
an intrachaln disulfide bond in the A chain similar to insulin. 
Although relaxin is considered primarily a hormone of pregnancy, its 
presence has been demonstrated in tissues from cyclic females as well as 
in reproductive tissues from the male. Thus, relaxin can neither be 
considered solely as a gestational hormone nor exclusively as a female 
hormone. The presence of a relaxin-like protein in Tetrahymena 
pyriformis, a ciliated protozoa, adds a new dimension to the evolution of 
relaxin and other related peptides. Relaxin has a multiplicity of 
sources, both luteal and extraluteal. Similarly, the actions of relaxin 
are numerous and diverse. Classically, relaxin's actions are threefold; 
on collagen in the (1) cervix, (2) pubic symphysis, and (3) on the 
smooth muscle of the uterus. However, recent evidence seems to indicate 
that relaxin is a multipurpose hormone with functions as numerous and 
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diverse as insulin and corticosteroids* Some of the currently emerging 
functions of relaxin include inhibition of prepartum myometrial activity 
of the uterus, ovulation, facilitation of parturition and direct 
interaction with neural tissue to affect the release of neurohypophysial 
hormones. 
The objectives of these studies were to determine the effects of 
purified porcine relaxin on parturition, pelvic relaxation, cervical 
dilation, steroidogenesis and subsequent reproductive fertility in late 
pregnant crossbred beef heifers. 
Review of Literature 
The biochemistry of relaxin 
Relaxin was discovered by Hisaw (1926) while working.on the 
phenomenon of prenatal separation of the pubic symphysis in rodents. 
Serum extracted from pregnant rabbits and guinea pigs, if injected into 
virgin guinea pigs immediately after estrus, elicited marked relaxation 
of the Interpubic ligaments (Hisaw, 1926). The hormone-dependent 
relaxation of the pubic symphysis present in the serum of pregnant 
rabbits and guinea pigs was later termed relaxin (Fevold et al., 1932). 
They showed that the crude preparation was stable in acidic solutions, 
had an isoelectric point of 5.4-5.5, and was trypsin digestible. Based 
on their findings that relaxin had about 11% nitrogen and was amphoteric, 
they concluded the hormone was a polypeptide. 
In 1963, the acid acetone method for extraction of relaxin, which is 
used to date, revealed that relaxin had a very high isoelectric point and 
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several fractions were present in the preparation, all of which possessed 
relaxin activity. The multiplicity of relaxin forms was later confirmed 
by Sherwood and O'Byrne (1974) by submitting porcine relaxin to ion-
exchange chromatography. The column yielded three fractions—CM-b, CM-a, 
and CM-a'—each of these having slightly different isoelectric points, 
but all were 2500-3000 guinea pig units (GPU) and equipotent in the mouse 
interpubic ligament assay. Chromatographic separation of bovine relaxin 
also revealed a similar multiplicity of relaxins; however, the biological 
activity of bovine relaxin is comparatively of lower specific activity 
although the protein yield per gram of tissue is the same for bovine and 
porcine corpora lutea (Fields et al., 1980a). Schwabe et al. (1976) 
reported the primary structure of A-chain and later the B-chain (Schwabe 
et al., 1977; Niall et al., 1977). The two chains of relaxin showed 
similarities with those of insulin, since the cysteine residues are 
distributed in the same manner as on the homologous chains of insulin. 
The other positions are not homologous; only 11 amino acids are 
conservatively substituted (James et al., 1977). 
The primary structure (amino acid sequence) of relaxin from the pig, 
rat, tiger shark, dog shark and human, in contrast with most other 
peptides, shows marked structural differences between species. Rat and 
porcine relaxins differ by as much as 50% of their amino acids; in 
contrast, there are only 8% amino acid differences between porcine 
insulin and rat insulin (Trsgear and Niall, 1984). In addition to the 6 
cysteine residues flanking the glycine residues, only the isoleucine at 
position 7 in the B-chain, arginine at positions 12 and 16 and leucine at 
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position 32 have been conserved. These cysteine residues are essential 
for the maintenance of the overall structure of the disulfide bond 
configuration (Tregear and Niall, 1984). It is most probable that this 
marked variation in the amino acid composition of the various relaxins 
may explain the poor immunological cross activity between relaxins from 
different species. There is also variation in the length of the B-chain 
and to some degree the A-chain; both the amino and carboxyl ends are 
variable (Tregear and Niall, 1984). 
The techniques of recombinant DNÂ technology made possible the 
isolation and characterization of the gene sequence responsible for rat 
(Hudson et al., 1981), pig (Hudson et al., 1984) and human relaxins 
(Hudson et al., 1984). Nucleotide sequences and comparison of amino 
acids reveal a common structural organization for the relaxln precursor 
protein. It consists of a signal peptide of about 25 amino acid 
residues, followed by a B-peptide of about 30 amino acid residues, a C-
peptide of 105 amino acids, and an A-chain of 22 to 24 residues. An 
interon interrupts the coding region of the C-peptide in man, pig. and 
the rat (Hudson et al., 1981; 1984). Attempts at chemical synthesis of 
relaxln have provided basic information about the bioactivity of the 
molecule. Synthetic relaxins and their analogues have confirmed that the 
full length of the A- and B-chains is not required for biological 
activity. Up to six amino acids can be removed from the carboxyl-
terminus of the B-chain and three amino acids can be removed from the 
amino terminal of the A-chain without affecting the biological activity 
of the molecule (Tregear and Niall, 1984). 
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Sources of relaxin 
Primarily, relaxin has been found in the reproductive tract of the 
female during pregnancy. Generally, in species in which the ovary is 
required for the maintenance of pregnancy such as the pig, rat, mouse and 
cow, the ovary is the primary source of relaxin. However, those animals 
that do not require the ovary to maintain pregnancy have little or no 
ovarian sources of relaxin (Larkin et al., 1983). The primary source of 
relaxin in the horse is the placenta; in the guinea pig, both the uterus 
and the placenta and in humans, both the placenta and the decidua contain 
relaxin (Larkin et al., 1983). Other sources of relaxin are presented in 
Table 1. 
In the pig, relaxin is associated with dense cytoplasmic granules in 
granulosa lutein cells (Belt et al., 1971). Immunofluorescent studies 
confirmed that these granules contained relaxin (Arakaki et al., 1980; 
Larkin et al., 1983). Three cells have been reported to contain relaxin 
in humans; these are basically the lutein cells, the basal plate cell of 
the placenta and the decidual cells (Weiss et al., 1976; 1977; O'Byrne et 
al., 1978; Fields and Larkin, 1980; Bigazzi et al., 1983). Bovine 
relaxin has been isolated from the corpus luteum of pregnancy and by use 
of immunoperoxidase and the hormone has been localized in the large 
lutein cells (Fields et al., 1980a,b). Biologically active relaxin in 
different bovine tissues as well as the possible existence of relaxin 
receptors in the cow has been reported (see Sorter, 1979). Comparison 
between bovine and porcine relaxin reveals that both peptides are eluded 
in the 6,000 molecular weight range, inhibit spontaneous myometrial 
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Table 1. Reported actions and sources (or putative sources) of relaxin 
(from Porter, 1984) 
Actions (stimulatory unless Sources 
otherwise indicated) (and putative sources) 
Pelvic ligaments Soften Corpus luteum Prostate 
Cervix Soften Follicle wall 
Uterus Growth theca: Nonmammals 
Water imbibition Decidua Tetrahymena 
Collagen re­ (Endometrium 
arrangement glands): Elasmobranch 
a. Myometrium Inhibition 
Coordination 
Glycogen deposition (Syncytio-
ovaries: 2 
species 
b. Endometrium Arteriolar endo­
thelial prolifera­
tion 
Granulocyte aggrega­
tion 
trophoblast) Avian testes 
Mammary gland 
a. Myoepithelium Blocks oxytocin 
stimulation 
b. Alveolar epi­ Growth 
thelium 
c. Ducts Growth 
d. Fibroblasts Mitosis 
Protein synthesis 
Vagina Opening 
Oestrogen-induced 
cornification 
Brain Inhibits oxytocin 
release 
Fat cells (ma­
ture, female) Insulin binding 
Spermatozoa Motility 
contraction of the mouse uterus, form a continuous precipitin line in the 
Onchtelony plate assay, and induce interpubic ligament formation in the 
mouse with no evidence for divergence in the log-dose response (Fields et 
alo, 1980a,b)» Isoelectric focusing (lEF) of the 6,000 dalton bovine 
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relaxln yielded three separate biologically active eluates similar to the 
porcine lEF pattern (Fields et al., 1980a). However, there was a wide 
discrepancy in biological specific activity between bovine and porcine 
relaxln (Table 2). Carboxymethyl cellulose chromatography (CMC) of lEF 
Isolates was designated as b CMl, b CM2 and b CM3 (Fields et al., 1980a). 
It is presently not known whether these fractions correspond to the three 
porcine relaxln Isolates CM-B, CM-a, CM-a' relaxlns with 28, 31, 29 amino 
acids in the B-chain, respectively (Sherwood and O'Byrne, 1974; Niall et 
al., 1977). 
Table 2. Comparison of lEF bovine and porcine relaxln (from Fields et 
al., 1980a) 
Bioactivity 
lEF pH unlts/mg protein 
Isolate 
No. Cow Sow Cow Sow 
15 11.5 11.1 45 2,500 
30 10.1 10.2 250 2,700 
65 8.8 8.9 30 400 
345 6,000 
Biological and physiological effects of relaxln 
Classically, relaxln's effects are threefold; namely, (1) 
collagenous matrix of the cervix, (2) the symphysis pubis, and (3) 
contractility of smooth muscle of the uterus. The recent findings of 
relaxln in tissues and species which had not been known to contain it, 
such as in the elasmobranch, in the bird and in males of some species as 
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well as the increasing reports of novel roles for relaxln currently 
emerging from recent studies Indicates that relaxln might be a 
multipurpose hormone much like insulin (Table 1). 
Relaxln might be a local hormone, particularly with regard to its 
presence in ovarian follicle and the decidua. Relaxln is present in the 
perlovulatory follicular fluid of the pig as well as in the follicle wall 
in vitro (Bryant-Greenwood et al., 1980). Thecal cells rather than the 
granulosa cells are the source of porcine relaxln (Evans et al., 1983; 
Loeken et al., 1983). Although relaxln has also been found in human 
follicular fluid, the principal site of its production, unlike the pig. 
Is the granulosa cell. Thecal levels of relaxln increase only as 
ovulation approaches (Noel et al., 1983; Loeken et al., 1981). Denovo 
synthesis of relaxln by human decidua.is supported by in vitro studies 
and by immunofluorescence studies which showed specific antibodies in the 
cytoplasm of some decidual cells (Bigazzl et al., 1983), thus supporting 
Bryant-Greenwood's (1982) hypothesis that relaxln may be a maintenance 
hormone acting locally. 
Relaxln on ovulation 
Ovulation of the mammalian ova requires the breakdown of normal 
healthy tissue usually starting at the apex of the follicular bulge. 
There is a generalized digestion of Che connective tissue in the follicle 
wall as well as changes in proteoglycan synthesis (Espey, 1976; 
Yanaglshita and Hascall, 1979). The macro molecules which comprise 
connective tissue are basically collagen, proteoglycans, elastln or 
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glycoprotein. Collagen fibrils provide shape and tensile strength for 
the tissue and are found embedded in a gel-like matrix of proteoglycans. 
Hydration of proteoglycans provides a swelling pressure to maintain 
volume and resistance to compressive force; these two properties are 
needed for effective tissue function (Hascall, 1981). Relaxin, which is 
classically related to the separation of interpubic ligament and changes 
in uterine tissue (Schwabe et al., 1978; Porter, 1978), is capable of 
remodeling collagen in these mammalian reproductive tissues. 
Synthesis of relaxin by thecal and/or granulosa cells could affect 
the contractility and metabolism of collagen in follicle walls. This is 
based on the ability of relaxin to induce plasminogen activator (PA), 
collagenase and proteoglycanase in granulosa cells, in vitro (Too et al., 
1984). PA is a protease shown to be present in follicular fluid and it 
catalyzes the conversion of plasminogen to plasmin (Strickland and Beers, 
1976). Plasmin is fibrinolytic and activates latent collagenase as well 
as degrades follicular fluid proteoglycans (Yanagishita and Hascall, 
1979). Thus, if relaxin can regulate the follicular release of 
plasminogin activator and possibly other enzymes that mediate collagen 
proteoglycan degradation such as proteoglycanase, collagenase and B-
glycanoxidase, then the suggestion that relaxin is an intrafollicular 
regulator of collagen and proteoglycan degradation may be a very likely 
possibility. This concept may shed more light on the role of relaxin 
sequestered in reproductive tissues of pregnant humans and primates. 
From this standpoint, local disintegration of the integrity of follicle 
wall could permit rupture of the follicle under intrinsic fluid dynamics. 
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Another possible mechanism by which relaxin could induce follicular 
rupture is based on the ability of relaxin to modulate smooth muscle 
activity in follicles. This is based on the recent finding that smooth 
muscles may be involved in ovulation (Martin and Talbot, 1981). 
Relaxin on uterine smooth muscle activity and 
remodeling of symphysial and cervical 
connective tissue 
Successful expulsion of the fetus requires a coordinated contraction 
of both uterine smooth muscle and involuntary contraction of abdominal 
muscles, as well as ripening and dilatation of the birth canal. The 
uterus is composed of a thin outer layer (perimetrium) and a thick 
myometrium. The myometrium consists of two layers of smooth muscle, a 
thick inner circular layer, and a thinner outer longitudinal layer. The 
amount of muscle tissue in the uterine wall increases both by an increase 
in cell number and enlargement. 
Usually the unstimulated uterine smooth muscle undergoes spontaneous 
arrhythmic uncoordinated contractions during late pregnancy. These 
consist of irregular episodes of prolonged activity in occupied uterine 
segments (Garfield et al., 1979a; Tarvene et al., 1979a; Liggins, 1979). 
Just before parturition, the frequency, amplitude and coordination of 
electrical impulses associated with uterine contraction increase due to 
the increased numbers of gap junction (or nexuses) formed (Garfield et 
al., 1979a; 1982). Individual cells of the myometrium communicate by 
means of gap junctions, which are believed to facilitate the 
synchronization of myometrial junction during labor. Few gap junctions 
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are formed or seen in the myometria of nonpregnant or early pregnant 
animals. However, gap functions become numerous at late pregnancy and 
during labor, at a time when rhythmicity of Braxton-Hicks contractions 
increase (Garfield et al., 1979b, 1982), 
Myosin and calcium are two essential components of muscle wall 
contractions. Myosin is a structural protein as well as being an enzyme 
that facilitates conversion of ATP to motion. Comparative analysis of 
myosin from pregnant and nonpregnant uteri of women, rabbits, rats and 
cows show that the two types of myosin differ structurally and in 
enzymatic properties (Huszar, 1981). Gestation thus brings about changes 
in myometrial function and new myosin isozymes specific to pregnancy. 
Calcium is a second messenger for induction of physiological changes 
similar to cAMP. Smooth muscle actin-myosin interaction is regulated 
through enzymatic phosphorylation or dephosphorylation of a 20,000 dalton 
myosin light chain. The phosphorylation occurs through the action of 
myosin light chain kinase, an enzyme activated by CA^. Uterine 
contractions during pregnancy in domestic animals may be initiated by 
increased intracellular Ca in myometrial smooth muscles and by gap 
junction formations. 
The factors which cause changes in calcium and gap junctions are 
unknown. However, hormones which influence smooth muscle activity act on 
mechanisms that regulate intracellular calcium concentration (Huszar, 
1981). Oxytocin lowers the threshold potential for initiation of action 
potential as well as affects the rate of calcium ion influx. PGFg^ acts 
to liberate Ga^ from intracellular sites as well as causes a slow 
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membrane depolarization that increases the frequency of bursts of action 
potentials and phasic contractions (Liggins, 1979). In vitro treatment 
of rat myometrial cells with oxytocin decreases mean cell length and 
area; however, relaxin treatment of these oxytocin-treated cells resulted 
in a significant increase in cell length and area within a minute. 
Relaxin also elicits a concentration-dependent increase in cell length 
and area (Hsu and Sanborn, 1986a). In the pig and sheep, increased 
myosin activity is dependent on decreased progesterone and increased 
estrogen (Forsling et al., 1979; Garfield et al., 1980b). The release of 
oxytocin seems to be related to decreased progesterone and elevated 
estrogens in the pig. Oxytocin has no effect on gap junction formation; 
however, inhibitors of RNÂ, or protein synthesis, prevent gap formation 
(Garfield et al., 1980a). Relaxin has a direct effect on myometrial cell 
myosin light chain kinase (MLCK) activity by Increasing the of the 
enzyme for calmodullin from 11 to 38 M. Thus, relaxin is able to 
decrease the activity of MLCK significantly within a minute by decreasing 
the affinity of the enzyme for myosin (Hsu and Sanborn. 1986b). This may 
be due to phosphorylation of MLCK, thereby promoting uterine relaxation. 
It has been proposed that steroid hormones regulate synthesis of gap 
junction protein connexine and that gap junction assembly may be 
dependent on connexine crosslinking by PGF^^» Gap junction also is 
regulated by cAMP and calcium (Garfield et al., 1980b). 
Relaxin plays a vital role in prepartum inhibition of myometrial 
activity, though this effect can usually be overridden by PGF^g^ and 
oxytocin (Porter, 1984; Porter and Watts, 1986). Relaxin has a profound 
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effect on the pregnant uterus by rendering it quiescent during pregnancy. 
Exogenous relaxin inhibits uterine contractility in the pig (Porter, 
1984; Porter and Watts, 1986), guinea pig (Porter, 1971; 1972), rat 
(Chamley et al., 1977), mouse, and hamster (Schwabe et al., 1978; Porter, 
1979). The effect of relaxin on uterine contractility is very rapid 
(Porter and Watts, 1986). Cross-circulation experiments demonstrated the 
presence of a myometrial inhibiting factor(s) with a more rapid effect 
than steroids in the blood of guinea pigs, rabbits and rats during 
pregnancy, coinciding with raising levels of relaxin in these species 
(Porter, 1971, 1984). Intravenous injection of porcine to ovariectomized 
nonpregnant mini pigs promptly rendered the uterus almost totally 
quiescent and the inhibition persisted for 2.5 h. Relaxin decreased the 
frequency of intrauterine pressure cycles (lUP) without affecting 
amplitude and uterine responsiveness to oxytocin. However, progesterone 
inhibition of myometrial activity took 0-24 h to exert its maximum effect 
by reducing both amplitude and frequency of lUP cycles as well as 
blocking uterile response to oxytocin (Porter and Watts ; 1986)= The 
interaction of relaxin, oxytocin and PGFg^ in inhibiting uterine 
myometrial activity may be Important in timing the onset of the events of 
prepartum labor (Porter, 1984). This is a very interesting possibility. 
In a series of elaborate experiments, suckling rats were used to 
demonstrate a dual effect of relaxin on mammary glands as well as on the 
central release of oxytocin. Relaxin reduces the sensitivity of the 
myoepithelium to exogenous oxytocin as well as centrally inhibiting 
oxytocin release. Although the mechanism by which oxytocin in the CNS is 
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affected by relaxin is unknown, it demonstrates the effects of relaxin on 
another target tissue (i.e., neural tissue) for the first time. 
In estrogen primed animals, relaxin induces extensive remodeling of 
the connective tissue by acting on fIbrocartllage of the symphysis pubis 
and cervix. There are three structural components of the mammalian 
cervix: smooth muscle, collagen and connective tissue. Connective 
tissue contains glycosamlnoglycans (dermatan sulfate and chondroltin-(2 
and 6)-sulfates and hyaluronic acids (Huszar, 1981). The major 
components of cartilage are; collagen fibers, proteoglycan aggregates 
and water (Lowther, 1981). During cervical ripening, flexibility 
increases while protein and collagen concentration decline due to a 
proteolytic digestion and subsequent elimination of soluble collagen 
peptides (Huszar, 1981). 
During pregnancy, dermatln and chondroitin sulfate bind tightly 
to collagen fibers and secure them in the cervical structure (Huszar 
et al., 1981). Hyaluronic acid is implicated in water retention 
capacity of the tissues (Huszar et al-. 1981)- The dense collagen 
framework and appreciated glycosamlnoglycans ensure that the cervix 
remains firm and closed. At the end of gestation, the E/P ratio, 
relaxin and other factors signal the disruption of collagen framework and 
the cervical matrix. This process is accomplished due to changes in 
collagen metabolism. Collagen degradation becomes more prominent as 
collagenase and other associated enzymes are activated. Secondly, 
cervical dermatln sulfate diminishes along with collagen and cervix 
becomes swollen due to Increased hyaluronic acid and water content. The 
15 
Increase in hyaluronic acid and water content account for the soft, 
fragile texture of the ripened cervix while the breakdown and loss of 
collagen and dermatin/chondroitin sulfate facilitate flexibility and 
distensibility (Huszar, 1980). The role of relaxin in these changes is 
supported by the fact that in nonpregnant estrogen primed animals 
(ovariectomized mice, rats, pigs, cows, and rhesus monkeys), relaxin 
administration induces histological, biochemical and biomechanical 
changes similar to normal cervical ripening (Steinetz et al., 1980). 
Relaxin on parturition 
Classically, the role of relaxin in parturition has been described 
in relation to its effects on the expansion of the birth canal. Very 
little is known about its role in the hormonal processes of parturition. 
However, recent research findings suggest that relaxin may be involved in 
aspects of parturition other than the relaxation of the birth canal. 
Intra-arterial infusion of relaxin to ovariectomized pregnant sows 
permitted to farrow, by withdrawal of progesterone replacement therapy, 
show arrested early uterine contractions. However, in spite of 
continuous infusion of relaxin, the inhibitory effects of the hormone 
were eventually overridden (Porter, 1984). Similarly, the high incidence 
of stillbirth in pigs associated with the artificial separation of the 
prepartum surge of relaxin from parturition and the observation that 
relaxin administered to ovariectomized progesterone-treated gilts 
resulted in increased live birth rates from 44 to 94% indicate that 
relaxin may be be essential for some other aspects of parturition 
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(Taverne, 1982; Nara et al., 1982). 
In cattle, three daily administrations of 1500 U of porcine relaxin 
intramuscularly were associated with earlier calving in some heifers as 
compared with saline treated controls (Perezgrovas and Anderson, 1982; 
Anderson et al., 1982). Similarly, intracervical administration of 
relaxin to women at term induced marked cervical dilatation as well as 
parturition (MacLennon et al., 1980). The role of relaxin in humans has 
been confusing, especially when related to levels of immunoreactive 
relaxin in the serum of pregnant women, which does not rise towards 
parturition. In fact, the levels of relaxin seem to decline toward 
parturition. From Intensive studies, we now know that although the 
levels of human relaxin the peripheral serum do not rise as parturition 
advances, there is evidence that the cervical accumulation of relaxin 
peaks coincident with parturition (Von Maillot et al., 1977). The human 
ovary, unlike the pig, is not the major source of relaxin. Instead, 
decidua and placenta play a prominent role in the synthesis of relaxin 
(Larkln et al,. 1983; Biga%zi et al:* 1980)= Thus * peripheral serum 
relaxin in humans does not reflect the changes in relaxin physiology. 
The role of accumulated relaxin becomes more important, particularly in 
view of the recent reports that relaxin acts on amniotic and chorionic 
cells, by inducing the release of proteolytic enzymes into the amniotic 
fluid. PA and collagenase are released from the amnion and chorionic 
cells in vitro (Bigazzl and Bryant-Greenwood, 1984). This local release 
of relaxin on extraembryonic membrane may be Important in causing their 
disintegration, resulting in a local rupture of these membranes. 
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Regulation of relaxin secretion 
The corpora lutea accumulate relaxin in dense cytoplasmic granules 
in lutein cells through pregnancy and after hysterectomy in the pig; the 
contents of these granules are released into peripheral blood just 
preceding parturition (Belt et al., 1971; Anderson et al., 1973; 1983). 
The mechanism regulating the release of relaxin from cytoplasmic granules 
is intriguing, but unresolved. It is thought that may be involved 
in the release of relaxin. PGFg^ has been implicated in some of the 
functions of relaxin, such as cervical softening at parturition and 
induces the regression of the corpora lutea (see Bazer and First, 1983). 
Luteolysis, whether induced by PGF^^ or naturally occurring, is 
accompanied by both luteal demise and release of relaxin. However, 
luteolysis is not a prerequisite for the release of relaxin from luteal 
cells. Nonluteolytic doses of PCF^^^ given to pregnant sows during late 
gestation independently induced the release of relaxin without luteolysis 
(Nara et al., 1982). Thus, the release of relaxin may not be dependent 
on luteolysis. The effects of PGF„ on ovarian release of relaxin mieht 
^cx ~ 
result from indirect effects of oxytocin (Ellendorff et al., 1979; First 
et al., 1982). Oxytocin causes the release of PGFg^^ as well as being 
involved in cervical distension. 
Relaxin release prior to parturition in sows can be inhibited by 
indomethacin (FG synthesis inhibitor) for 2 to 4 days after termination 
of indomethacin treatment (Sherwood et al., 1979). This may imply that 
the prepartum release of relaxin depends upon endogenous release of PG. 
However, using another PG synthesis inhibitor (meclafenamic acid, MFA), 
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it was shown that relaxin surges in the peripheral blood in late pregnant 
sows occur in the absence of PG synthesis. Continuous administration of 
MFÂ delays the decline in progesterone, the relaxin surge release and 
farrowing; however, these events eventually occurred in the absence of 
increased endogenous PG (Bryant-Greenwood et al., 1982). Thus, it would 
seem that the endogenous rise in blood levels of relaxin relates more to 
luteolysis than an endogenous increase in PG. However, the timed release 
of relaxin in both mated and hysterectomized pigs would suggest that 
these events may be under a genetic memory (Anderson et al., 1983; Felder 
et al., 1985). The role of PG cannot be discounted, PGF^^ (1 yg/ml) and 
LH (0.25 ijg/ml) induced more relaxin in cultured follicle wall by 23 h 
with maximal by 47 h before declining (Bryant-Greenwood et al., 1980). 
Similarly, there is a rapid 5— to 7-fold increase in uterine relaxin in 
guinea pigs (ovariectomized estrogen-progesterone treated) in response to 
PGFg^ (0.5 ug). Thus, PGF^^ is a potent and direct releasing substance 
for relaxin from corpora lutea as well as nonluteal sources (Bryant-
Greenwood, 1982). 
Hormonal regulation and maintenance of homeostasis require that 
there be receptors specific for the hormone at its target tissues. 
131 Zarrow and McClintock (1966) used 1-labeled gamma globulin iodinated 
from rabbit antiserum prepared against a porcine relaxin extract to 
explore the distribution of relaxin in tissues of pregnant mice and rats. 
131 Their study showed that in pregnant mice accumulation of I occurred in 
the ovary and placenta, while in rats, accumulated relaxin was found in 
the ovary, placenta, cervix, mammary gland, but not the pregnant uterus. 
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Thus, the changes in uterine accumulation of radioactive isolated 
antirelaxin gamma globulin cannot be correlated with the rise in serum 
levels of relaxin in this species (O'Byrne and Steinetz, 1976)• 
Comparative analysis of changes in relaxin receptor in rat myometrial and 
plasma levels Indicate that maximal receptor populations occur between 
days 17 to 19 (Sherwood et al., 1980; Mercado-Simmen et al., 1981). 
There is a continuous rise in endogenous relaxin between day 19-21, a 
period during which relaxin receptors are decreasing. This may indicate 
that relaxin regulates its own receptor population beyond day 19 while it 
induces receptor formation between days 13 and 17 (Bryant-Greenwood et 
al., 1982). Subsequent studies have confirmed that in rat relaxin can 
down regulate its own receptor population (Mercado-Simmen et al., 
1982). 
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McMurtry et al. (1978) have studied the binding of [ I]-iodo-
succinylated porcine relaxin to homogenates of mouse and guinea pig pubic 
symphysis, rat and mouse uterine tissue, late pregnant rat mammary gland 
extract and a guinea pig cervix homogenate. The binding was temperature. 
pH and time dependent and could be prevented by addition of unlabeled 
relaxin to the incubation medium. Insulin and epidermal growth factor, 
two structurally related hormones, did not displace the radio-iodinated 
relaxin; neither did estrogen priming, which is necessary for the 
biological actions of relaxin on the pubic symphysis and uterus did not 
affect the binding of the labeled hormone to these tissues. McMurtry et 
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al. (1978) investigated the binding of [ I]—iodo-succinylated porcine 
relaxin to fibroblasts Isolated from mouse pubic symphysis and from human 
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skin. Again the binding was time, pH and temperature dependent and the 
labeled hormone was degraded at 37°C in the presence of cells from either 
source. The binding was inhibited by excess unlabeled relaxin but not by 
other hormones including insulin and epidermal growth factor. Addition 
of relaxin to cultures of fibroblasts also was associated with increased 
cell replication. 
Hormonal mechanism of bovine parturition 
The length of the gestation period in cattle ranges from 270 to 292 
days. The juration depends upon the number, breed and sex of the fetuses 
in the uterus (Guilbaut et al., 1985). Twins cause gestations to be.3 to 
6 days shorter than a single birth, and male calves are carried 1 or 2 
days longer than female calves (Jainudeen and Hafez, 1980). Parturition 
can occur within a few hours or as long as a day after the animal becomes 
restless. The first stage of labor lasts 2 to 6 hours. The period of 
delivery is approximately 30 to 40 minutes after which the placenta is 
dropped between 2 to 6 hours, although retention of it for as long as 12 
hours is considered normal (Bazer and First, 1983). 
In the cow, as in all farm animals, the parturition is thought to be 
initiated by the fetus. The mechanism of bovine parturition, 
particularly that relating to the role of the fetal adrenal glands 
interaction with estrogens, progesterone and producing systems, 
have not been completely elucidated. The final hormonal changes 
associated with parturition are related to the final maturation of the 
fetus, termination of the pregnancy, expansion of the birth canal. 
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initiation of uterine contractions, maternal behavior synthesis and the 
ability to secrete milk (Bazer and First, 1983). In cattle, sheep, goats 
and pigs, activation of the fetal pituitary-adreal axis at term seems to 
be critical for the initiation of parturition (Bazer and First, 1983; 
Thorburn and Challls, 1979). This is supported by the findings that 
parturition is absent in fetuses with congenital pituitary defects or 
after ablation of the fetal pituitary gland (First, 1979). In sheep, 
parturition has been induced after administering adrenocorticotropic 
hormone (ACTH) replacement after fetal hypophysectomy (Jones et al., 
1978), thus suggesting that the essential pituitary product is ACTH. 
ACTH from the fetal pituitary acts on the fetal adrenals to induce both 
growth and a change in adrenal steroid secretion from other steroids to 
the production of Cortisol (Gllckman and Challls, 1980; Lohse and First, 
1981; Lohse and Nara, 1982; Rose et al., 1982). 
In the fetal calf, circulating blood levels of Cortisol Increase 
during the last week of gestation (Comllne et al., 1974). Maternal 
plasma -shows corresponding increases in estrogens just before calving 
(Dobson and Dean, 1974; Comline et al., 1974), while the levels of 
androgens which are the precursors to estrogen, remain relatively 
constant (MSstl et al., 1981). Increasing levels of Cortisol cause an 
elevation of PGFg^ which is presumed to cause the regression of the 
corpora lutea, but the means by which this is accomplished are unknown 
3 (First et al., 1982). The bovine placenta metabolizes [ H]-pregne/nolone 
3 
to [ H] estrogens (Evans and Wagner, 1981). In addition, there is an 
Increase in the amount of 17a-hydroxylase in vitro in bovine placenta 
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after exposure to endogenous or synthetic glucocorticoids in vivo (Flint 
et al., 1979-). Increasing maternal concentrations of estrogen occur in 
response to fetal Cortisol, but increase in maternal PGFgg are in 
response to estrogens. The mechanism of parturition in cattle, though 
not fully understood, may involve estrogens, progesterone, oxytocin and 
PGF-producing systems. Endogenous release of PGF^^ is the final trigger 
in the complex series of events that finally lead to luteolysis which 
coincides with the decline in progesterone in peripheral blood 
circulation. In cattle, the corpus luteum is required for maintenance of 
pregnancy and progesterone produced by it must be terminated for 
parturition to occur (First, 1979; First et al., 1982). Although the 
demise of the corpora lutea and in particular the decrease in 
progesterone levels are essential for parturition, current data would 
suggest that peripheral plasma levels of progesterone are not adequate 
for the exact monitoring of the bovine luteal function at parturition. 
The levels of progesterone in ovariectomized-pregnant cows and in normal 
pregnant cows at ters are similarj while jugular venous blood 
concentrations of progesterone are greater than in ovarian venous blood 
(Hoffmann et al., 1979). Progesterone from body stores may account for 
this apparent discrepancy. Body fat stores up to 500 ng/g (Hoffmann et 
al., 1977; Schmidt et al., 1977). 
Induction of parturition 
Under certain conditions, pharmacological induction of early calving 
is desirable if not essential. The practicality of early induced calving 
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depends upon- when the induction is performed. Usually best results are 
obtained when heifers are induced to calve not earlier than 14 days 
before term. The normal duration of gestation is 270-292 days, depending 
upon the number, breed, and sex of the fetus (Jainudeen and Hafez, 1980). 
Parturition is usually induced in cattle by use of prostaglandins or 
glucocorticoids. Corticoid dexamethasone (Day, 1977; Davis et al., 
1979), dexamethasone trimethyl acetate (Welch et al., 1977; 1979), 
flumethasone (Davis et al., 1979) and betamethasone (Diskin, 1982); 
prostaglandins; tham salt of (Lauderdale, 1975; Henricks et al., 
1977; Diskin, 1982); PGFg^ analogue cloprostenol (Johnson, 1981), and 
estrogens (Henricks et al., 1977). Dexamethasone administered im (20 mg 
between days 260-284) induced calving within 72 hours with a mean of 52 + 
10 hours for primiparous heifers and 44.5 + 8.6 hours for multiparous 
cows (Adams, 1969; Davis et al., 1979). Prostaglandin (30 mg PGFg^ 
tham salt in 2 ml 0.9% saline) administered on day 267 induced calving 
within 90 ± 17 hours. For heifers treated on days 273 and 284, the 
interval between treatment and calving was 51=42 ± 19=23 and 43;71 ± 
10.41 hours, respectively (Henricks et al., 1977; Plenderleith, 197 8). 
Cloprostenol administration between days 250-255, 260-265, 270-275 and 
280 induced parturition at 114.66 ± 57.76, 49 ± 1.41, 35 ± 7.25 and 29.33 
± 1.5 hours, respectively (Johnson and Jackson, 1982). 
The major limitation in the use of glucocorticoids, and PGFg^ and 
PGF analogues has been to the high incidence of dystocia and retained 
placenta which usually accompany these inductions of parturition (Wagner 
et al., 1974; Henricks et al., 1977; Welch et al., 1977; 1979). 
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Induction of- parturition with dexamethasone often results in 83-95% and 
52-90% retained placenta for first- and second-term heifers, respectively 
(Adams, 1969; Davis et al., 1979). PGFg^ treatment similarly results in 
83.3% retained placenta, 50% dystora, 41.66% abnormal presentation and 
25% calf mortality (Henricks et al., 1977; Plenderleith, 1978). The use 
of PGFg^ analog, cloprostenol, produced similar results in cattle. 
Estrogens administered with dexamethasone or PGFgg to combat the high 
incidence of retained placenta and dystocia have not been completely 
satisfactory (Henricks et al., 1977; Davis et al., 1979). Henricks et 
al. (1977) administered PCFg^ in combination with estradiol benzoate (400 
mg daily from day 270 to calving). The mean gestation was 273 ± 1.1 
days, 138 ± 28 hours from PGF^^ treatment to calving, 71.43% retained 
placenta, 57% dystocia, 28% abnormal presentation and 28.5% calf 
mortality. Neither has the practice of priming with a long acting 
glucocorticoid and inducing parturition with short glucocorticoids been 
any more successful in alleviating the incidence of dystocia and retained 
placenta (Davis et al=; 1979)= Calving difficulties and retained 
placenta associated with early induced calving invariably limit the large 
scale application of glucocorticoids and prostaglandins for inducing 
calving. 
The bovine pelvis and parturition 
The bovine pelvic girdle (bony pelvis) is composed of the ossa 
coxarum, the sacrum and the first three coccygeal (caudal) vertebrae 
(Habel, 1980). The ventral wall of the bovine pelvis is formed by the 
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pubic and ischial bones while Che lateral walls are formed by the ilia 
and acetabular part of the ischia. The dorsal wall of the pelvic girdle 
is formed by the three caudal bones (Getty, 1980). The pelvic inlet is 
bounded by the terminal line or brim which is composed of the base of the 
sacrum dorsally, the ilio-pectineal (arcuate) lines laterally and pecten 
of the pubis ventrally. The pelvic inlet has two diameters. Â conjugate 
diameter or the sacro-pubic diameter, which is measured from the sacral 
promontory to the cranial end of the symphysis pubis (tuberculum 
pubicum). The second diameter of^ the pelvic inlet is the transverse 
diameter which is measured from the greatest width, just above the psaos 
minor tubercle. In the cow of medium size, the conjugate diameter is 
22.5-25 cm and the transverse diameter is 18-20 cm (Habel, 1980). 
The caudal pelvic outlet is much smaller than the pelvic inlet, and 
it is incomplete in bone. The pelvic outlet is bounded dorsally by the 
third coccygeal vertebra, ventrally by the ischial arch and in the fresh 
state it is completed on the lateral side by the broad sacro-tuberous 
ligaments and the semimembranosus muscles which enclose the peritoneum 
(Getty, 1980). The expansion of the pelvic canal or more specifically 
the pelvic outlet is crucial to parturition, and it is directly related 
to the ease of calving and incidence of dystocia. The opening of the 
pelvic outlet and the total area it compasses is determined by measuring 
the height and width of the pelvis at the outlet. The height of the 
pelvis is determined by measuring the linear distance from the midpoint 
of the dorsal surface of the symphysis pubis to the prominent junction of 
the third and fourth sacral vertebrae. The width of the pelvis is 
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determined as the greatest linear distance between the depression points 
in the bodies of the ilia at right angles to the vertical measurement 
(Rice and Wiltbank, 1972; Perezgrovas and Anderson, 1982). 
The integrity of the pelvic girdle is maintained by several pelvic 
ligaments. The dorsal sacroiliac ligaments attach to the tuber sacrale 
and to the summits of the sacral spines. The lateral sacro-iliac 
ligaments are a triangular, thick sheet which is attached to tuber 
sacrale and the adjacent parts of the medial border of the ilium above 
the major ischiatic notch and below to the lateral border of the sacrum. 
This ligament also blends with the dorsal sacro-iliac ligaments. The 
broad sacro-tuberous ligaments are very extensive quadralateral sheet 
which completes the lateral wall of the pelvic cavity. The dorsal border 
of the sacro-tuberous ligament is attached to the border of the sacrum 
and the transverse processes of the 1-2 caudal vertebrae. The ventral 
border of the broad sacro-tuberous ligaments is attached to the spine and 
to the tuber ischii. The ventral border of the sacro-tuberous ligaments 
fuses with the semimembranosus, this ligament thus completing the minor 
ischiatic foramen and the major ischiatic foramen. The last of the 
ligaments of the pelvic girdle is the iliolumbar ligament which has a 
triangular sheet that attaches at one end to the lumber transverse 
processes to the ventral surface of the ilium below the attachment of the 
longissimus muscle (Getty, 1980). 
The symphysis of the pelvis is formed at the junction of the two 
ossa coxarum at the ventral midline. In the young, these bones are 
united by a layer of cartilage (lamina fibrocartiliginea). In the adult. 
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the cartilage is gradually replaced by bone. The process by which the 
lamina fibrocartiliginea begins at the pubic end and extends caudally. 
Commonly, the ischial part of the symphysis is not fused. 
Calving difficulties in cattle 
Dystocia is a significant source of economic loss in the cattle 
industry in terms of calf loss as well as subsequent impaired 
reproductive performance. Calving difficulties in cattle are primarily 
related to the size of the calf at birth and the pelvic area of the dam. 
About 37% of the variability in dystocia score can be accounted for by 
the ratio of the calf birth weight to calf body length and pelvic area of 
the dam at 35 days postpartum (Price and Wiltbank, 1978). The most 
frequent birth-related problems in cattle are dystocia and retained 
placenta; about 6.4% of calves born die around the time of parturition 
(Bellows et al., 1969). An average of 75% of these deaths result from 
dystocia (Anderson and Bellows, 1967). There are several reasons for the 
incidence of dystocia such as: medical conditions (late abortions, 
hydrops, and monsters); hormonal; and the relationship of the calf birth 
weight to the pelvic area. 
Pelvic area 
Pelvic area is inversely related to the occurrence of dystocia in 
cattle (Bellows et al., 1969). Heifers with pelvic areas of less than 
200, 200'-229, and 230-269 cm^ have 69, 30 and 25% incidence of dystocia, 
respectively, in 2year-old heifers (Price and Wiltbank, 1978). The 
incidence of dystocia thus decreases as pelvic area increases. During 
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gestation, the pelvic area Increases linearly at the rate of 
2 
approximately 0.5 cm /day and then Increases during the last days before 
2 parturition (Rice and Wlltbank, 1972). Thus, an additional 20 cm of 
pelvic area Is required for each 4.5 kg Increase In calf birth weight. 
Large frame size heifers In general have larger pelvic openings. 
The pelvic area before parturition Is highly and significantly correlated 
with hip width (0.47), rump length (0.48) and body weight (0.54) In 
three-year-old heifers (Bellows et al., 1971). These correlations are 
variable. The correlation of body weight and pelvic area of 0.56, 0.50 
and 0.66 in three groups of Angus and Hereford heifers (Jones et al., 
1974). 
The influence of breed of dam on pelvic area has not been well-
documented. A significant breed effect on pelvic dimension exists, but 
little difference in dystocia rate of the pelvis up to 365 days of age 
was reported in Angus, Brahman, Charolals, Hereford and Santa Gertrudis 
cows (Fltzhugh et al., 1972). Pelvic conformation (PA/PW) was least for 
Brahman-based breed and highest for Kcrsford, Charclais crosses at 365 
days and at primlparity (Price and Wlltbank, 1978). The ratio of PW/PA 
and PH/Heifer body weight decreases from weaning to primlparity, 
suggesting that heifers matured earlier for the pelvic measurements than 
for body weight (Lesmelster et al., 1972; Fltzhugh et al., 1972). 
The age of the cow accounts for a large part of the variation in the 
pelvic area. Pelvic area in 2-year-old primiparous heifers was reported 
2 to be 42 cm smaller than in three-year-old heifers of the same breed 
(Price and Wlltbank, 1978). The partial regression coefficient of weight 
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and age on pelvic area is 0.36 cm /kg and 0.10 cm /day, respectively. 
This would suggest that growth is more dependent on frame size; i.e., 
body weight, than age (Jones et al., 1974). 
Calf birth weight 
The birth weight of the calf is an index of the calf size. Calf 
growth rates are maximal by day 230 of gestation and gradually decrease 
until parturition (Price and Wiltbank, 1978). The effect of birth weight 
and the incidence of dystocia are highly correlated (Price and Wiltbank, 
1978) with a correlation of 0.44 (Rice and Wiltbank, 1972). The 
incidence of dystocia increases by 2.3 4- 0.21% for each additional 
kilogram increase in birth weight of the dam; this effect of age is 
dependent upon the age of the dam (Laster et al., 1973). The incidence 
of dystocia increased 3.3 ± .34, 1.5 ± .35, 0.9 ± 0.42 and 5 ± 0.31% per 
each kg increase in the calf birth weight for 2, 3, 4, and >5 years cows, 
respectively (Laster et al., 1973; Sagebiel et al., 1969; Nelson and 
Huber, 1971). The calf size is influenced by genetic factors such as 
sex, length of gestation, breed, heterosis, inbreeding and the genotype 
(Price and Wiltbank, 1978). Some genetic factors also contribute 
significantly to calf size* These factors include age and parity of the 
dam as well as nutrition of the dam during gestation (Price and Wiltbank, 
1978). 
Sex of calf 
The average birth weight of male calves is consistently larger than 
females, an average of 4=5 pounds heavier (Laster et al., 1973; Nelson 
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and Ruber, 1971; Wilson, 1973). The differences in the birth weight 
between male and female also are associated with a higher incidence of 
dystocia in cows carrying male calves than those carrying female calves. 
The increase in dystocia rate in male-calf-carrying dams is greater in 
younger dams and in sire breeds which are heavier (Smith et al., 1976; 
Nelson and Ruber, 1971). The sex of the calf also influences other 
parameters. The male has a larger cannon bone circumference (5.6%), more 
rump (3.8%), and longer bodies (2.2%) than female heifers (Wilson, 1973). 
The birth weight is highly correlated with head circumference (0.58), 
heart girth (0.82), hook width (0.80), rump length (0.70), body length 
(0.63) and cannon bone length (0.61) (Wilson, 1973). 
Age and parity of dam 
There is a negative correlation between age and parity of the dam 
and calf birth size (Price and Wiltbank, 1978). About 5.9 and 5.7% of 
the total variation in birth weight of Hereford and Angus, respectively, 
can be accounted for by the age component of the dam (Price and Wiltbank, 
1978). Partial correlation of birth weight on parity is significant in 
Angus (0.43) and shorthorn (0.34). The birth weight in Angus cows 
increases to age 7 years and then declines slightly thereafter. The 
largest increase in calf birth weight occurs in first- and second-term 
heifers. The second largest increase in birth weight occurs from second 
to third birth. Associated with this increase in calf weight is an 
increase in dystocia of 29.7 and 10.5% in first— and second-term heifers 
(Price and Wiltbank, 1978). 
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The length of gestation 
The birth weight of the calf is positively correlated (0.15-0.57) 
with the duration of gestation, k similar relationship exists between 
the sex of the calf and the duration of gestation. Generally, males have 
a longer gestation period (0.9 ±0.7 days) than females (Price and 
Wiltbank, 1978). The length of gestation is primarily a function of 
genotype. The source variation in gestation has been partitioned as: 
calf genotype, 48%; calf sex, 28.6%; and maternal characteristic, 21% 
(Price and Wiltbank, 1978). A correlation of 0.09 between the length of 
gestation and dystocia is low and nonsignificant. However, this 
correlation depends upon breed; it is as low as 0.1 in the Angus and as 
high as 0.25 in Hereford dams (Price and Wiltbank, 1978). 
The breed contribution of dystocia 
The breed of the sire has a prominent effect on birth weight, 
dystocia and calf mortality. Angus and Hereford cows' calves sired by 
Charolais, Simmental, Limousin and South Devon bulls were found to be 
heavier at birth and caused more dystocia (PCO.Ol) than calves sired by 
Jersey, Hereford and Angus bulls (Laster et al., 1973). Similarly, the 
breed of the dam has been shown to significantly affect calf birth weight 
and dystocia (Sagebiel et al., 1974; Thomas and Cartwright, 1971). 
Heterosis and inbreeding effect 
Heterosis contributes to calf birth weight (Bredahl, 1971). In 
Brahman Hereford crosses, the birth weight of the calf varied 
considerably with the heterosis: 10.8% for first cross calves, 5.5% for 
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second cross calves, and 8*2% of backcross calves from purebred cows and 
2.0% for F2 calves (Ellis et al., 1965). Heterosis also increased birth 
weight in Brahman, Santa Gertrudis and Criolla calves by 4.8%. The 
measurement of the overall effect of heterosis on dystocia is variable. 
Equal dystocia rates were found among crossbred and straightbreed calves 
from Hereford and Angus (Laster et al., 1973). Some reports indicate a 
decrease of about 4% in the same breeds (Smith et al., 1976). 
Inbreeding at high levels decreases birth weights significantly and 
increases dystocia (Bovard et al., 1972). For each 1% increase in 
inbreeding, there is 0.28 lb reduction in birth weight. Moderate 
inbreeding (1-30%) reduces, while high levels of inbreeding (31-46%) 
increases, the rate of dystocia in cattle (Bovard et al., 1972; Brinks et 
al., 1973). 
Nutrition and environmental factors 
The environmental factors that contribute to variation on birth 
weight directly affect the incidence of dystocia in cattle. These 
factors include: prepartum nutrition level of the dam (Corah et al., 
1975), geographical location and heat stress (Collier et al., 1982). The 
energy levels in the diets of pregnant cows before parturition can 
significantly influence the fetal size and perinatal mortality. Dietary 
supplementation has a greater effect on birth weight. There is also a 
negative correlation between the body weight of the cow prior to calving 
and pelvic area (Bellows et al., 1971). Calf birth weight is positively 
correlated with the dam's weight throughout gestation (Bellows et al.. 
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1971)* The dystocia rate tends to Increase with increasing ratio of calf 
weight and dam weight (Price and Wiltbank, 1978). 
Explanation of Dissertation Format 
This dissertation has been written in accordance with the 
specifications for the alternative dissertation format outlined in I.S.U. 
Graduate College Manual (1985). The dissertation has been divided into 
five sections representing various research efforts between 1984 and 
1986. The first two sections were completed in 1984 and during the 
interim were written and presented at scientific meetings in 1985. 
Sections I and II were written in the style of Biology of Reproduction 
and Endocrinology. to be published in March and April of 1986, 
respectively. The form in which they are presented in the dissertation 
has been modified due to the need to maintain uniformity of style 
throughout the dissertation. Thus, all sections have been written in the 
style of Biology of Reproduction in accordance with the requirements of 
the thesis office. 
Supplemental materials which could not be included in the scientific 
journals but which nevertheless are important have been presented in 
Appendices A-E. 
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SECTION I. PELVIC DEVELOPMENT AS AFFECTED 
GENETICALLY SELECTED FRAME SIZES OF 
BY RELAXIN IN THREE 
BEEF HEIFERS 
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ABSTRACT 
Purified porcine relaxin was administered into the cervical os on 
Day 278 of gestation to determine its effects on pelvic development in 
three genetically selected frame sizes of primlparous beef heifers. 
Heifers were categorized as small, medium and large frame based upon 
their genetic composition. Pelvic height, pelvic width and cervical 
dilatation were determined from Day 270 to 2 days postpartum. On Day 
270, heifers were assigned at random to one of three treatments: vehicle 
control, n= 16 (relaxin once (3,000 w), n = 14 and relaxin twice (2 
times 3,000 y 72 h apart), n = 17. Each heifer-frame size was 
represented in each treatment. Relaxin caused marked increases in pelvic 
height and width, as well as in the rate of linear increase (cm/day) of 
these parameters (p<0.05). These linear increases in pelvic height were 
510, 264 and 204%, and pelvic width, were 280, 213, and 204% of the 
respective pretreatment rates for small, medium and large heifers. The 
rate of linear increase in pelvic width was greater than pelvic height in 
all heifers, but maximal in small-frame heifers; relaxin attenuated these 
intrinsic differences. For small heifers, the rate of linear increase in 
pelvic width was 121 and 145% of Increases for medium and large heifers, 
respectively, before treatment, and 160 and 200% after treatment. The 
rate of postpartum involution of pelvic width was -0.03, -0.36 and -0.50 
cm/day and, for pelvic height, -0.02, -0.27 and -0.29 cm/day in small, 
medium and large heifers, respectively. Changes in cervical dilatation 
were unrelated to frame size of heifers (p>0.05). We conclude from this 
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study that relaxln induces different patterns of growth for pelvic width 
and pelvic height among three markedly different frame sizes of beef 
heifers. Relaxin then has a potential for alleviating calving 
difficulties as a result of insufficient or inadequate growth of the 
pelvic (birth) canal in beef heifers. 
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INTRODUCTION 
Relaxln inhibits uterine contractions in the sow, rat and guinea pig 
and induces interpubic ligament formation in the mouse, rat and guinea 
pig (Schwabe et al., 1978; Porter, 1979; 1984). Relaxin also induces 
cervical softening in the rat, guinea pig, pig, cow and human (MacLennan 
et al., 1980; Steinetz et al., 1980; Perezgrovas and Anderson, 1982). 
This hormone may be associated with relaxation of the symphysis pubis and 
sacroiliac joints in some species (Schwabe et al., 1978; Porter, 1979; 
1985). The corpora lutea of the pig are a rich source of relaxin, 
particularly during late pregnancy (Anderson et al., 1973; 1982; 1983; 
Sherwood et al., 1975). The ease of normal parturition usually observed 
in the sow may result from increasing blood concentrations of relaxin 
during the last days of pregnancy, as well as the peak release of the 
hormone immediately preceding parturition (Belt et al., 1971; Sherwood et 
al., 1975). The injection of porcine relaxin during late pregnancy 
increases the rate of growth in pelvic width and height, as well as 
cervical dilatation in gilts (Kertiles and Anderson, 1979) and heifers 
(Perezgrovas and Anderson, 1982; Anderson et al., 1982). 
Insufficient dilatation of the pelvic (birth) canal results in calv­
ing difficulties (dystocia). When pelvic area in beef heifers increases 
2 
normally from 200 to 250 cm , the incidence of dystocia is low (Rice and 
Wiltbank, 1972). During gestation, the pelvis grows linearly at about 
0.5 cm /day. There may be a slight but nonsignificant increase in the 
rate of growth of the pelvis during the last 4 days before parturition 
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(Rice and Wiltbank, 1972; Price and Wlltbank, 1978). Heifers from breeds 
with small frames carrying large calves are exposed to an Increased 
Incidence of dystocia. Although relaxln causes cervical dilatation and 
pelvic expansion In cattle, there Is no Information on the growth of 
pelvic height and width In heifers with genetically different frame sizes 
In response to relaxln. The objective to this study was to determine the 
effects of relaxln on pelvic development among beef heifers genetically 
selected for body size. 
MATERIALS AND METHODS 
Forty-seven crossbred beef heifers approaching their first calving 
were used in this study. All heifers were bred by artificial 
insemination at estrus (Day 0); pregnancy lasted approximately 283 days. 
Heifers calved at an average age of 25 ± 1 mo (± SE). The animals were 
categorized by genetic selection as small, medium and large. Cattle used 
in this study are from a long-term breeding project designed to 
synthesize breeds of beef cattle of different sizes for studies in the 
physiology of growth and reproduction. For the production of the heifers 
used in this study, the breed contribution of sires was 0.25 Jersey and 
0.25 Angus for the small frame; 0.125 Jersey, 0.125 Angus and 0.25 
Simmental for the medium frame; and 0.25 Angus and 0.25 Simmental for the 
large frame. Breed and breed-error cows of 10 breeds (Jersey, Angus, 
Simmental, Hereford, Holstein, Brown Swiss, Charolais, Shorthorn, 
Limousin and Maine-Anjou) were used to initiate the project in 1977. 
These cows were phenotyplcally divided into size groups. A significant 
difference (p<0.05) now exists among frame sizes with regard to adjusted 
yearling body weight, yearling hip height and pelvic canal area of the 
progeny from this crossbreeding program. Heifers had free access to hay 
and water throughout gestation. The hay was supplemented by mixed silage 
(6.8 kg/animal/day) during the winter months. A week before calving, 
corn (2.3 kg/animal/day) and mixed silage (9.0 kg/animal/day) were fed in 
addition to the ad libitum supply of hay. 
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Experimental Groups 
The experimental design is presented in Figure 1. Beginning on Day 
273 of gestation, the animals were assigned randomly to one of three main 
treatment groups: controls (gel-vehicle), n » 16; relaxln-slngle, n = 
14; and relaxin-double, n » 17. Each main treatment group was subdivided 
into three groups classified as small, medium and large heifers. Pelvic 
-height and width and cervical dilatation were measured daily, except on 
the treatment and calving days when the parameters were measured at 0800 
and 2000 h for 48 h. 
Intracervical Infusion of Relaxln or Placebo 
Purified porcine relaxln (3,000 U/mg; Schwabe and McDonald, 1977; 
Schwabe et al., 1978; BUllesbach and Schwabe, 1985) was suspended in 1 ml 
of placebo vehicle prepared by mixing sterile gel (KY-4, Johnson and 
Johnson, Inc., New Brunswick, NJ) and 0.01 M phosphate-buffered saline, 
pH 7.0 (1:1, v:v). On Day 278, 1 ml (3,000 U) of relaxln in placebo was 
deposited 4 cm into the cervical os. In heifers given relaxin-double, 
the first administration of the hormone was at 0800 h, and the second at 
2000 h (2 times 3,000 U). The relaxln or placebo was administered with a 
sterile insemination pipette. A gloved hand was inserted in the repro­
ductive tract (vulva and vagina) of the heifer to guide the pipette into 
the cervical sphincter. This approach facilitated precise placement of 
relaxln, gel-vehicle and the cervical probe in the cervix, and minimized 
variations in site of deposition. Repeatable cervical measurements were 
obtained by intravaginally placing the probe at the same reference point 
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Sequence of Measuring Pelvic Dimensions 
Figure 1. A description of the experimental groups Indicating the day 
of treatment and sequence of measuring pelvic dimensions 
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in the cervical os of each heifer. 
The dilatation of the cervix was measured intravaginally by using a 
special stainless steel probe (Perezgrovas and Anderson, 1982). The 
pelvic area was calculated from determinations of pelvic height and width 
using a pelvimeter (Lane Manufacturing, Inc., Denver, CO). Pelvic height 
was determined, by measuring the linear distance from the approximate 
midpoint of the dorsal surface of the symphysis pubis to the ventral 
surface of the prominent junction of the third and fourth sacral 
vertebrae (Rice and Wiltbank, 1972; Perezgrovas and Anderson, 1982). The 
pelvic width was determined by measuring the greatest linear distance 
between the depression points in the shafts (bodies) of the ilia at right 
angles to the vertical measurements. The area was obtained by 
multiplying the height and width of the pelvis. 
Statistical Analysis of Data 
Experimental units in this study were the individual heifers, which 
were assigned to the treatments at random. The data were analyzed by 
split-plot design using the general linear model and Student's t-test for 
comparisons between treatment groups (Blair et al., 1979; Snedecor and 
Cochran, 1980). 
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RESULTS 
Intracervlcal administration of relaxin induced pelvic expansion 
(dilatation) (p<0*001) but at different rates in genetically selected 
beef heifers of different frame sizes (Figure 2). Relaxin Increased not 
only the total pelvic area, pelvic width and pelvic height, but also the 
rate of linear Increase of these parameters as determined by linear 
regression coefficients (p<0*05; Tables 1 and 2, Figures 3 and 4). There 
was a highly significant (p<0*0001) interaction between the day of 
pregnancy, treatment and the frame size of the heifers during the period 
between treatment and calving. 
Table 1. Rate of change of pelvic width in beef heifers of different 
frame size 
Frame size 
of heifer 
Fretreatment 
B (cm) 
Post-treatment 
3 (cm) 
Postpartum 
6 (cm) 
Small 
Medium 
Large 
0.103+0.023^ 
0.085±0.025® 
0.071+0.025^ 
0.289±0.04g 
0.181±0.04C 
0,145±0,04 
-0.276±0.082^ 
-0.35710.082® 
-0=496±0=0S2 
*The values are pooled for size groups across all treatments and 
adjusted for number of each size in each group. 
^6 defines rate of linear increase for each parameter as cm/day. 
c—i Columns and rows with different superscripts are different 
(p<0.05). 
The linear increases in pelvic height and width in response to a 
single relaxin administration were least in small heifers as compared 
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Figure 2. The effect of relaxln-double (2 times 3000 U, 12 h apart), 
top: relaxln-single (3000 U); middle: and gel-vehicle; 
bottom: administration on pelvic growth in three geneti­
cally selected frame sizes of beef heifers: (a) large frame, 
(A) medium frame, and (•) small frame. Values are means ± 
SEM taken 0 ± 6 days (Day 0 • day of treatment) 
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Figure 3. The response of pelvic width to relaxin-double (2 times 3000 
U, 12 h apart), top: relaxin-single (3000 U); middle: and 
gel-vehicle; bottom: in (•) large-frame, (A) medium-frame 
and (•) small—frame beef heifers. Values are means ± SEM 
taken 0 ± 6 days (Day 0 » day of treatment) 
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Figure 4. The response of pelvic height to relaxln-double (2 times 
3000 U, 12 h apart), top: relaxin-slngle (3000 U); middle: 
and gel-vehicle; bottom: in (•) large-frame, (A) medium-
frame, and (•) small-frame beef heifers> Values are means ± 
SEM taken 0 ± days (Day 0 • day of treatment) 
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with medium and large heifers (p<0.05); however, the ordinal rankings of 
pelvic area, pelvic width and pelvic height were maintained after the 
treatment with relaxin or gel-vehicle to 2 days postpartum (Figures 3 and 
4). For large heifers, the linear increase in pelvic width was greater 
(p<0*05) than pelvic height in response to relaxin. There were no 
differences in the mean linear increases in pelvic width and height in 
response to a single relaxin administration in medium heifers (p>0.05). 
The linear Increases in pelvic width and height in response to relaxin 
administered once or twice were similar in medium and large heifers 
(p>0.05). In the small-frame heifers, however, a second administration 
of 3,000 U of relaxin 12 h after the first Induced significant (p<O.OS) 
increases in pelvic area, pelvic width and height. The mean linear 
increases in pelvic height in small heifers in response to the second 
administration of relaxin were comparable (p>0.05) to those in pelvic 
height in medium and large heifers given either one or two treatments of 
relaxin (Figure 4). 
The rates of linear increase (cm/day) in pelvic width after 
treatment but before calving were 280, 213 and 204% of the respective 
pretreatment rates for the small, medium and large heifers (Table 1). 
Before treatments, the rates of linear increase in pelvic width for small 
heifers were 121 and 145% of the respective pretreatment rates for the 
medium and large heifers. Relaxin increased these intrinsic differences 
within frame size of heifers (Tables 1 and 2). These rates of linear 
increase in pelvic width for small heifers are 160 and 200% of Che 
respective post-treatment rates for medium and large heifers 
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Table 2. Rate of pelvic height in beef heifers of different frame size^ 
Frame size 
of heifer Pretreatment Post-treatment Postpartum 
Small 
Medium 
Large 
0.05110.02^ 
0.061+0.02^ 
0.061+0.02^ 
0.26+0.035^ 
0.16±0.035® 
0.09+0.035^ 
-0.196±0.084g 
-0.266±0.084 
-0.293+-.084® 
*The values are pooled for size across all treatments and adjusted 
for numbers of each size in each treatment group. 
^ ^Columns and rows with different superscripts are different 
(p<0.05). 
(Table 1). 
During the post-treatment period, the rates of linear increase in 
pelvic height were greater (p<0.05) in small than in medium and large 
heifers (Table 2). Compared with the pretreatment rates, the changes in 
the rate of linear increase in pelvic height in response to relaxin were 
510, 264 and 147% for small, medium and large heifers, respectively. 
Although there were no significant differences (p>0-05) in the post-
treatment rates of linear increase in pelvic width and height in small 
heifers, the increase from pretreatment to post-treatment was greater 
(p<0.05) for pelvic height than width (281% vs. 51%). The rates of 
linear increase in pelvic width and height were similar (p>0.05) in 
medium as well as in large heifers during the post-treatment periods. 
The increase in pelvic height was 213% and pelvic width was 200% of the 
respective pretreatment rates during the period from treatment to calving 
in medium heifers. In large heifers, these increases in pelvic width and 
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height were 204 and 148% of the respective pretreatment rates during the 
post-treatment precalvlng period. During Involution In the postpartum 
period, pelvic height decreased slowly (p<0.05) as compared to pelvic 
width In all frame sizes of beef heifers (Tables 1 and 2). 
The correlation coefficients of heritable traits are presented in 
Table 3. Pelvic area, pelvic height and pelvic width were correlated 
with the adjusted yearling weight, body weight at Day 273 of gestation 
and the yearling hip height of the dam. The ratio of calf birth weight 
to the dam's body weight during late pregnancy was similar (p>0.05) among 
the different body frame sizes of beef heifers (Table 3). There was no 
occurrence of oversize newborn calves associated with any of the three 
frame sizes. In this study, there was no incidence of calving 
difficulties or retained placenta beyond 24 h in relaxin-treated heifers 
(0 of 31). However, 2 of 16 gel-vehicle-treated heifers experienced 
calving difficulties with retained placenta beyond 24 h. These relaxin-
treated heifers calved an average of 3 days earlier than the gel-vehicle 
treated controls. There was no relation between the head circumference 
and the degree of pelvic expansion or cervical dilatation (p>0.05) in 
these heifers. 
Table 3. Pelvic height, pelvic width, heifer body weight, ratio of calf birth weight to heifer 
body weight, and the correlation of pelvic area on pelvic height and width 
Pretreatm»nt 
Frame 
size 
Pelvic 
height® 
cm 
Pelvic 
width^ 
cm 
Heifer 
body weight, 
day 273 kg 
(mean±SE)C 
Yearling Ratio of 
hip calf birth 
height, cm weight to Pelvic 
(mean±SE)d heifer weight® height 
Correlation of 
pelvic area to 
Pelvic 
widthf 
Small 17.29° I6..75P 309±8.8® 274±3 .2V 0.112* 0.98? 0.98? 
Medium 17.90P 16.,85S 341±9.7t 298±4 .3" 0.115V U.882 0.90% 
Large 18.35q 17.04^ 376±8.3" 311±4 .8% 0.111* 0.89% 0.932 
All frame sizes 0.95 0.96 
Pooled standard error was 0.03 cm; columns with different superscripts differ (p<0.10). 
^Pooled standard error was 0,02 cm; columns with different superscripts differ (p<0.10). 
^Columns with different superscripts differ (p<0.05). The correlations of pelvic area to 
body weight and hip height were 0.38 and 0.64, respectively. These correlations are significant 
(P<0.01). 
^Columns with different superscripts differ (p<0.05). 
^Pooled standard error was 0.004; columns with different superscripts differ (p<0.10). 
p values for correlation were 0.0001; columns with different superscripts differ (p<0.10). 
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DISCUSSION 
Intracervical administration of relaxin during late pregnancy 
induced marked increases in cervical dilatation and expansion of the 
pelvic area in all frame sizes of beef heifers. The changes in these 
parameters, however, were different among the different frame sizes of 
heifers. The increase in pelvic area resulted from an accelerated rate 
of linear increase as well as total linear increase in both pelvic height 
and width. Calving difficulties usually occur in primiparous beef 
heifers calving at 2 yr of age. Thus, the rate of pelvic growth, 
measured as the rate of linear increase in pelvic parameters, is 
important in predicting whether the pelvic (birth) canal will be maximal 
at the time of parturition. This is particularly important when small-
frame heifers carry large fetuses as a result of crossbreeding with 
large-frame bulls. The endogenous rate of pelvic growth under such 
circumstances may not produce adequate pelvic opening at parturition. 
Although calf birth weight has been implicated as a primary cause of 
dystocia (calving difficulty), 37% of the variability score in dystocia 
can be attributed to the relationship between the calf birth weight and 
the pelvic opening (Rice and Wiltbank, 1972). This variability is 
greater in small heifers given glucocorticoids and prostaglandins to 
induce calving up to 10 days before the normal duration of gestation 
(Johnson and Jackson, 1982). This study indicates that relaxin 
administered to heifers during the last week before parturition increased 
the rate of pelvic growth as well as pelvic canal opening. In small— 
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frame heifers, the mean increase in pelvic height in response to two 
infusions of relaxin into the cervical os 12 h apart was similar to a 
single infusion of relaxin in medium- and large-frame beef heifers. 
The patterns of pelvic growth in response to relaxin are different 
among different frame sizes of beef heifers. These differences in pelvic 
area usually are attributed to pelvic height rather than width. The 
intrinsic genetic differences in pelvic height may be particularly 
important in predicting pelvic area. The rate of increase in pelvic 
height and width during the last week preceding parturition may be a 
useful indicator of the potential of the pelvic canal to expand and 
accommodate different sizes of fetuses. The results in the present study 
indicate that pelvic growth during the last 10 days before parturition 
can be modified by the intracervical administration of relaxin. Apart 
from modifying these pelvic parameters, the administration of relaxin at 
this time significantly reduces the duration of gestation by inducing 
earlier calving (Musah et al., 1985). The mean interval between the 
administration of relaxin or eel-vehicle and calving was 2.1. 2?5 and 5,3 
days for heifers given relaxin twice, once, and gel-vehicle, 
respectively. 
The mechanism of pelvic canal expansion in cattle is unknown. The 
pelvic canal may increase in area as a result of relaxation of sacroiliac 
ligaments (Rice and Wiltbank, 1972; Fields et al., 1981), formation of 
interpubic ligaments (Leitch et al., 1959), and modification of the pubic 
symphysis by structurally transforming symphysial cartilage and bone 
(Rice, 1969). The ratio of the birth weight of the calf to the weight of 
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the dam (F/M ratio) seems to be a major factor in determining whether or 
not an animal experiences a relaxation of the pelvic ligaments with 
formation of interpubic ligaments (Leitch et al., 1959). Usually, 
species with F/M ratios of greater than 5%, such as the guinea pig, show 
a marked prepartum separation of the pubic symphysis. In the present 
study, the average F/M ratios were more than 115 in all frame sizes of 
beef heifers, indicating that, in some of these heifers, a possible 
separation of the pubic symphysis could have occurred. The use of 
radiographic analysis in studying pelvic growth in heifers has 
demonstrated an increase in the interilial diameter and, in some heifers, 
widening of the pubic symphysis (Rice, 1969; Rice and Wiltbank, 1972). 
We conclude from this study that relaxin given intracervically a few 
days before expected parturition induces significant expansion of the 
pelvic canal. This relaxin treatment causes an increase in both the rate 
of linear Increase as well as absolute increase in pelvic height and 
pelvic width as compared with those parameters in gel-vehicle-treated 
controls. The growth in pelvic height and width differs markedly between 
different frame sizes of beef heifers. We suggest that the increase in 
pelvic dimensions in heifers may result not only from the relaxation of 
the pelvic ligaments but also from a remodeling of the pubic symphysis. 
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SECTION II. RELAXIN ON INDUCTION OF PARTURITION IN BEEF HEIFERS 
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ABSTRACT 
Purified porcine relaxln (3000 U/mg) was administered into the 
cervical os of primiparous beef heifers on Day 278 of gestation (-5 days 
before parturition normally occurs) to determine its effects on the 
induction of parturition, changes in progesterone, estrone (E^), 176-
estradiol (17B-E2), cervical dilatation, and pelvic relaxation. Heifers 
were assigned randomly to 1 of 3 treatments: relaxin-double (two 
infusions of 3000 U, 12 h apart; n « 17), relaxin-single (3000 U; n • 
14), and PBS-gel vehicle (n = 16)* Relaxln induced marked earlier 
calving (P<0.002) than PBS-gel vehicle. The intervals between the 
administration of relaxln or the PBS-gel vehicle and calving were 2.0, 
2.5, and 5.3 days for heifers given relaxin-double, relaxin-slngle, and 
PBS-gel vehicle, respectively. The duration of gestation was 
significantly reduced (P<0.002) in relaxln—treated heifers compared with 
that in control heifers. À precipitous decrease in progesterone (7.1 
ng/ml) occurred in peripheral blood plasma within 24 h after relaxln 
trsatzent. Coincident with a decline in levels of progesterone, and 
I76-E2 increased by 1700 and 400 pg/ml, respectively, an increase of 35% 
compared with the 12% increase in these steroids in control heifers. 
Mean deviations of cervical dilatation increased 643%, 526%, and 11% in 
heifers given relaxin-double, relaxin-slngle, and PBS-gel vehicle, 
respectively. Relaxln induced maximum pelvic opening between 12-36 h 
after treatment. Although relaxln Induced significantly earlier calving, 
there was no incidence (0 of 31 heifers) of retained placenta. We 
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conclude from this study that purified relaxin administered 
intracervlcally to prlmlparous beef heifers during late pregnancy Induced 
premature parturition. Marked shifts of progesterone, , ITg-Eg, pelvic 
canal expansion, and cervical relaxation reflect the premature 
parturition induced by relaxin. 
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INTRODUCTION 
Relaxin is a polypeptide with partial structural homology to insulin 
(Sherwood and 0'Byrne, 1974; Schwabe et al., 1976; Schwabe and McDonald, 
1977; Schwabe et al., 1977; Niall et al., 1977; Blundell and Humbel, 
1980)). Porcine relaxin is produced by the corpora lutea during 
pregnancy and after hysterectomy (Belt et al., 1971; Anderson et al., 
1973; Anderson et al., 1983). It also is produced by the human corpus 
luteum during the menstrual cycle as well as by the basal plate cells of 
the placenta and decidual cells (Fields and Larkin, 1981; Larkin et al., 
1983; O'Byrne et al., 1978; Bigazzi et al., 1980). During late 
pregnancy, bovine corpora lutea produce biologically active relaxin; 
however, the concentrations are markedly lower than those in pigs on the 
basis of inhibition of uterine contractility and homologous RIA for 
porcine relaxin (Anderson, 1982; Fields et al., 1980; Anderson et al., 
1982). Pelvic area increases gradually in cattle throughout gestation, 
then the rate increases during the last 4 days preceding normal 
parturition, which coincides with increasing blood concentrations of 17$-
estradiol (17B-Eg) and estrone (E^) (Fields et al., 1980; Anderson et 
al., 1982; Rice and Viltbank, 1972; Hoffmann et al., 1979; Anderson et 
al., 1979a; Bazer and First, 1983). Administration of porcine relaxin 
increases both pelvic area and cervical dilatation in beef heifers during 
late pregnancy (Perezgrovas and Anderson, 1982; Musah et al., 1985). The 
objectives of this study were to determine the effects of intracervical 
administration of purified porcine relaxin during late gestation in 
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cattle on the induction of parturition, cervical dilatation, and pelvic 
relaxation as well as plasma concentrations of , ITg-Eg, and 
progesterone. 
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MATERIALS AND METHODS 
Animals 
Forty-seven crossbred beef heifers approaching their first calving 
were used in this study. All heifers were bred by artificial 
insemination at estrus (day 0); pregnancy lasts approximately 283 days 
(SE-0.9). Heifers calved at an average age of 25 ± 1 months (±SE). 
Heifers were maintained under pasture conditions during the spring, 
summer, and fall throughout gestation. Mixed silage (6.8 kg/animal*day) 
supplemented the hay fed during the winter. During the month before 
calving, corn (2.3 kg/animal*day) and mixed silage (9.0 kg/animal«day) 
were fed in addition to the ad libitum supply of hay. 
Experimental Groups 
The experimental design is presented in Figure 1. Beginning on day 
270 of gestation, the animals were assigned randomly to one of three 
treatment groups: gel vehicle-treated controls (n •» 16), single relaxin-
treated heifers (relaxin-single; n 14), and double rslaxin-treated 
heifers (relaxin-double; n - 17). A daily blood sample (10 ml) was 
obtained from an external jugular vein via hypodermic needle (16 gauge; 
3.8 cm in length). The blood was divided equally into two culture tubes 
containing 0.1 ml heparinized saline (100 U/ml) maintained on ice, and 
centrifuged (2000 x g; 4 C); plasma was decanted into two culture tubes, 
frozen, and stored at -20 C for RIA of progesterone, E^, and 
Pelvic and cervical measurements were obtained immediately after the 
blood collection except on the day of treatment and postcalving when the 
64 
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Figure 1. Description of experimental design, indicating treatments, 
day of relaxin (R) or gel vehicle (C) administration, day of 
sequential collection of blood from anterior vena cava, and 
measurement of pelvic width, height, and cervical diameter 
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measurements were obtained at 12-h Intervals for 60 h. Relaxin (1 mg; 
3000 U/mg) was Infused 4 cm Into the cervical os by a sterile 
Insemination pipette on day 278. 
Intracervical Infusion of Relaxin or Gel Vehicle 
Ovaries of pregnant pigs were purified according to procedures 
described previously (Perezgrovas and Anderson, 1982). Purified porcine 
relaxin (3000 U/mg) was suspended in 1 ml vehicle, prepared by mixing 
0.01 M PBS pH 7.0, and sterile gel (1 ml KY-4, Johnson and Johnson, Inc., 
New Brunswick, NJ). Relaxin or gel vehicle was infused by means of a 
sterile insemination pipette after the cervical probe was withdrawn. A 
gloved hand was maintained in the reproductive tract (vulva and vagina) 
of the heifer to guide the pipette through the cervical sphincter. 
Relaxin or the gel vehicle then was introduced and deposited 4 cm into 
the cervix. 
Cervical Dilatation 
Dilatation of the cervix was measured intravaginally using a 
specially designed stainless steel probe (Perezgrovas and Anderson, 
1982). The probe consists of two 12-mm stainless steel rods anchored to 
a brass bracket, and the rods are distended by rotating a conical brass 
swivel. The autoclaved probe was maintained in a glass cylinder with 70% 
ethanol between measurements of heifers and autoclaved at the end of each 
series of measurements. Before use, the probe was rinsed with 0.9% NaCl 
containing 1000 U penicillin G/ml. The probe was inserted into the 
vaginal lumen and guided by a gloved hand into the cervical os to a depth 
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of 3 cm. The tips of the rods were expanded by rotating the conical 
swivel to a uniform resistance against the cervical wall, then were 
withdrawn, and the separation of the rods was measured. 
Pelvic Area Measurements 
The area of the pelvic canal was calculated from determination of 
height and width using a pelvimeter (Lane Manufacturing, Inc., Denver, 
CO) of internal landmarks, as described previously (Rice and Wiltbank, 
1972; Ferezgrovas and Anderson, 1982). Pelvic height was determined by 
measuring the linear distance from the midpoint of the dorsal surface of 
the symphysis pubis to the ventral surface of the prominent junction of 
the third and fourth sacral segments. Pelvic widths were determined by 
measuring the greatest linear distance between depression points in the 
shaft (bodies) of the ilia at right angles to the vertical measurements. 
The pelvimeter was guided by a hand into the rectum to obtain vertical 
and horizontal measurements. The pelvimeter was cleansed with tap water 
between successive measurements. 
RIA of Progesterone in Peripheral Plasma 
Progesterone was determined in duplicate 200-^1 aliquots of 
peripheral plasma by RIA procedures described previously (Anderson et 
al., 1979b), using the same fully characterized antibody (GDN-337) 
(Niswender, 1973; Gibori et al., 1977). Experiments revealed little 
variance in procedural losses (extraction efficiency, 88 ± 2.8%); hence, 
the mass of progesterone determined in each unknown was corrected for 
average loss of tracer. The minimum detectable concentration of 
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progesterone was 0.25 ng/ml, and plasma samples containing less than 0.25 
ng/ml were assigned this value for statistical analysis. The inter- and 
intraassay variabilities for progesterone were determined from replicates 
of a peripheral plasma pool from beef heifers in estrus. The inter- and 
intraassay coefficients of variation were 6.8% (n = 3) and 3.6% (n = 6), 
respectively. 
RIA of Ej and I76-E2 in Peripheral Plasma 
Concentrations of and rZB-Eg in peripheral blood plasma were 
quantified by a modification of an earlier procedure (Koligian and 
Stormshak, 1977; Tulchlnsky and Abraham, 1971). Procedural losses were 
determined by adding 1000 dpm [.2,4,6y,7-N-H]Ej (92.8 Ci/mmol; New England 
Nuclear Corp., Boston, MA) ad 1000 dpm [2,4,6,7-N-H]17g-E2 (90.0 Ci/mmol; 
New England Nuclear Corp.) to the samples before extraction (Musah et 
al., 1984). The estrogens were submitted to RIA using the fully 
characterized antiserum S-310 5/G (Tulchlnsky and Abraham, 1971). 
The assay sensitivity, defined as E^ or ITG-Eg standard that yielded 
95% of the radioactive counts in buffer control tubes, was 2 pg. Wlthln-
assay variabilities for E^ and yielded coefficients of variation 
of 4.0% and 3.5%, respectively. Between-assay coefficients of variation 
for E^ and I73-E2 were 7.0% and 6.4%, respectively. Plasma samples from 
luteal phase heifers were used as blanks, and they averaged 3.6 and 2.9 
pg/ml E^ and I73-E2, respectively. Maximum antibody binding was 47.5% 
and 50.3%, respectively, for E^^ and 176—Eg. Nonspecific binding was 2.8% 
and 2.4% for and respectively. The range of steroid recovery 
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after extraction was 85-95% and 86-95% for and IVG-Eg, respectively. 
Statistical Analysis 
Experimental units in this investigation were the individual 
heifers, and they were assigned to treatments at random. The data were 
analyzed by split plot design using the general linear model and 
Student's t-test for comparisons among treatment groups (Blair et al., 
1979; Snedecor and Cochran, 1980). 
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RESULTS 
Relaxln-lnduced Parturition in Beef Heifers 
Intracervical administration of purified porcine relaxin to 
prlmiparous beef heifers during late pregnancy induced markedly (P<0.002) 
earlier calving than in controls given a PBS-gel vehicle (Table 1). 
Relaxin given once (3000 U) or twice (two Infusions of 3000 U, 12 h 
apart) significantly reduced (P<0.001) the interval between treatment and 
calving (Table 1 and Figure 2). Heifers given relaxin twice calved an 
average of 3.3 days earlier than PBS-gel vehicle-treated heifers. Within 
24 h after treatment, there were significantly (P<0.001) more heifers 
calving from the relaxln-treated group (Figure 2 and Table 1). 
Relaxin on Steroid Hormone Concentrations In 
Peripheral Blood Plasma 
Pelvic area and cervical dilatation were similar (P>0.05) before 
relaxin or PBS-gel vehicle treatment (Tables 2-4). Twelve hours after 
treatment, there were marked increases in pelvic area In all relaxln-
trsatcd heifers (P<C.05; Figure 3). Msxlmum pelvic opening occurred at 
12-24 h and 24-36 h in heifers given relaxin once or twice, respectively 
(Tables 3 and 4). Cervical dilatation Increased 11%, 526%, and 634% 
within 24 h after administration of PBS-gel vehicle and relaxln-slngle or 
-double, respectively (P<0.01). There was no incidence of retained 
placenta beyond 24 h postpartum in all (0 of 31) relaxln-treated heifers. 
In the PBS-gel vehicle^treated heifers, the placenta was retained beyond 
24 h in 2 of 16 animals. All 47 calves in the 3 treatment groups were 
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Table i. Effect of relaxln on parturition in beef heifers^ 
Heifers Mean interval 
calving of days 
No. of Day of Day of. within 48 between 
heifers treat­ calving h after first treat­
ment treatment ment and 
No. % calving 
Gel vehicle 16 278.2= 283.6+0.9^ 1® 5 5.3^ . 
Relaxin-single 14 277.9 280.5±0.8*'* 6 45 2.5^'* 
Relaxin-double 17 277.4^ 278.6±1.2 15® 88 2.0 ' 
^Porcine relaxin (3000 U/mg) dissolved in a vehicle consisting of 1 
ml 0.01 M PBS and sterile gel was administered into the cervical os 
either once (3000 U) or twice (two infusions of 3000 U, 12 h apart). 
Controls received 1 ml gel vehicle intracervically. 
^Values are mean +SE. 
^3>0.05 (NS). 
S<0.002. 
®P<0.001. 
^P<0.001. 
®P<0.05. 
n?<0.05. 
born alive, and there was no mortality of calves from any of the relaxin-
treated or control heifers up to 1 week, postpartum. 
Relaxin on Steroid Hormone Concentrations 
in Peripheral Blood Plasma 
Changes in progesterone, and 176—in peripheral blood plasma 
are presented in Figures 4 and 5 and Table 5. The levels of these 
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Figure 2. Percent cumulative frequency of numbers of heifers calving 
at half-day intervals from time of treatment in celaxin-
double (•; n » 17), relaxin-single (o; n = 14), and gel 
vehicle control (&; n - 16) groups 
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Table 2. Mean deviations In cervical dilatation from pretreatment 
means In beef heifers* 
Pretreatment Hours after treatment 
(cm) 0 12 24 36 
Gel vehicle 
Relaxln-single 
Relaxln-double 
3.5±0.08h 
3.5±0.08® 
3.5+0.08 
0.6±0. 
0.5±0. 
0.6+0. Ig 0.710.10% 2.3±0.16* 2.4+0.18 0. 2. 4. 
7±0.11= 
9±0.80 ' 
2±0.92® 
0.9±1. 
3.0+0. 
5.0±0. 48® 
Porcine relaxin (3000 U/mg) dissolved in a vehicle consisting of 1 
ml 0.01 M PBS and sterile gel was administered into the cervical os 
either once (3000 U) or twice (two Infusions of 3000 U, 12 h apart). 
Controls received 1 ml gel vehicle Intracervlcal. Means are given in 
centimeters. Values are the mean ±SE. 
^Means within column do not differ (P>0.05). 
c,d,e,f,g^g^^g within columns and within rows with different 
superscripts differ (P<0.01). 
Table 3. Mean deviations in pelvic height from pretreatment means in 
beef heifers 
Pretreatment Hours after treatment 
(cm) 0 12 24 36 
Gel vehicle 17.8^ 0.2+0.09^ 0.3*0.09^ 0.3±0.08^ 0.3+0.02^ 
Relaxln-single 18.1* 0.110.06^ 0.7±0.13® 0.9±0.19^ 0.9±0.15" 
Relaxln-double 17.8 0.1±0.30*^ 0.7±10® 1.0+0.11 1.2+0.11* 
^Porcine relaxin (3000 U/mg) dissolved in a vehicle consisting of 1 
ml 0.01 M PBS and sterile gel was administered into the cervical os 
either once (3000 U) or twice (two Infusions of 3000 U, 12 h apart). 
Controls received 1 ml gel vehicle Intracervically. Means are given in 
centimeters. Values are the mean +SE. Means within columns and rows 
with different superscripts differ (P<0.05). 
^P>0.05 (NS); pooled SE = 0.12. 
®P>0.05 (NS). 
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Table 4. Mean deviations in pelvic width from pretreatment means in 
beef heifers® 
Pretreatment Hours after treatment 
(cm) 0 12 24 36 
Gel vehicle 16.5^ 0.1±0.09*^ 0.510.09* 0.5±0.09j 0.5±0.08^ 
Relaxin-single 16.9° 0.1*0.04° 0.8±0.09 1.3+0.14^ 1.3+0.16® 
Relaxin-double 16.8 0.1±0.30° 0.7±0.11® 1.1+0.11 1.1+0.09 
^Porcine relaxin (3000 U/mg) dissolved in a vehicle consisting of 1 
ml 0.01 M PBS and sterile gel was administered into the cervical os 
either once (3000 U) or twice (two infusions of 3000 U, 12 h apart). 
Controls received 1 ml gel vehicle intracervlcally. Means are given in 
centimeters. Values are the mean ±SE. Means within columns and rows 
with different superscripts differ (P<0.05). 
bp>0.05 (NS); pooled SE - 0.12. 
Cp>0.05 (NS). 
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Figure 3. Sequential changes in pelvic area (upper) and cervical 
diameter (lower) in beef heifers receiving relaxin-double 
(•; n " 17), relaxin-single (o; n = 14), and gel vehicle 
(A; n • 16). Day of treatment is day 0. Values are the 
mean ±SE 
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Figure 4. Progesterone concentrations in peripheral blood plasma in 
relation to the day of treatment (A) and day of parturition 
(B) in beef heifers receiving relaxin-double (•; n = 17), 
relaxin-single (o; n » 14), and gel vehicle (A; n » 16). 
•; Sequential profiles of progesterone in peripheral blood 
plasma in all 47 heifers before treatment. Day of parturi­
tion is day 0. Values are the mean ±SE 
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Figure 5. E. (top) and (bottom) in peripheral blood plasma 
in relation to the day of treatment (A) and day of parturi­
tion (B) in beef heifers receiving relaxin-double (•; n = 
17), relaxin-single (o; n » 14), and gel vehicle (i; n » 16). 
•, Sequential profiles of E (upper) and 176-E (lower) 
in all 47 heifers preceding treatment. Day of parturition 
is day 0. Values are the mean ±SE 
Table .5. Effect of relaxln on progesterone, E^, and 17B-E2 in peripheral plasma of beef heifers^ 
24 h belcore treatment 24 h after treatment 
Progesterone 
(ng/ml) 
El 
(ng/ml) 
173-E2 
(pg/ml) 
Progesterone 
(ng/ml) 
El 
(ng/ml) 
17 3~E2 
(pg/ml) 
Gel vehicle 9.1±0.51^ 2.010.04^ 189+4^ 9.2+0.68^ 2.4+0.09^ 230112^ 
Relaxin-single 10.0±0.63b 2.0±0.26h 206±6P 3.1+0.69® 3.010.30; 300±25f 
Relax in-double 9.9+0.38b 1.9±0.35b 210+8° 2.910.62® 3.6+0.34 360+39^ 
^Porcine relaxin (3000 U/mg) dissolved in a vehicle consisting of 1 ml 0.01 M PBS and sterile 
gel was administered into the cervical os either once (3000 U) or twice (two infusions of 3000 U, 
12 h apart). Controls received 1 ml gel vehicle intracervically. Values are the mean ±SE. 
Means within columns with different superscripts differ. Within-treatment and between-time com­
parisons for each hormone differ, 
'^P>0.05 (NS). 
C'Gp<0.001. 
^^fp<0.05. 
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hormones remained similar (P>0.05) among groups before the administration 
of relaxin or PBS-gel vehicle. Steroid hormone concentrations in 
relation to the time of relaxin or PBS-gel vehicle administration are 
presented in Figures 4Â and 5Â, and Figures 4B and 5B present the changes 
in these steroid hormone concentrations in relation to the day of 
parturition (day 0). As early as 24 h after relaxin treatment, a 
precipitous drop (P<0.001) in progesterone concentrations occurred that 
coincided with a marked elevation (P<0.05) in and l^g-Eg in peripheral 
blood of relaxln-treated heifers* The latency between the decline in 
progesterone and the rise in and was positively correlated 
(P<0.01) with the latency between relaxin or PBS-gel vehicle and 
calving. 
In a separate experiment, porcine relaxin concentrations in 
peripheral plasma of heifers were determined by R1Â, as described 
previously (Anderson et al., 1983), and validated in ovariectomized 
bovine plasma. In four heifers on day 273 of pregnancy, 3000 U relaxin 
were given IM or in the cervical os. In four other heifers on the same 
day of pregnancy, PBS was given IM, or PBS-gel vehicle was given in the 
cervical os. Each heifer was bled via an indwelling jugular cannula ac 
12, 6, 1.5, 0.5, and 0 h before treatment, every 30 min for 6 h after 
treatment, and at hourly intervals thereafter to 24 h after treatment (0 
h). Plasma concentrations of porcine relaxin increased abruptly to peak 
values (21 ± -6 ng/ml) within 1 h in the heifers given 3000 U porcine 
relaxin either IM or in the cervical os. Relaxin levels decreased 
gradually to less than 1 ng/ml by 13 h after treatment. In the control 
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heifers given PBS or PBS-gel, Immunoreactlve levels of relaxin remained 
less than 0.5 ng/ml throughout the 36 h of sequential bleedings. 
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DISCUSSION 
The results of this study Indicate that intracervical administration 
of purified porcine relaxin to primiparous beef heifers during late 
pregnancy induced earlier calving. Some evidence suggests that relaxin 
may be involved in aspects of parturition other than inducing cervical 
dilatation and pelvic relaxation. Intracervical administration of 
relaxin to women during late pregnancy induces marked cervical dilatation 
as well as parturition (MacLennan et al., 1980). Similarly, the high 
incidence of stillbirths associated with the artificial separation of the 
prepartum surge of relaxin from parturition and the observation that 
relaxin administered to ovariectomized progesterone-treated gilts 
resulted in increased live birth rates from 44% to 94% also indicate that 
relaxin might be essential for other aspects of parturition in addition 
to cervical and pelvic relaxation (Taverne et al., 1982; Nara et al., 
1982). In cattle, daily administration of 1000 U relaxin, IM, causes 
earlier calving compared with that in saline-treated controls 
(Ferszgrovas and Anderson, 1982). 
The patterns of steroid hormone secretion in heifers induced to 
calve with relaxin were similar to blood levels found during normal 
parturition or parturition induced by im injection of prostaglandin 
(PGF2^) (Bazer and First, 1983; Johnson and Jackson, 1982). For example, 
a rapid decrease in progesterone plasma concentrations occurred in 
heifers given relaxin. However, heifers induced to calve before the 
normal duration of gestation with either glucocorticoid or PG treatment 
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have a high Incidence of retained placenta (Bazer and First, 1983; 
Johnson and Jackson, 1982). In the present study, there was no incidence 
of retained placenta in heifers given relaxin. Furthermore, calving ease 
in these early calving heifers was similar to that observed in all PBS-
gel-treated controls who experienced uneventful calving at the end of a 
normal gestation. 
Although relaxin-induced parturition was associated with changes in 
progesterone, , and ITg-Eg levels, which typify normal parturition, the 
mechanisms by which relaxin induces these changes are unknown in cattle. 
A possible mechanism could be the result of a feedback interaction with 
oxytocin, PGF^^, and relaxin. The caruncular tissue in the cow is a 
source of PGF^^, whereas oxytocin is produced by both the ovary and the 
neurohypophysis (Flint and Sheldrick, 1982; McCracken et al., 1981; 
McCracken et al., 1972; Simmon and Hansel, 1964). Both PGFg^ and 
oxytocin are luteolytic in cattle, but oxytocin-induced luteolysis is 
thought to be mediated by the release of PCs (Simmon and Hansel, 1964; 
Summerlee et al., 1984; Mitchel and Flint, 1978; Chan, 1977). PGs affect 
the release of oxytocin, but oxytocin can markedly influence the release 
of PGs (Mitchel and Flint, 1978; Chan, 1977; Ellendorff et al., 1979; 
Flint and Sheldrick, 1983). Based on these observations, it has been 
suggested that PGF^^ and oxytocin are engaged in feedback interaction, 
leading to a decrease in progesterone secretion and making substrates 
available for the synthesis of E^ and I7&-E2 (Flint and Sheldrick, 1983). 
Relaxin may affect oxytocin at both the uterine and hypothalamic levels, 
but there is no direct evidence for this in cattle. 
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The results presented here indicate that purified relaxin infused 
intracervically during late pregnancy induces highly significant 
premature parturition in cattle. The relaxin causes marked cervical 
dilatation within a few hours compared with that in PBS-gel vehicle-
treated controls. Furthermore, pelvic height and width Increase 
significantly during the prepartum period as a result of relaxin 
treatment compared with those parameters in the control heifers. The 
shifts in progesterone, , and lys-E^ secretion reflect premature 
parturition induced by relaxin in cattle. Although pharmacological 
dosages of relaxin are associated with pelvic and cervical relaxation and 
abrupt luteal demise in cattle, a role for endogenous relaxin in these 
prepartum events is unknown in this species. The application of relaxin 
during late pregnancy in first pregnancy heifers could provide a useful 
way to control the onset of parturition, increasing calving ease, and 
reduce the incidence of retained placenta. Another application of 
relaxin could be to combine treatment of it with PGs or glucocorticoids 
to Induce earlier calving. Most calving difficulties associated with 
induced calving relate to insufficient dilatation of the pelvic canal and 
a high incidence of retained placenta. Thus, by appropriately timing the 
administration of relaxin with PGs or glucocorticoids, parturition may be 
Induced in cattle without the complications of dystocia. 
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ABSTRACT 
Purified porcine relaxln (3,000 U/mg) was administered 
intramuscularly (RLX-IM, 1 mg, n = 2); and in the cervical OS (RLX-OS, 1 
mg, n = 2), on day 273 of pregnancy in beef heifers to determine the 
depletion profiles of porcine relaxln and its effects on progesterone, 
estrone (E^^) and 17g-estradlol (E^) secretion in peripheral plasma. 
Controls received either 0.01 M phosphate buffer saline (PBS, 1 ml, IM, n 
= 2), or 0.01 M gel-PBS (gel, 1 ml, 0.5, n = 2). Blood was sampled from 
a jugular catheter at -12, -6, -1.5, -0.5, 0 (time of treatment), 0.5 h 
Intervals to 6 h and hourly intervals to 24 h after treatment for RIA. 
Relaxln-treated heifers showed an acute elevation in relaxln, a 
precipitous decrease in progesterone and significant (P<0.05) elevation 
of E^ and E^. Plasma relaxln level was 4.95, 1.5 and 0.24 ng/ml at 0.5 h 
in RLX-IM, RLX-OS and control, respectively. Peripheral plasma relaxln 
peaked between 23—31 ng/ml at 1-2.5 h before returning to less 0.5 ng/ml 
at 5-12 h after treatment. Relaxln administration accounted for 70, 73 
and 58% of the progesterone, E^, and E^ variability between treatments, 
respectively. An abrupt decrease (P<0.01) in progesterone preceded the 
rise (P<0.05) in Ej^ and E^ at 1.5, 2-2.5 and 2-3.5 h, respectively. 
Maximum progesterone deviation from pretreatment mean concentration was 
-5.43, -3.05 and -0.92 ng/ml for RLX-IM, RLX-OS and controls. 
Progesterone rebounded from 36 to 61% and 62 to 79% of respective 
pretreatment means for RLX-IM and RLX-OS. Peak elevation of E^ was 
407-3, 306.5 and 71.5 ng/ml and was 82.2, 35.8 and 7.8 pg/ml for RLX-
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IM, RLX-OS, and controls, respectively» These results provide strong 
evidence that a pharmacological dosage of relaxin induces an acute 
depression of progesterone secretion by the corpora lutea in beef heifers 
during late pregnancy. We suggest that the marked luteolytic effect of 
relaxin on progesterone secretion could be a direct or indirect action, 
but the mechanisms are yet unknown. 
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INTRODUCTION 
Administration of relaxln by Intramuscular injection (IM) or into 
the cervical OS (OS) induces marked changes in cervical dilatation, 
pelvic relaxation, separation of the pubic symphysis, interpublc ligament 
formation and facilitates parturition in some species (Schwabe et al., 
1978; Porter, 1979; 1984; Musah et al., 1986a,b). The physiological 
changes induced by relaxin usually occur a few hours later and the 
duration is shortlived (Schwabe et al., 1978; Perezgrovas et al., 1982; 
Musah et al., 1985a,b). The profile of exogenous porcine relaxin 
administered to late pregnant beef heifers in relation to patterns of 
steroidogenesis has not been investigated. In vivo, relaxin affects 
steroidogenesis, central release of oxytocin, as well as myoepithelial 
contractions (Porter, 1984). In vitro studies indicate that relaxin 
affects CÂMF accumulation, and the enzymes involved in collagen and 
proteoglycan remodeling (Uchima and Greenwood, 1981; Too et al., 1984). 
The objective of this study was to investigate the effect of IM or 
cervical OS administration of relaxin on peripheral blood levels of 
relaxin, progesterone, estrone (E^), and 176-estradlol (176-Eg) during 
late pregnancy in beef heifers. 
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MATERIALS AND METHODS 
Animals 
Eight beef heifers approaching their first calving were used in this 
study. The heifers were from a crossbreeding study and were classified 
as small based on body frame size (Musah et al., 1986a,b). All heifers 
were bred by artificial insemination at estrus (day 0). The average 
duration of pregnancy is 283 days. 
Experimental Groups 
On day 270 of gestation, eight heifers were assigned at random to 
one of four treatments: relaxin administered by IM (3000 U, n=2), 
relaxin administered into the cervical OS (3000 U, n=2), gel-vehicle 
control administered into the cervix (n=2), and PBS-vehicle control 
injection IM (n=2). The volume of hormone or vehicle was 1 ml. On day 
272, the heifers were fitted with an indwelling catheter into the jugular 
vein (Tygon Microbore tubing, ID 0.125 cm and OD 0.225 cm CAT No. 14-170-
15 E, Fisher Scientific Co.). Blood samples were collected on day 273 
at -12 h, -6 h, -90 min, -60 min, -30 min, 0 min and 30 intervals to 360 
min and 1 h intervals to 24 h. Ten milliliters of blood were collected 
each time and transferred into culture tubes containing 0.1 ml of 
heparized saline (100 U/ml), maintained on ice and centrifuge at 2,000 ^  
at 4°C. Plasma was decanted into culture tubes immediately, frozen on 
dry ice, and stored -20°C until required for RIA of relaxin, 
progesterone, and 176-Eg. 
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RIA of Progesterone, Estrone and 176-Estradiol 
Progesterone was determined in duplicate 200-ul aliquots of 
peripheral serum by RIA procedures as described by Musah et al (1986a), 
and utilizing the same fully characterized antibody (GDN-337) (Niswender, 
1973; Gibori et al., 1977). Experiments revealed little variance in 
procedural losses (85 ± 4.0%, extraction efficiency); hence, the mass of 
progesterone determined in each unknown was corrected for average loss of 
tracer. The minimum detectable concentration of progesterone was 0.25 
ng/ml, and those serum samples containing <0.25 ng/ml were assigned this 
value for statistical analysis. The inter-assay and intra-assay 
variabilities for progesterone were determined from replicates of a 
peripheral serum pool from mid-gestation sham-operated heifers. The 
inter-assay and intra-assay coefficients of variation were 7.2% (n=3) and 
4.1% (n=6), respectively. 
Concentrations of E^ and I76-E2 in peripheral blood plasma were 
quantified as described previously by Musah et al. (1986a). Recovery 
after extraction was 85-95% and 86-95% for and respectively= 
The estrogens were submitted to RIA by using the fully characterized 
antiserum S-310 5/G (Tulchinsky and Abraham, 1971). 
Assay sensitivity, defined as E^ or 11standard that yielded 95% 
of the radioactive counts in buffer control tubes, was 2 pg. Within-
assay variabilities for E^ and 176-Eg yielded coefficients of variation 
of 4»36 and 4.94%, respectively. Between-assay coefficients of variation 
for Ej^ and 176—E^ were 7.92 and 6.84%, respectively. 
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RIA of Porcine Relaxin Bovine Peripheral 
Blood Plasma 
Porcine relaxin concentration in bovine peripheral blood plasma was 
quantified in duplicate aliquots of 50-200 ul using a homologous RIA for 
porcine relaxin as previously described by O'Byrne and Steinetz (1976). 
Monotyrosyl relaxin (3000 U/mg, from Dr. C. Schwabe, Medical University 
of South Carolina, Charleston, SC) was iodinated by a modified version of 
the chloramine T procedure. Labeled iodine (10 ul, 1 mCi, Na^^^I, IMS 
30; Amersham Corp., Arlington Heights, IL) was added to 5 yg monotyrosyl-
relaxin (50 Pi 0.5 M PB pH 7.5) in a Wheaton vial. The reaction was 
started by adding chloramine T (25 yl of 2 mg/ml solution of 0.05 M PB) 
and terminated after 60 seconds with sodium metabisulphite (100 yl of 1 
mg/ml in 0.05 M PB). The contents of the Wheaton vial were applied to a 
Biogel P6 column (Bio-Rad. Labs, Riverside, CA), rinsed with 100 yl KI 
and applied to the column again. The column was eluded with 0.05 M PB 
and 1 ml fractions were collected in culture tubes containing 100 yl 0.05 
M PB 1% BSA. The fraction with the highest antiporcine relaxin binding 
and least nonspecific binding was used for the RIA. 
Unknown bovine plasma samples and porcine relaxin standards (0.025, 
0.05, 0.10, 0.50, 1.00, 1.50, 2.00, 2.50, 3.00, 4.00, 5.00 ng/ml in 0.01 
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M PBS 1% BSA) were quantified by a double antibody RIA 100 yl of I-
porcine relaxin (35,000-45,000 cpm in 0.01 M PBS 1% BSA) was added to all 
tubes (volume adjusted with 0.01 M PBS 1% BSA to 5000 yl). Anti-porcine 
relaxin antibody (Dual Rabbit R^ from Dr. B. G. Steinetz, New York 
University, Tuxedo, NY) was added at a titre of 1:15,000 in 0.05 M EDTA 
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PBS and 6% NRS, to all tubes except nonspecific binding and total count 
tubes which received the buffer (0.05 M EDTA PBS ± 6% NRS). Tubes were 
incubated for 24 h at 4°C and then 200 ul of 1:10 goat-rabbit gamma 
globulin antlsera (Antibodies Inc., Davis, CA, in 0.01 M PBS) was 
added to all tubes except total count tubes which received the buffer 
(0.01 M PBS). After incubating for 18-24 h, 3 ml of 0.01 M PBS 1% BSA 
was added to all tubes (except total count), centrifuged at 2,200 rpm for 
30 min; the supernatant decanted and the precipitate counted in a gamma 
counter. 
Included in each assay were: buffer control tubes (n=4), plasma 
blank (ovariectomized hysterectomized heifer, n=4) and porcine relaxin 
standard (1.2 ng/ml, n=4). The maximum binding of the antibody was 
34.56-37.25%, and nonspecific binding (NSB) was 2.93-3.24%. The 
intraassay and interassay variabilities were 4.35 and 6.21%, 
respectively. The sensitivity of the assay defined as the amount of 
relaxin standard that yielded 90% of radioactivity (cpm) in buffer 
control tubes was 37 pg. However, the limits of the porcine relaxin RIA. 
in quantifying immunoreactive relaxin in bovine peripheral blood plasma 
were between 0.05-0.10 ng. The precision and accuracy were evaluated by 
adding known quantities of porcine relaxin to plasma from ovariectomized-
hysterectomized heifers. Relaxin standards and assay quantification 
standard (mean ± SE, coefficient of variance, CV) were: 0.10 ng (0.11 ± 
0.01, 6.94%); 0.25 ng (0.25 ± 0.01, 5.66%); 0.50 ng (0.47 ± 0.01, 2.99%), 
1.00 ng (1.07 ± 0.03, 2.66%); 2 ng (1.90 ± 0.08, 4.29%), and 3.00 ng 
(2.98 ± 0.11, 3.56%). Added standards 0.025 and 0.05 ng were 
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indistinguishable from each other* Plasma from ovariectomized-
hysterectomlzed heifers yielded undetectable levels of relaxin and was 
assigned as 0 ng/ml. 
Statistical Analysis 
The experimental units in this study were the individual heifers. 
Data were analyzed using the general linear model and student ^-test for 
comparison between treatments (Blair et al., 1979; Snedecor and Cochran, 
1980). 
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RESULTS 
Intracervlcal or intramuscular administration of porcine relaxin 
(3,000 U/mg) to primiparous beef heifers during late pregnancy (10 days 
before expected parturition) caused an acute elevation in peripheral 
plasma concentrations of relaxin (P<0.01), a rapid depression of 
progesterone (P<0.01), and a transient elevation of E^and ITg-Eg 
(P<0.05). One of the four heifers calved within 7 h after giving 
relaxin. The results from this study indicated that a temporal 
relationship exists between the elevation in plasma level of relaxin, the 
acute depression of progesterone, and the gradual rise in E^ and 
Significant (P<0.05) levels of relaxin were present in the plasma 
relaxin-treated heifers whether given intramuscularly (IM) or in the 
cervical OS (OS) (Figures 1 and 2, Table 1). 
Beginning at 30 min after treatment, plasma levels of relaxin 
increased in relaxin-treated heifers (Table 2, Figures 1 and 2). Peak or 
mean maximum deviation of relaxin was similar (P>0.05) in heifers given 
relaxin either IM or OS (23 ± 2 or 31 ± 9.5 ng/ml) and was measurable 
between 60-150 min after treatment (Table 2, Figures 1 and 2). The 
cumulative mean deviation of relaxin was higher (P<0.05) between 30-240 
min and lower (P<0.05) between 270-360 min in heifers given relaxin IM as 
compared with OS. 
The mean deviation of relaxin in peripheral plasma.returned to less 
than 0.5 ng/ml at 5 and 12 h in heifers given relaxin IM and OS, 
respectively (Table 1). Mean maximum deviation of relaxin in vehicle 
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cervical os (C,D) administration porcine relaxln (1 mg, 3,000 U); IM (o), cervical os 
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Table 1, Mean deviations from pretreatment means of peripheral plasma relaxin^ 
Time (minutes) 
Treatment — 
30 60 90 120 150 180 210 240 270 300 330 360 720 1440 
Relaxin 
3000 U, 
IN 
4.8 12.1 12.1 17.4 22.9 23.1 14.7 12.7 0.7 0.5 0.4 0.0 0.2 0.00 
Relaxin 
3000 U', 
OS 
1.3 30.3 17.9 15.8 5.1 4.5 12.6 4.9 11.1 2.0 7.7 6.2 0.5 0.2 
Gel-PBS, 
1 ml, OS 
0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 -0.1 
PBS 
1 ml, IM 
0.1 0.2 0.4 0.6 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 
^Values are means (ng/ml), pool S.E.M, = 4.02, LSD = 7.88 (P<0.05). 
Table 2. Mean deviations from pretreatment means of peripheral plasma progesterone* 
Time (minutes) 
Treatment 
30 60 90 120 150 180 210 240 270 300 330 360 720 1440 
Relaxin 
3000 U, 
IM 
-0.2 -0.2 -1.71 -2.85 -3.6 -4.6 -5.0 -5.4 -5.2 —4.8 -4.5 -4.6 -1.4 0.00 
Relaxin 
3000 U, 
OS 
-0.3 -0.1 -1.9 -2.7 -3.0 -2.3 -2.4 -2.3 -2.2 -2.8 -2.5 -2.9 -2.0 -2.2 
Gel-PBS, 
1 ml, OS 
-0.0 -0.1 -0.0 -0.1 -0.5 -0.2 -0.3 -0.2 -0.3 -0.2 -0.4 -0.8 -0.9 -0.8 
PBS, 
1 ml, IM 
-0.1 -0.3 -0.3 -0.5 -0.3 -0.4 -0.6 -0.3 -0.5 -0.6 -0.4 -0.4 -0.9 -0,4 
^Values are means (ng/ml), S.E.M. = 0.812, LSD = 1.59 (P<0.05). 
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control heifers was between 0.125-0.75 ng/ml, and changes in plasma 
relaxin concentrations within the time of the study were nonsignificant 
(P>0*05)« In the experimental heifers, relaxin accounted for 70.12, 
72.75, and 57.62% of the variability in progesterone, and I76-E2 
between treatments and time, respectively. 
A. significant decrease (P<0.05) in peripheral blood levels of 
progesterone (-1.8 ng/ml) was evident in relaxin-treated heifers as early 
as 90 min after treatment (Table 2, Figure 3). Mean maximum deviation 
(P<0.01) jLn progesterone from the pretreatment mean occurred between 120-
240 min after treatment, as -5.43, -3.05, and -0.92 ng/ml for heifers 
given relaxin IM, OS and vehicle, respectively (Table 2). Â slow rebound 
in progesterone levels occurred in relaxin-treated heifers following the 
period of decreased secretion (Figure 3, Table 2). Progesterone was 
depressed to 36.34 and 61.62% of pretreatment mean values in heifers 
given relaxin IM and OS, respectively. Peripheral blood levels of 
progesterone did not attain the original pretreatment mean values during 
the rebound period (Table 2, Figure 3). At 20 ± 4 h after treatment, 
progesterone was 61.08 and 79.09% of the pretreatment means in heifers 
given relaxin IM and OS, respectively (Figure 3). There was no 
significant rebound (P>0.05) in progesterone levels in the control 
heifers; instead, a gradual decline was evident (Table 2, Figure 3). 
Plasma of and 176.-Eg increased gradually in both treated and 
control heifers (Tables 3 and 4, Figure 4). Significantly higher mean 
deviations (P<0.05) in plasma levels of Ej^ and rZg-Eg were evident in the 
plasma by 150 min after relaxin treatment. However, mean maximum 
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Figure 3. Bovine peripheral blood plasma progesterone levels after cervical os (A) and IM (B) 
administration of porcine relaxln (1 mg, 3,000 U) (#,A) and vehicle (o,A) at 0 h on 
day 273 of gestation, a = S.E.M. 
Table 3. Mean deviations from pretreatment means of peripheral plasma estrone^ 
Treatment Time (minutes) 
30 60 90 120 150 180 210 240 270 300 330 360 720 1440 
Relaxln, 
3000 U, 
IM 
10.7 34.0 58.8 177 188 251 342 232 315 336 407 324 367 335 
Relaxin 
3000 U, 
OS 
8.8 42.5 113 107 148 138 82.8 127 109 198 186 306 252 281 
Gel-PBS, 
1 ml, IM 
-6.6 -12 -1.1 -30 -5.5 -30.6 -6.0 25.4 50.1 27.4 50.7 38.4 45.8 80.4 
PBS, 
1 ml, IM 
13.1 -6.5 5.4 81.1 24.9 32.3 8.7 25.4 24.1 55.4 46.5 51.8 68.4 71.5 
^Values are means (pg/nl), S.E.M. = 85.1, LSD = 167 (P<0.05). 
Table 4. Mean deviations from pretreatraent means in peripheral plasma of 17g-estradiol^ 
Time (minutes) ireaLmeuL 
30 60 90 120 150 180 210 240 270 300 330 360 720 1440 
Relaxin 
3000 U, 
IM 
-3.0 4.3 10.1 14.6 20.9 30.2 44.2 55.6 61.0 59.7 63.3 82.0 36.0 33.8 
Relaxln 
3000 U, 
OS 
0.9 4.1 1.6 4.0 2.0 3.0 3.6 10.8 6.9 9.8 13.3 20.0 35.7 23.2 
Gel-PBS 
1 ml, OS 
0.1 -1.5 -3.3 2.4 2.4 -0.5 2.8 0.25 3.2 3.5 3.3 -0.4 2.6 0.7 
PBS, 
1 ml, IM 
7.3 7.7 7.7 3.5 -1.1 7.3 1.1 -1.0 7.0 7.4 7.9 7.1 3.1 4.6 
^Values are means (pg/nl), S.E.M. = 13.9, LSD = 26.25 (P<0.05). 
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Figure 4. Peripheral plasma estrone and 17B-estradiol levels after IM (A) and cervical os (B) 
administration of porcine relaxln (1 mg, 3,000 U) (A,#) and vehicle (A,o) 
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deviations were measured at 210-300 and 270-720 min for and 176-Eg in 
relaxin-treated heifers, respectively. Mean maximum deviation in was 
407, 307 and 76 pg/nl for heifers given relaxin IN, OS and vehicle, 
respectively. Mean maximum deviation in was 82.2, 35.7 pg and 5.7 
pg/nl for relaxin IM, OS and vehicle, respectively. Although there was a 
gradual increase in E^ and I7S-E2 plasma concentrations in the vehicle 
controls, there was no significant change (P>0.05) during this 24-h 
period (Tables 3 and 4, Figure 4). 
After heifers had been assigned at random to the treatments, they 
were observed during the 2 days before treatments, and there were no 
imminent signs of impending calving in any of the 8 animals. At 3 h 15 
min after administration of relaxin IM, heifer No. 33 showed signs of 
labor. Heifer No. 33 had pretreatment means relaxin, progesterone, 
and 176-Eg were 0.141 ± 0.008 ng/ml, 9.83 ± 0.14 ng/ml, 534.83 ± 7.61 
pg/ml and 45.27 ± 1.19 pg/ml, respectively. The post-treatment levels of 
relaxin, progesterone, E^ and 17B-E^ were 17.5 ng/ml, 3.7 pg/nl, 681 
pg/nl, and 108 pg/nl, respectively. Heifer No. 33 calved at 4 h 36 min 
after relaxin administration. The placenta was delivered at 3 h 31 min 
after calving, or 8 h 17 min after relaxin treatment. 
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DISCUSSION 
Administration of a pharmacological dose of relaxin in primiparous 
beef heifers during late pregnancy induced a precipitous decrease in 
peripheral plasma progesterone concentrations, such as reported earlier 
in similar studies (Ferezgrovas and Anderson, 1982; Musah et al., 1986a). 
A temporal relationship exists among the abrupt rise in plasma relaxin, 
the precipitous decrease of progesterone and the rise in and 17g-Eg in 
response to exogenous porcine relaxin given IM or into cervical OS. 
Using a homologous radioimmunoassay for porcine relaxin, significant 
levels of endogenous immunoreactive relaxin were found in the plasma of 
vehicle—treated heifers, comparable with previous studies (Anderson et 
al., 1982). 
The mechanism by which exogenous porcine relaxin mediates luteolysis 
in beef heifers is unknown. This and earlier studies confirm that the 
dose and time of relaxin administration are important in determining 
whether complete luteal demise and parturition, or a temporarily 
suppressed luteal progesterone secretion without parturition would occur 
(Ferezgrovas and Anderson, 1982; Musah et al., 1986a). We speculate that 
both oxytocin and prostaglandin may be involved in a feedback 
interaction with relaxin to mediate these changes. However, for a 
hormone which inhibits uterine myometrial activity and induces uterine 
quiescence presumably by inhibiting oxytocin release (Forter, 1984; 
Schwabe et al., 1978), such a role requires relaxin to be able to 
affect two opposing phenomena. Relaxin affects the central nervous 
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system control of oxytocin release In rats (Summerlee et al., 1984). 
Both oxytocin and prostaglandin (PGF^^) can cause the release of 
relaxln in the pig (Anderson et al., 1973; Nara and First, 1981). 
Similarly, oxytocin and PGF^^ affect each other's release in the pig 
(Chan, 1977; Ellendorff et al., 1979; Flint and Sheldrick, 1983). 
The relatively low and steadily increasing peripheral concentrations 
of relaxln in the plasma of pregnant animals may inhibit uterine 
myometrial activity and oxytocin release. However, the precisely timed 
release of ovarian relaxln in pregnant and hysterectomized pigs (Felder 
et al., 1986) may have a different physiological bearing by probably 
inducing neurohypophysial oxytocin release. Thus, pelvic and cervical 
relaxation, Inhibition of uterine myometrial activity, and mediation of 
luteolysls may be due to very different and probably opposing mechanisms 
limited to specific endocrine and physiological states. Such a mechanism 
is possible, administration of relaxln (1 ug per rat) into the cerebral 
hemispheres profoundly disturbed the patterns of reflex milk let down 
without affecting the response of the mammsry gland to oxytocin 
(Summerlee et al., 1984). Changes and availability of relaxln and 
oxytocin receptor population during late pregnancy may change the 
effectiveness of relaxln as gestation advances. The role of endogenous 
relaxln in mediating luteolysls is unknown. In the pig and rat, relaxln 
levels, as quantified by immunochemistry, vary throughout the estrous 
cycle, with peak levels of ovarian relaxln found just preceding 
luteolysls (Sherwood and Rutherford, 1981; Anderson et al., 1983; Fields 
and Fields, 1985; All et al., 1986). The results of these studies 
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provide clear evidence that a pharmacological dosage of relaxin causes an 
acute decrease in progesterone secretion, followed by a significant 
elevation in and ITG-E^  secretion within a few hours in late pregnant 
beef heifers. The mechanisms by which relaxin mediates luteolysis in 
late pregnant heifers are as yet unknown. 
I l l  
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SECTION IV. INDUCTION OF PARTURITION WITH RELAXIN COMBINED 
WITH DEXAMETHASONE OR CLOPROSTENOL 
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ABSTRACT 
Sixty prlmlparous beef heifers from a crossbreeding study were used 
to examine the effects of inducing parturition with relaxln (RLX; 3,000 
U/mg) combined with cloprostenol (Clo; 500 g, IM, n = 30) or 
dexamethasone (Dex; 20 mg, IM, n = 30) at d 273, 10 ± 1 d before expected 
parturition (d 283)• Heifers were assigned at random within Clo and Dex 
groups to receive RLX (1 mg, n = 5/treatment); IM or in the cervical OS 
(OS), at 0 h (the same time as Clo and Dex), or 24 h later. In lieu of 
RLX, controls received .01 M PBS (1 ml, IM, n = 5) or .01 M Gel-PBS (1 
ml, OS, n = 5). Eleven and six first calving and 16 and nine second 
calving heifers also received Clo + RLX and Clo + PBS, respectively. 
Radioimmunoassay of dally plasma samples indicated an abrupt decrease In 
progesterone with time (P<.001), from 7.5 ± .50 to 1.0 ± .30 ng/ml (mean 
- SE) within 48 h for all groups. The rate of progesterone decrease was 
accelerated (P<.01) in RLX-treated heifers, in contrast with Dex and Clo 
control heifers, 5.3 ± .36 and 2.8 ± .40 ng/ml mean decrease in 24 h, 
respectively. Peripheral plasma progesterone was similar (P>.05) In all 
groups by 48 h after RLX administration. Relaxln combined with Clo or 
Dex shortened the calving period by these heifers by reducing the 
interval between treatment and calving (33 vs. 55 h; P<.01). The 
incidence and duration of retained placenta in Clo and Dex groups were 
reduced by RLX, 23 and 75% and 12 and 24 h for RLX and Clo or Dex treated 
controls, respectively (P<.01). The incidence and duration of retained 
placenta were unrelated to progesterone concentrations 24 h before (r = 
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.29) and after (r = .38) parturition. Pelvic area increased (P<.05) 3.5 
± 1.38, 10.7 ± 1.70, 5.3 ± 1.60 and 12.6 ± 2.60 cm^  (mean ± SE) from 
pretreatment means at 24 h for Clo, Clo + RLX, Dex, and Dex + RLX, 
respectively. Similarly, cervical dilatation increased (P<.001) .56, 
2.35, .85 and 2.5 cm for Clo, Clo + RLX, Dex, Dex + RLX, respectively. 
Route of administration (IM or OS) and time (0 or 24 h) of relaxin 
treatment affected (P<.05) pelvic area and cervical dilatation within 24 
h. The incidence and severity of dystocia were reduced by relaxin 
(P<.05), 62 and 35% calving ease and 1.8 and 2.6 dystocia score for 
relaxin and control heifers, respectively. Pelvic and cervical 
dilatation were greater (P<.01) and the incidence of dystocia and 
duration of labor were reduced (P<.01) in relaxin-treated in contrast 
with Clo alone in second as compared with first calving heifers. Thus, 
induction of parturition with relaxin combined with cloprostenol or 
dexamethasone reduced the incidence of dystocia as a result of increased 
pelvic and cervical development, reduces the incidence of retained 
placenta, as well a» shortens the period of calving in first-calf bsef 
heifers. 
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INTRODUCTION 
Parturition has been successfully induced in cattle with the use of 
glucocorticoids, prostaglandin and analogues of these compounds 
(Wagner et al., 1974; Day, 1977; Davis et al., 1979; Diskin, 1982; 
Johnson and Jackson, 1982). High incidence of retained placenta, 
dystocia, calf mortality and impairment of subsequent reproductivity 
fertility limits early induction of parturition as a management tool 
(Laster et al., 1973; Brinks et al., 1973; Johnson and Jackson, 1982). 
Induction of parturition with dexamethasone results in 83-95% and 52-90% 
retained placenta for first- and second-term heifers, respectively 
(Adams, 1969; Wagner et al., 1974; Davis et al., 1979). Similarly, 
treatment results in 83.3% retained placenta, 50% dystocia, 41-66% 
abnormal presentation and 25% calf mortality (Henricks et al., 1977; 
Plenderleith, 1978). 
Most of these complications are due to insufficient relaxation of 
the birth canal, calf size at birth and the pelvic area of the dam (Price 
and Wiltbank, 1978). We have demonstrated that relaxin administered to 
beef heifers during late pregnancy induces significant pelvic relaxation 
cervical dilatation and induced early calving (Perezgrovas and Anderson, 
1982; Musah et al., 1986a,b). The objective of this study is to 
determine if relaxin can be used in combination with glucocorticoids and 
PGFg^  to reduce induced early calving with a decrease in retained 
placentas and dystocia (arising from the softening of the cervix and 
increase in pelvic area). 
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MATERIALS AND METHODS 
Animals 
Heifers used in these studies were crossbred primiparous beef 
heifers approaching their first calving. Heifers were bred by artificial 
insemination at estrus (day 0), the approximate duration of gestation 
being 283 days. Heifers calved at an average age of 25 ± 1 mo (± SE). 
Heifers were maintained under pasture conditions during the spring, 
summer, and fall throughout gestation. Mixed silage (6.8 kg/animal/day) 
supplemented the hay fed during the winter. During the month before 
calving, corn (2.3 kg/animal/day) and mixed silage (9.0 kg/animal/day) 
were fed in addition to the ad libitum supply of hay. 
Experimental Groups 
Study 
The experimental design is presented In Figure 1. Beginning on day 
270 of gestation, 30 heifers were randomly assigned to one of the six 
treatment groups. Dexasone 20 mg (dexamethasone, 2 mg/ml, John D. 
Copanos, Inc., Baltimore, MD) was administered by IM between day 273-275 
to all heifers. Purified porcine relaxin (3,000 U/mg) was then 
administered either into the cervical OS or by IM at the same time of 
dexamethasone treatment (time 0) or 24 hours after the administration of 
dexamethasone. Control heifers received either I ml of 0.01 M PBS IM at 
24 hours after dexamethasone treatment or had 1 ml of 0.01 M gel-PBS 
vehicle deposited into the cervix. In the second part, 30 heifers were 
similarly assigned to six treatments of estrumate 500 Ug (Cloprostenol 
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Cloprostenol 
EXPERIMENTAL DESIGN 
Relaxin 
Control 
(PBS or 
PBS + gel) 
U h 
No. of 
heifer 
5 
5 
24 h 
0 h 
Dexamethasone! 
• Relax in 
Control 
(PBS or 
PBS + gel ) 
5 
5 
24 h 
Figure 1. A description of the experimental design indicating treatment 
groups, types of treatment and number of heifers per treat­
ment. Cloprostenol (500 yg) or dexamethasone (30 mg) was 
administered on day 273-274 
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sodium, 250 p Cloprostenol Inc., 1 Cl, Great Britain), Table 1. À daily 
blood sample (10 ml) was obtained from an external jugular vein via a 
hypodermic needle (16 gauge, 3.8 cm length). The blood was divided 
equally into two culture tubes containing 0.1 ml of heparinized saline 
(100 U/ml), maintained on ice, and centrifuged (2,000 x g; 4 C); plasma 
was decanted into two culture tubes, frozen, and stored at -20 C until 
required for RIÂ of progesterone. 
Study 2_ 
Sixteen first-term and twenty-five second-term calving crossbred 
heifers were assigned at random to one of two treatments as in Table 1. 
Heifers were given 500 ng Cloprostenol in between day 273-275 of 
gestation. At the same time of Cloprostenol treatment (time 0), relaxin 
(3000 U) (n=27) or PBS (n=14) was administered by IM. Pelvic and 
cervical parameters were measured twice a day at 12-hour intervals. The 
Table 1. Experimental design for first- and second-year heifers given 
relaxln and eloprosuenul by IM 
Cloprostenol Relaxin or Vehicle 
Group N Dose Route Dose Time Route 
First calf 11 Cloprostenol 3000 U 0 IM 
heifers 5 Cloprostenol 1 ml PBS 0 IM 
Second calf 16 Cloprostenol 3000 U 0 IM 
heifers 9 Cloprostenol 1 ml PBS 0 IM 
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onset of labor, duration of labor, presentation duration of retained 
placenta were also recorded. 
Administration of relaxin 
Pelvic and cervical measurements were obtained immediately after the 
blood collection as described previously (Musah et al., 1986a,b). 
Relaxin (1 mg, 3,000 U/mg) was deposited 4 cm depth into the cervical os 
by a sterile insemination pipette or injected into the rump. 
Relaxin was extracted from ovaries of pregnant pigs and purified 
according to procedures described previously (Musah et al., 1986a,b). 
Purified porcine relaxin (3,000 U/mg) was suspended in 1 ml of vehicle 
prepared by mixing 0.01 M PBS, pH 7.0, for IM injections or by mixing 
0.01 M PBS, pH 7.0, and sterile gel (1 ml v/v KY-4, Johnson and Johnson, 
Inc., New Brunswick, NJ), for depositing into the cervical os. Relaxin 
or gel vehicle was infused by means of a sterile insemination pipette 
after the cervical probe was withdrawn. A gloved hand was maintained in 
the reproductive tract (vulva and vagina) of the heifer to guide the 
pipette through the cervical sphincter. Relaxin or the gel vehicle, 
then, was introduced and deposited 4 cm depth into the cervix. 
Treatments administered by IN were inserted into the rump. 
Pelvic area measurements 
The area of the pelvic canal was calculated from determination of 
height and width by using a pelvimeter (Lane Manufacturing Inc., Denver, 
CO) of internal landmarks as described. Pelvic height was determined by 
measuring the linear distance from the midpoint of the dorsal surface of 
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the symphysis pubis to the ventral surface of the prominent junction of 
the third and fourth sacral vertebra. Pelvic widths were determined by 
measuring the greatest linear distance between depression points in the 
bodies of the ilia at right angles to the vertical measurements. The 
pelvimeter was guided by a hand into the rectum to obtain vertical and 
horizontal measurements. The pelvimeter was cleansed with tap water 
between successive measurements. 
Cervical dilatation 
Dilatation of the cervix was measured intravaginally by using a 
specially designed stainless-steel probe (Ferezgrovas and Anderson, 
1982). The probe consists of 2 12-mm stainless-steel rods anchored to a 
brass bracket, and the rods are distended by rotating a conical brass 
swivel. The autoclaved probe was maintained in a glass cylinder with 70% 
ethanol between measurements of heifers and autoclaved at the end of each 
series of measurements. Before use, the probe was rinsed with 0.9% NaCl 
containing 1,000 U penicillin G/ml. The probe was inserted into the 
vaginal lumen and guided by a gloved hand into the cervical os to a depth 
of 3 cm. The tips of the rods were expanded by rotating the conical 
swivel to a uniform resistance against the cervical wall, then withdrawn, 
and the separation of the rods was measured. 
Score codes 
The scoring codes for dystocia/ease, presentation and retention of 
placenta are presented in Table 2. 
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Table 2. Scoring codes for dysCocia/ease, presentation and retention 
of placenta 
Dystocia/ease Presentation Retention 
Col. 1 Col. 2 
1. No help 1. Front 1. Normal 1. No, less than 
2. Hand pull 2. Back 2. 1 leg back 24 h 
3. Chain and hand 3. 2 legs back 2. Yes, greater than 
4. Chain and jack 4. Head back 24 h 
5. C section 5. Head and leg 
6. Fetotomy 6. Torsion 
RIA of progesterone 
Progesterone was determined in duplicate 200-yl aliquots of 
peripheral serum by RIA procedures as described by Musah et al. (1986a), 
and utilizing the same fully characterized antibody (GDN-337) (Niswender, 
1973; Gibori et al., 1977). Experiments revealed little variance in 
procedural losses (85 - 4% extraction efficiency); hence, the mass of 
progesterone determined in each unknown was corrected for average loss of 
tracer. The minimum detectable conceritEâtlûn. û£ progesterone was 0.25 
ng/ml, and those plasma samples containing <0.25 ng/ml were assigned this 
value for statistical analysis. The inter-assay and intra-assay 
variabilities for progesterone were determined from replicates of a 
peripheral plasma pool from beef heifers in estrus. The inter-assay and 
intra-assay coefficients of variation were 7.2% (n =» 3) and 4.1% (n = 6), 
respectively. 
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Statistical Analysis of Data 
Experimental units in this study were the individual heifers. Data 
were analyzed by split-plot design using the general linear model and 
students ^ -test for comparisons between treatment groups (Blair et al., 
1979; Snedecor and Cochran, 1980). 
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RESULTS 
Progesterone Secretion after Induced Parturition with Relaxin in 
Combination with Cloprostenol or Dexamethasone 
Peripheral plasma progesterone levels were significantly (P<0.01) 
reduced in heifers given relaxin combined with cloprostenol or 
dexamethasone and in cloprostenol or dexamethasone alpne (Figures 2 and 
3). Relaxin (IM or OS, 0 or 24 h) accelerated the rate of cloprostenol 
and dexamethasone induced luteal demise (P<0.01) in contrast with heifers 
receiving cloprostenol or dexamethasone alone (Figures 2, 3). At 24 h 
after relaxin administration, peripheral plasma levels of progesterone 
were 5.3 ± 0.36 and 2.8 ± 0.4 ng/ml in relaxin with cloprostenol or 
dexamethasone and cloprostenol and dexamethasone, respectively. Plasma 
progesterone levels were less than 3 ng/ml at calving (Figure 2). 
Generally, progesterone levels were decreased to below 1 ng/ml at 48-60 h 
after first treatment. 
Changes in Pelvic Area and Cervical Dilatation after Inductor of 
Parturition with Rêlâxlri Combined with ClopfûsCêfiol 
or Dexamethasone 
Cervical dilatation, pelvic height and pelvic width increased with 
time to peak volumes at 24-48 h after first treatment (Figures 4 and 5). 
Both cloprostenol and dexamethasone induced changes in pelvic area and 
cervical dilatation; however, these changes were significantly 
potentiated by combining relaxin with the treatment (Table 3, Figures 4 
and 5). Pelvic area in relaxin treated was larger (P<0.05) than in 
cloprostenol or dexamethasone controls. Cervical dilatation was 
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PARTURITION 
DAYS FROM PARTURITION 
Figure 2» Peripheral plasma progesterone levels (ng/ml) after treatment 
with relaxin (RLX) and cloprostenol (Clo) or dexamethasone 
(Dex) in primiparous beef heifers; Clo or Dex (O); Clo or 
Dex and Rlx (IM or OS) at 0 h (#); and Clo or Dex and Rlx 
(IM or OS) at 24 h (A) 
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prostenol (Clo) or dexamethasone (Dex) 
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Table 3. Effects of relaxln combined with cloprostenol or dexamethasone 
on mean deviations of pelvic area and cervical dilatation from 
pretreatment means at 24 h after treatments In beef heifer^  
Treatment N Pelvic area^  
Cervical 
dilatation^  
Cloprostenol 20 3.55+1.25^  .56+.38^  
Cloprostenol and 
relaxln 10 10.70+1.67^  2.35±.48® 
Dexame thas one 20 5.3511.01^  .84±.17^  
Dexamethasone 
and relaxln 10 12.62+2.60® 2.51±.52® 
V^alues are mean ± SE. 
V^alues in this column with different superscripts differ P<0.01. 
V^alues in this column with different superscripts differ P<0.001. 
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Table 4* Mean deviations of pelvic areas and cervical dilatation from 
pretreatment means at 24 h after administration of relaxin 
(IM, OS) at 0 or 24 h in combination with cloprostenol or 
dexamethasone 
Treatment 
Mean deviations 
PelviCgarea, 
cm 
Mean deviations^  
Cervical dila­
tation, cm 
Dexamethasone + relaxin 
Dexamethasone + vehicle 
13.13*1.59% 
8.52+3.18 
3.08±.44^  
1.75±.53® 
Dexamethasone + relaxin IM 
OS 
0 h 
24 h 
13.13+1.59^  
11.76+2.52 
12.27+1.50^ . 
12.62±2.01 
3.151.42^  
3.01±.45 
3.651.35^  
2.51+.52 
Cloprostenol + vehicle 
Cloprostenol + relaxin 
5.28±1.44% 
9.47+1.91 
1.211.34^  
2.34+.53® 
Cloprostenol + relaxin IM 
OS 
0 h 
24 h 
9.34+1.26^  
9.60±2.57 
8.24+2.13r 
10.70±1.67r 
2.74+.48f 
1.94±.64^  
2.33+.58^  
2.35±.48^  
Dexamethasone or cloprostenol 
+ vehicle 
Dexamethasone or cloprostenol 
+ relaxin 
6.90±2.31r 
10.96±1.98s 
1.48±.47^  
2.711.48-
Dexamethasone or 
cloprostenol + relaxin 
IM 
OS 
11.24+1.43s 
10.68+2.54s 
2.95±.45® 
2.48±.55® 
0 h 
24 h 
10.26+1.79s 
11.66+1.58s 
2.99±.46® 
2.43+.50® 
Values are mean ± SE* 
V^alues in the same column within blocks with different superscripts 
differ, P<0.05. 
V^alues in the same column within blocks with different superscripts 
differ, P<0.001. 
129 
CLO. RLX-iM CLO. RLX ^ 6 
_ t 
h  
u) ai 
H 
O ItJ 
S I  
5 g 
u s 
»i_ #—# 
/ 
i « i ' i ' i ' i ' i ' i 
CLO RLX^ 
" o o 
/ ,.-1 
i ' i ' i « i ' i ' i ' i 
CLO PBS-tM 
" o o 
I • I . I . I 
4—e-
I I I I I I I 1 I I I I I 
CLO Rue-OS 
• o o 
I t I I I I t I I I I I I 
CLO âCLOa 
• o c> 
I » 1 > 1 t I I I I i t I 
- 1 0  1 3  3  4  5  - 1  O  1  2  3 * 5  
days ArreR rclaxin treatment 
2 Figure 4. Mean deviations in pelvic area (cm ) from pretreatment 
means in primiparous beef heifers after administering relaxin 
(RLX) with cloprostenol (Clo) during late pregnancy 
130 
DEX. RLX4M OCX. RLX-08 
i l  
îi 
< 2 
• s 
î! 
a 
-i—i—i—1—1 i i 11 i • i 
•ex RLX-IM 
" "=> A 
s / \_s 
I—1—1—I—1—I 1 I 1 1 1 1 I 
oex PB8-IM 
I I I 1 1—1 I I I ' I ' I 
l— a— 
I I I I I I I ' ( ' I ' I 
oex ALX^S 
o o 
y 
l. 
i 1 1 1 1 1—1 1—1 I 1 i_J 
oex QEL'OS 
o o 
1 , 1 , 1 , 1 , 1 , 1 , 1  
- 1  0 1 2 3 4 9  - 1  0 1 2 3 4 0  
DAYS AFTER RCLAXIN TREATMENT 
2 Figure 5. Mean deviations in pelvic area (cm ) from pretreatment 
means in beef heifers after administering relaxin (RLX) 
with dexamethasone (Dex) during late pregnancy 
131 
z 
o 
£ 
10 y 
o  s  p 
CLO RLX-IM 
^ i— 0 O 
3 -
a -
1 -
ol 
3 -
2 -
1 -
ol 
4p 
3 -
2 . 
1 . 
ol 
CLO. RLX^ 
t I 1 1 t I ] I \ I 1 
1 . 1 , 1 , 1 . 1 , 1  
CLO PBS*(M 
o o 
CLO. RLX-OS 
o 
K 
a" a 
1 ' I ' 1 L-J L-_L 
CLO RLX-OS O o 
\ r y  ^
I I I ' I ' I ' I ' I 
CLO âCL-OS 
• o o 
./X 
tl 
L_i. I I I I I I 1 I I I I 
-1 o 1 2 3 4 
days after relaxin treatment 
1 , 1 , 1 , 1  
Figure 6. Mean deviations in cervical dilatation (cm) from pretreatment 
means in beef heifers after administering relaxin (RLX) with 
cloprostenol (Clo) during late pregnancy 
132 
oex. RLX-IM 
o 
OEX. RLX-OS O 
DEX RLX-IM DCX RLX-08 
o o 
- 1  0 1 2 3 4  * 1 0 1 2 3 4  
days after relaxin treatment 
Figure 7» Mean deviations in cervical dilatation (cm) from pretreatment 
means in beef heifers after administering relaxin (RLX) with 
cloprostenol during late pregnancy 
133-134 
similarly greater (P<0.01) in relaxln treated heifers within 24 h after 
relaxln treatment (Table 4). The route and time of relaxln treatment 
relative to cloprostenol or dexamethasone significantly (F<0*05) affected 
pelvic and cervical relaxation. 
Onset of Parturition after Combined Relaxln and Cloprostenol 
or Dexamethasone Induced Calving 
Parturition was Induced in all groups between 22-61 hours after 
first treatment (Table 5). The treatments were administered on the same 
day 274 (P>0.05) (Table 6). The interval between treatment and calving 
was the same (P>0.05) for heifers given relaxln by IM or cervical OS, at 
0 or 24 h or with dexamethasone (Table 7). However, the time (0 or 24 h) 
of relaxln administration relative to cloprostenol and route of treatment 
affected the mean Interval between treatment and calving (P<0.05; Table 
5). Overall, the time (0 or 24 h) of relaxln administration relative to 
cloprostenol or dexamethasone treatment or route of treatment did not 
affect the mean Interval between treatment and calving (P>0.05) (Tables 4, 
5). The administration of relaxln with cloprostenol or dexamethasone 
produced significant (P<0.05) treatment differences in the interval 
between treatment and calving (Tables 5, 7, 8). 
Incidence and Severity of Dystocia in Beef Heifers Induced to Calve 
with Relaxln Combined with Cloprostenol or Dexamethasone 
High incidence of severe cases of dystocia occurred in heifers 
induced to calve with cloprostenol or dexamethasone (Tables 5, 9), 
Inclusion of relaxln with these hormones for the purpose of inducing 
calving reduced the incidence and severity of dystocia (P<0.05; Table 9), 
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Table 5. Effect of relaxln in combination with dexamethasone or do-
prostenol on induction of parturition in first calf beef 
heifers^  
Group 
No. 
of 
heif­
ers 
Interval 
between 
treatment 
and calv­
ing, h 
Animals 
with 
placenta 
retained 
>24 h, % 
Duration 
of 
retention 
of 
placenta, h 
Relaxin vs dexamethasone 
Dexamethasone + relaxin 
IM vs cervical OS 
Dexamethasone + relaxin 
24 h vs 0 h 
Relaxin vs cloprostenol 
Cloprostenol + relaxin 
IM vs cervical OS 
Cloprostenol + relaxin 
24 h vs 0 h 
Relaxin vs dexamethasone 
or cloprostenol 
Dexamethasone or clo­
prostenol 4- relaxin 
IM vs cervical OS 
Dexamethasone or clo­
prostenol + relaxin 
24 h vs 0 h 
30 36 vs 62** 15 vs 70*** 11 vs 29** 
20 35 vs 32 9 vs 25** 8 vs 14* 
20 31 vs 36 11 vs 22* 10 vs 11 
30 30 vs 48* 30 vs 80*** 14 vs 30*** 
20 29 vs 38* 50 vs 30* 20 vs 10** 
20 28 vs 34* 70 vs 20*** 11 vs 19** 
60 33 vs 55* 23 vs 75** 12 vs 24** 
40 32 vs 35 30 vs 28 14 vs 12 
40 30 vs 35 40 vs 21*** 10 vs 15* 
All comparisons with no difference indication are similar. 
*Comparisons differ (P<0.05). 
**Comparisons differ (P<0»01). 
***Comparisons differ (P<0.001). 
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Table 6* Analysis of variance means for treatment (TRT) groups^  
TRT DDC DREL RTIME DYST DPART VALDC VALREL 
CI 274.800 274.800 19.800 2.800 275.600 25.646 25.646 
C2 274.600 274.600 4.000 1.600 275.400 25.250 25.250 
C3 274.400 275.400 22.000 3.000 276.400 41.550 15.360 
C4 274.000 275.000 17.400 2.800 276.000 42.042 18.308 
C5 273.800 274.800 21.200 2.400 276.000 55.716 31.680 
C6 273.000 274.000 48.000 3.400 275.400 58.152 34.626 
D1 274.200 274.200 11.800 1.000 275.200 25.558 25.558 
D2 274.000 274.000 12.400 1.600 274.800 22.076 22.076 
D3 274.000 275.000 4.000 1.750 275.500 42.343 19.025 
D4 274.167 275.167 7.833 1.167 275.667 42.533 16.555 
D5 273.500 274.500 19.250 1.750 275.500 49.525 24.513 
D6 274.400 275.400 39.600 3.000 277.400 61.978 38.200 
D^DC = day of dexamethasone or cloprostenol treatment; DREL = day of 
relaxin treatment; RTIME = duration of retained placenta; DYST = 
dystocia; DPART = day of parturition; VALDC = interval between DDC and 
calving; VALREL = interval between DREL and calving. 
Table 7« Analysis of variance: Interval between relaxin treatment and 
calving 
Source df Sum of Mean S.= 
squares square value PR > F square C.V. 
Model 11 2672.88 242.98 2.10 0.0404 0.34 44.03 
Error 45 5214.43 115.87 
Corrected 
total 56 7887.31 
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Table 8. Analysis of variance: Interval between cloprostenol or dexa-
methasone treatment and calving 
Source df Sum of Mean F- R-
squares square value PR > F square C.V. 
Model 11 9784.37 889.49 8.05 0.0001 0.66 25.77 
Error 45 4973.53 110.52 
Corrected 
total 56 14757.90 
Table 9. Effects of relaxin combined with cloprostenol or dexa-
methasone ease of calving and mean dystocia score 
Ease of Mean dystocia 
Group calving, % score 
Relaxin vs dexamethasone 80 vs 30** 1.37 vs 2.38* 
Dsxaaethasone + relaxin IM vs OS 78 vs 38** 1.37 vs 1.33 
Dexamethasone + relaxin 24 h vs 0 h 87 vs 33** 2.20 vs 2.80 
Relaxin vs cloprostenol 45 vs 50 2.55 vs 2.90 
Cloprostenol + relaxin IM vs OS 40 vs 50 2.80 vs 2.00 
Cloprostenol + relaxin 24 h vs 0 h 30 vs 50* 1.30 vs 1.45 
Relaxin vs cloprostenol or dexamethasone 62 vs 35** 1.86 vs 2.64* 
Cloprostenol or dexamethasone + relaxin 59 vs 44 2.08 vs 1.66 
IM vs OS 
Cloprostenol or dexamethasone + relaxin 59 vs 42 1.75 vs 2.12 
24 h vs 0 h 
«Comparisons differ at P<0.05. 
**Comparisons differ at P<0.01. 
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The administration of relaxin whether by IM or OS was equally effective 
in reducing dystocia (P<0.05) in dexamethasone treated heifers. However, 
with cloprostenol, OS administration of relaxin was more effective 
(P<0.05) than IM at reducing incidence of dystocia when given at the same 
time than at 24 h after cloprostenol treatment (P<0.05). 
Induced Parturition and Retained Placenta 
Induction of parturition in beef heifers with cloprostenol or 
dexamethasone is associated with high incidence of retained placenta 
beyond 24 h (Tables 5 and 6). Combining relaxin with cloprostenol or 
dexamethasone for induction of parturition effectively reduces (P<0*006) 
the Incidence as well as the severity (P<0«005; Table 10). In 
dexamethasone treated heifers, IM administration of relaxin was more 
effective and with cloprostenol groups OS administration was more 
effective (P<0.05) at reducing duration of retained placenta (Table 11). 
With regard to the time of relaxin administration, the mean duration of 
retained placenta was shorter in cloprostenol treated heifers if relaxin 
was administered at 24 h instead of 0 h (P<0.001). 
Induction of Parturition with Cloprostenol and Relaxin; First Versus 
Second Calving Heifers 
Relaxin was combined with cloprostenol given IM on day 273. Age 
difference reflected in higher calving ease in second year control 
heifers as compared with first year control heifers (P<0.05; Table 12). 
There was no significant difference in the mean interval between 
treatment and calving, duration of retained placenta (P<0.05; Table 12). 
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Table 10. Analysis of variance: Incidence of retained placenta 
Source df Sum of Mean F- R-
squares square value PR > F square C.V. 
Model 11 
Error 44 
Corrected 
total 55 
7.52 0.68 3.96 
7.60 0.17 
15.12 
0.0005 0.50 30.23 
Table 11. Analysis of variance: Duration of retained placenta 
Source df Sum of Mean F- R-
squares square value PR > F square C.V. 
Model 11 8861.39 805.58 2.88 0.0056 0.40 83.49 
Error 47 13127.58 279.31 
Corrected 
(.uudx 
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Table 12. Effect of cloprostenol and relaxin or phosphate buffer saline 
(PBS) administered intramuscularly on induction of parturi­
tion in first and second calf beef heifers 
Interval Animals 
between with 
treat­ Ease pla­ Dura­
No. ment of centa tion 
of and calv­ re­ of 
heif­ calving* ing** tained*** labor* 
Group Treatment ers (h*) (%) >24 h (%) (h) 
First calf 
heifers 
Cloprostenol 
+ relaxin 11 20+6® 00
 
to
 m 18"^ 2 .2+0.45® 
Cloprostenol 
+ PBS 5 46+5^ O
 rt 00
 0 CO
 
4 .0±1.00^ 
Second calf 
heifers 
Cloprostenol 
+ relaxin 16 23±4® ICQ" 0*^ 1 .8+0.45® 
Cloprostenol 
+ PBS 9 44+7^ 75® 100* 3 .4+0.45^ 
First and second 
calf heifers 
Cloprostenol 
+ relaxin 27 22+5® 93SU 8^ 2 .0+0.45® 
Cloprostenol 
+ PBS 14 45+6^ 63^ 93" 3 .6±0.65^ 
^Values are the mean ±- SE. Means with different superscripts within 
coluiûnB uiffêr. 
*P<0.05 within group. 
**P<0.02 within group. 
***P<0.01 within group. 
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The incidence of dystocia and duration of labor were reduced (P<0.01) in 
relaxin treated in contrast with cloprostenol alone and in second as 
compared with first calving heifers* 
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DISCUSSION 
These results suggest that combined induction of parturition in beef 
heifers with porcine relaxin and cloprostenol or dexamethasone is 
beneficial. The combined induction resulted in reduced intervals between 
drug treatment and calving, shortened the calving period, reduced the 
incidence and severity of dystocia, reduced the proportion of heifers 
with retained placenta as well as the duration of retained placenta. 
These events were preceded by an accelerated decrease of plasma 
progesterone, and pelvic and cervical relaxation in much the same manner 
as reported earlier (Musah et al., 1986a,b). 
In this study, the profile of plasma peripheral progesterone levels 
during the periparturient period was similar to those observed during the 
periparturient period associated with normal calving, relaxin facilitated 
calving, prostaglandin or glucocorticoid induced calving (Johnson and 
Jackson, 1982; Bazer and First, 1983; Musah et al., 1986a). Relaxin 
alone or combined with cloprostenol and dexamethasone is associated with 
luteal demise, consistent with earlier reports (Musah et al., 1986a). 
The relaxin mediated progesterone demise may be a direct or an indirect 
effect. The mechanism of this demise is as yet unknown. A related 
paradox is the peak release of relaxin which always precedes total or 
partial luteal demise in pregnant and hysterectomized gilts (Sherwood et 
al., 1975; 1981; Anderson et al., 1983; Felder et al., 1986). The source 
of the signal for the timely peak release of relaxin in the presence or 
absence of the fetus and uterus is as intriguing and elusive as the 
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mechanism responsible for the partial luteal demise after the peak 
release of relaxin in hysterectomized gilts. 
Cloprostenol and dexamethasone induce cervical and pelvic softening, 
decrease progesterone concentrations in peripheral plasma and elevates 
plasma levels of estrogens (Mostle et al., 1985; Johnson and Jackson, 
1982). This study shows that these effects are potentiated by relaxin. 
In cows, the mechanism by which relaxin mediates these pelvic changes is 
unknown. Pelvic canal expansion is due to increase both the rate of 
linear growth as well as an absolute increase in pelvic height and width 
(Musah et al., 1986b). The increase in pelvic height and width may be a 
result of relaxation of sacroiliac ligaments (Rice and Wiltbank, 1972; 
Fields et al., 1981), formation of Interpubic ligaments (Leltch et al., 
1959) and modification of the pubic symphysis, by transforming symphyseal 
cartilage and bone (Rice, 1969). Use of radiographic analysis in 
studying pelvic growth in heifers has demonstrated an increase in the 
interilial diameter, and, in some heifers, widening of the pubic 
symphysis (Rice, 1969; Rice and Wiltbank, 1372). In vitro relaxin 
induces the release of cathepsln B and dipeptidyl peptidase I in the 
mouse pubic symphysis (McDonald and Schwabe, 1982). These are lysosomal 
cystine protease and exopeptidase, respectively, which break down 
cartilage. 
The results are consistent with earlier reports that cloprostenol or 
dexamethasone induced parturition causes high incidence of dystocia and 
retained placenta (Adams, 1969; Wagner et al., 1974; Davis et al., 1979; 
Johnson and Jackson, 1982). The incidence and severity of dystocia and 
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the duration of retained placenta seem to depend upon the stage of 
gestation when the induction occurs (Johnson and Jackson, 1982). The 
problem of retained placenta is more prevalent in cattle and the 
incidence is about 3-12% and higher (30-50%) in brucellosis infected herd 
(Grunert, 1980)• Â disturbance in the loosening mechanism in placentomes 
results in all or portions of fetal membranes being retained. This study 
indicates that a combined treatment of relaxin with cloprostenol or 
dexamethasone reduced the incidence and severity of dystocia due to 
increased cervica^. and pelvic relaxation (Musah et al., 1986b) as well as 
reduced the incidence of retained placenta as reported earlier (Musah et 
al., 1986a). 
The mechanisms by which relaxin may reduce retained placenta are 
unknown* The maternal and fetal connective tissue in placentome becomes 
progressively collagenized up to the time of parturition. At the onset 
of parturition, the tissue of the placentome becomes loose, a process 
that is essential for expulsion of the fetal membranes (Grunert, 1980). 
Transformation of placental cormecCive tissue is thought to be a 
requisite for the delivery of the fetal membranes. Relaxin may 
facilitate easy delivery of fetal membrane by acting on the connective of 
the placentomes to break down collagen. Relaxin acts on collagen of the 
cervix and pelvis and causes relaxation by inducing the disintegration of 
the collagen matrix (Schwabe et al., 1978; Porter, 1979). 
In this study, the periparturient levels of progesterone were 
unrelated to the problem of retained placenta. This is consistent with 
earlier results (Johnson and Jackson, 1982). We conclude from this study 
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that combined induction of parturition in beef heifers with relaxin and 
cloprostenol or dexamethasone reduced the incidence of dystocia as a 
result of increased pelvic and cervical dilatation, reduced the incidence 
of retained placenta, as well as shortening the calving period. 
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ABSTRACT 
The postpartum reproductive fertility of crossbred beef heifer was 
examined after induction of parturition with relaxln (n = 31); relaxin 
combined with cloprostenol or dexamethasone (n = 51), and cloprostenol 
dexamethasone treated controls (n = 20). Untreated herd mates (n = 25) 
and vehicle treated herd mates were also considered in a 2-year 
experiment. Heifers were also categorized as small, medium and large 
based on genetic composition. Because Induction of parturition with 
cloprostenol, dexamethasone and their analogues often results in high 
incidence of dystocia, retained placenta and impairment of subsequent 
postpartum fertility, we examined these post-treatment reproductive 
performances of these heifers to determine the effects of relaxln on 
postpartum reproductive function. Conception rates were 95, 83.7, 88.9 
93.3, 87, and 88.1% for heifers given relaxln, relaxln combined with 
cloprostenol or dexamethasone, cloprostenol or dexamethasone, untreated 
herdmates, and herd average, respectively. Failure to be bred and 
conception failures were 29, 19.6, 20.0, 12.5, 16.2, and 17.7% for 
relaxln, relaxin with cloprostenol or dexamethasone, cloprostenol or 
dexamethasone, untreated herdmates, and herd average, respectively. A 
higher (P<0.05) proportion of relaxin treated heifers were not bred as 
compared with untreated controls. This was evident in only one season. 
Relaxln combined with cloprostenol or dexamethasone had similar 
nonconception rates (P>0.05). Medium and large frame sizes of beef 
heifers tended to have higher nonconception and not bred rates (P<0.05) 
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11, 19 and 24% for small, medium and large. Relaxln did not affect this 
intrinsic genetic differences (P>0.05). The results suggest relaxin does 
impair subsequent reproductive performance and as such can be used with 
other hormones or alone to facilitate parturition. Conception rate is a 
function of the genetic composition of the animal. 
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INTRODUCTION 
The temporal hormonal changes of the perlparturlent period are 
important not only for parturition but also resumption of postpartum 
reproductive function (Thatcher et al., 1980; Eley et al., 1981). 
Similarly, uterine horn and cervical involution are dependent upon breed 
and concentration of prostaglandin (PCFg^) during the postpartum 
period (Guilbaut et al., 1985). Thus, hormones which affect cervical 
relaxation and dilatation during calving are likely to have consequences 
during postpartum involution, as demonstrated by glucocorticoids and 
prostaglandins. The use of these compounds on induction of parturition 
often results in high incidences of dystocia, retained placenta and 
impairment of subsequent postpartum fertility (Adams, 1969; Wagner et 
al., 1974; Henricks et al., 1977; Davis et al., 1979; Plenderleith, 1978; 
Musah et al., 1986b,c). The calving-conception interval and increased 
infertility may occur in some cows. Relaxin is a polypeptide with 
partial structural hormonology to insulin and is produced primarily 
during pregnancy in several mammalian species (Porter, 1979; 1984; 
Schwabe et al., 1976). Administration of porcine relaxin or in 
combination with cloprostenol or dexamethasone increases both pelvic 
area, cervical dilatation, increases calving ease, as well as induces 
early parturition in late pregnant beef heifers (Musah et al., 1986a,d). 
Furthermore, there is a reduction or absence of dystocia or retained 
placenta beyond 24 h (Musah et al., 1986a,b,c,d). Relaxin in combination 
with dexamethasone or cloprostenol reduced the incidences of dystocia and 
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retained placenta, as well as significantly decreasing the latency 
between treatments and calving (Musah et al., 1986a,b,c,d). The 
objective of this study was to quantitatively describe the subsequent 
rebreeding characteristics of these heifers after hormonal induction of 
calving. 
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MATERIALS AND METHODS 
All animals used in this study were pooled from two experiments 
conducted in Spring 1984 and 1985* The experimental design is presented 
in Table 1. All heifers were bred by artificial insemination at estrus 
Table 1. Experimental treatments for induction of parturition in beef 
heifers 
Group 
Spring 
season 
No. of 
heifers 
Experimental and 
control treatments 
Relaxin (RLX) 
PBS-Gel (Gel) 
1984 31 
1984 16 
RLX plus do- 1985 51 
prostenol (Clo) or 
dexamethasone (Dex) 
PBS or PBS-Gel 
Clo or DEX 
1985 20 
Relaxin administered in cervical 
OS on d 278 once (3,000 U) or 
twice (2 X 3,000 U 12 h apart) 
PBS-Gel (1 ml) administered in 
cervical OS on d 278 once or 
twice (2 X 1 ml 12 h apart) 
Relaxin (3,000 U IM or in cervi­
cal OS) at 0 or 24 h after clo-
prostenol (500 pg IM) on d 273 
Relaxin (3,000 U IM or in cervi­
cal OS) at 0 or 24 h aftsr dsxa— 
methasone (20 mg IM) on d 273 
PBS (1 ml IM) or PBS-Gel (1 ml 
in cervical OS) at 0 or 24 h after 
cloprostenol (500 Ug) on d 273 
PBS (1 ml IM) or PBS-Gel (1 ml 
in cervical OS) at 0 or 24 h after 
dexamethasone (20 mg) on d 273 
Untreated 
controls 
1984-1985 260 Untreated herd mates 
Herd 1984-1985 378 Treated and untreated heifers 
in breeding herd 
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insemination at estrus (day 0); the duration of pregnancy lasts 
approximately 283 days in this herd. The heifers calved at an average 
age of 25 ± 1 mo (± SE). They were maintained under pasture conditions 
during the spring, summer, and fall months throughout gestation. Mixed 
silage (6.8 kg/anlmal/day) supplemented the hay fed during the winter 
months. During the month before calving, corn (2.3 kg/anlmal/day) and 
mixed silage (9.0 kg/anlmal/day) were fed in addition to the ad libitum 
supply of hay. 
Purified porcine relaxln (3,000 U/mg; Schwabe and McDonald, 1977; 
Schwabe et al., 1978; Blillesbach and Schwabe, 1985) was suspended In 1 ml 
of placebo vehicle and deposited 4 cm depth into the cervical OS on day 
278 (Musah et al., 1986c,d). In the second study, estrumate (5000 yg, 
cloprostenol sodium 250 yg/ml ICI, 6B) or dexasone (20 mg, dexamethasone, 
2 mg/ml, John D. Copanos Inc., Baltimore, MD) was administered IM at 9 
and 10 d from expected parturition. Relaxln was administered IM or OS at 
0 h (time of dexasone or cloprostenol) or 24 h later as described in 
Table 1. 
Animals were categorized by genetic selection as small, medium and 
large. Heifers used In this study are from a long-term breeding project 
designed to synthesize breeds of beef cattle of different sizes for 
studies in the physiology of growth and reproduction. For the production 
of the heifers used in this study, the breed contribution of sires was 
0.25 Jersey and 0.25 Angus for the small frame; 0.125 Jersey, 0.125 Angus 
and 0.25 Slmmental for the large frame. Breed and breed-error cows of 10 
breeds (Jersey, Angus, Slmmental, Hereford, Holsteln, Brown Swiss, 
157 
Charolais, Shorthorn, Limousin and Maine—Anjou) were used to initiate the 
project in 1977. These cows were phenotypically divided into size 
groups* A significant difference (P<0.05) now exists among frame sizes 
with regard to adjusted yearling body weight, yearling hip height and 
pelvic canal area of the progeny from this crossbreeding program (Musah 
et al,, 1986b). Results from the first study were thus analyzed with 
regard to frame size and treatments. 
Statistical Analysis 
The parameters evaluated for determination of postpartum 
reproductive performance were: pregnancy rates (number of heifers 
pregnant in relation to the number receiving at least one insemination 
during the breding season); numbers of heifers present in the breeding 
herd which were not bred; number of services per conception and 
conception failure (numbers of heifers presented in herd which failed to 
conceive after four consecutive AI services). Heifers treated in 
addition to untreated herd mates were included in the statistical 
analysis. Data were analyzed using chi-square, students t-test and the 
general linear model analysis (Blair et al., 1979; Snedecor and Cochran, 
1980). 
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RESULTS 
Administration of purified porcine relaxin to prlmlparous beef 
heifers during the last trimester of gestation to facilitate parturition 
does not impair subsequent postpartum fertility as Indicated by the 
pregnancy rates (Table 2, Figure 1). Similarly, induction of parturition 
in late pregnant beef heifers using relaxin combined with cloprostenol or 
dexamethasone did not adversely affect postpartum pregnancy rates (Table 
2, Figure 1). The relative proportions of heifers with successful 
pregnancies in heifers induced to calve with relaxin, or relaxin in 
combination with cloprostenol or dexamethasone was similar (P>0<05) to 
the untreated heifers (Table 2, Figure 1). After four AX services, 95, 
94 and 93% of relaxin alone, gel vehicle and untreated herdmates in the 
breeding herd maintained pregnancy to term, respectively. Of these, 87, 
87 and 85% of relaxin treated, gel vehicle and untreated were pregnant 
after two AI services. There was no significant difference (P>0.05) in 
number of services required per conception between relaxin treated, 
relaxin with Clo or Dex, and untreated herdmates. However, significant 
(P<0.05) differences in conception rates exist between the different 
genetic body frame sizes (Figure 2). Fewer of the large frame sizes 
required more than one service in contrast with the small and medium. 
Relaxin did not affect these intrinsic differences (Table 4). 
There were differences (P<0.05) in numbers of heifers not bred, and 
not bred or not pregnant, between the different body frame sizes and 
between relaxin, relaxin combined with Clo or Dex, and untreated 
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herdmates (Tables 3 and 4, Figures 3 and 4). Reproductive failure in 
relaxin treated heifers was confined to only one season (Table 2, Figure 
3). When combined with Clo or Dex in the next season, the number of 
heifers which were not bred was lower (P<0.05) for heifers given Clo or 
Dex alone and similar (P>0.05) with the untreated herdmates (Figure 3). 
Clo or Dex had a higher (P<0.05) proportion of conception failures as 
compared with relaxin or control (Tables 3 and 4, Figures 3 and 4), 
though the large frame size heifer had a higher (P<0.05) proportion not 
bred (Tables 3 and 4, Figure 3). The medium and large frame size heifers 
had higher (F<0.05) conception failures than the small frame size 
heifers. The pattern of reproductive performance in the different frame 
size heifers was unaltered (P<0.05) by the administration of relaxin 
(Table 4). 
Table 2. Postpartum fertility aff;er induction of parturition in beef heifers with relaxln alone 
and in combination with an analog of prostaglandin or glucocorticoid 
Treatment 
Total no. 
of 
Heifers 
not 
Number of services 
per conception 
Animals 
inseminated 
and 
Animals not 
bred and 
not remaining 
heifers bred 
1 2 3 4 
remaining 
pregnant, % 
pregnant after 
insemination, ! 
Relaxln 31 8^ 17 3 2 0 95.0* 29.0* 
Relaxln plus 
cloprostenol or 
dexamethasone 
51 2^ 33 7 0 1 83.7^ 19.6*b 
PBS or PBS-Gel plus 
cloprostenol or 
dexamethasone 
20 2^ 16 0 0 0 88.9*^ 20.0*^ 
PBS-Gel 16 l'' 12 1 1 0 93.3* 12.5^ 
Untreated 260 12 155 48 11 4 87.9^ 16.2^= 
Herd 378 25 233 59 14 5 88.1*b 17.7^^ 
^^^^Columns with different superscripts differ (P<0.05). 
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Figure 1. Pregnancy rate (%) for several calving crossbred beef heifers 
induced to calve during first calving with relaxin (3,000 
U/mg) alone or in combination with cloprostenol (500 mg) or 
dexamethasone (20 mg), Percentage (Y-axis) is drawn on 
a log scale 
Table 3. Postpartum fertility In beef heifers of different genetic frame sizes 
Genetic Total 
frame no, of 
size heifers 
Heifers 
not bred 
No. % 
Number of services 
per conception 
12 3 4 
Heifers 
remaining 
pregnant 
No. % 
Heifers not 
bred and not 
remaining pregnant 
No. % 
Small 44 5 11® 19 13 6 1 39 100* 5 11* 
Medium 36 1 3^ 20 8 1 0 29 83^ 7 19^ 
Large 42 9 21^ 24 8 0 0 32 97* 10 24^ 
*^^Columns with different superscripts differ (P<0.05). 
Table 4. Postpartum fertility Im beef heifers of different genetic frame sizes after induction 
of parturition by intracervlcal administration of relaxln 
Heifers Heifers not 
Genetic Total Heifers Number of services remaining bred and not 
frame Treatment no. of not bred per conception pregnant remaining pregnant 
size heifers 
No. % 1 2 3 4 No. % No. % 
Relaxln 8 2 25 4 0 2 0 6 100* 2 25* 
Small PBS-Gel 5 1 20 3 0 1 0 4 100* 1 20* 
Untreated 31 2 6 12 13 3 1 29 100* 2 6^" 
Relaxln 9 1 11 6 1 0 0 7 
cd 00 00 
2 22* 
Medium PBS-Gel 5 0 0 5 0 0 0 5 100* 0 0^ 
Untreated 22 0 0 9 7 1 0 17 77b 5 23* 
Relaxln 14 5 36 7 2 0 0 9 100* 5 36'» 
Large PBS-Gel 6 0 0 4 1 0 0 5 83*' 1 17* 
Untreated 22 4 18 13 5 0 0 18 100* 4 18* 
*^^^Columns with different superscripts differ (P<0.05). 
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Figure 2. Cumulative conception rate (%) for second calving crossbred 
beef heifers induced to calve during first calving with 
relaxin (3,000 U/mg) alone or in combination with clo-
prostenol (500 jjg) or dexamethasone (20 mg) ; gel control 
(o); relaxin in cervical OS (•); herd (O); untreated herd-
mates (•); Clo or Dex (A); Clo or Dex and RLX (A); large 
frame (4^) ; medium frame (0) ; and small frame (O) 
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Figure 3. Proportion (%) of heifers in the breeding herd not bred in 
second calving heifers induced to calve during first calving 
section with relaxin or relaxin in combination with clo-
prostenol (500 y-g) or dexamethasone (20 mg) . Percentage 
CY-axis) is drawn on a log scale 
166 
100 
50 
LU 
(D 
§ 10 
o 
tu 
LU 
CL i 
^ SMALL 
S MEDIUM 
B LARGE 
H RELAXIN - (os) 
S GEL-PBS (OS) 
M UNTREATED 
• HERD 
EU RELAXIN + CLOP OR DEX 
M CLOP OR DEX 
UNTREATED 
HERD 
NOT PREGNANT 
Figure 4. Relative reproductive failures (%). Data from second calving 
beef heifers Induced to calve during first calving with 
relaxin or relaxin in combination with cloprostenol (500 mg) 
or dexamethasone (20 mg). Percentage (Y-axis) is drawn on 
a log scale 
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DISCUSSION 
Several studies have demonstrated that the use of glucocorticoids, 
prostaglandins and analogues of these compounds for inducing parturition 
in beef cattle invariably resulted in very high incidences of dystocia, 
increased calf mortality at birth and lowered postpartum conception 
(Laster et al., 1973; Brinks et al., 1973; Henricks et al., 1977; Davis 
et al., 1979). The analysis of the reproductive performance of heifers 
induced to calve with relaxin, relaxin in combination with cloprostenol 
or dexamethasone indicates that conception rates were not adversely 
affected by these treatments. The cumulative frequency distribution of 
the number of services per conception was similar (P>0.05) between 
relaxin treated and untreated herd mates (Figure 2). 
Higher (P<0.10) proportions of beef heifers treated with relaxin or 
relaxin with cloprostenol or dexamethasone were not bred or failed to 
maintain pregnancy compared with controls (Table 2, Figures 3 and 4). 
Conception rates can be adversely affected by severe dystocia and/or 
longer periods of retained placenta. Relaxin administration lowers the 
incidence and severity of dystocia (Musah et al., 1986b,c,d), thus 
accounting for the satisfactory conception rates in this study. 
Though the incidence of dystocia and retained placenta adversely 
affects the reproductive performance of beef heifers, the immediate 
prepartum and postpartum hormonal environment influences the resumption 
of postpartum reproductive function (Thatcher et al., 1980; Eley et al., 
1981). In this study, we reported a high proportion of relaxin treated 
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were not bred. This report showed that large and medium frame size 
heifers had significantly higher conception failure. This particular 
trend was unrelated to relaxin treatment and is an intrinsic reproductive 
function of this synthetic body frame size. We do not know exactly why 
these heifers were not bred, though those bred had excellent conception 
rates. Failure to be bred could be due to silent heat or postpartum 
anestrus. Postpartum anestrus is due to three major factors: uterine 
involution, calf suckling intensity, and pre- and postpartum nutrition 
(Beal, 1986). Uterine involution depends upon the breed and PGF levels 
during the postpartum period (Guilbaut et al., 1985). We showed in 
earlier studies that relaxin in peripheral blood plasma at 12-16 h after 
administration of relaxin by IM or into the cervical os was low (Musah et 
al., 1986d) and that postpartum involution measured as a reduction in 
size of the cervix was progressing normally (Musah et al., 1986a). A 
reduction in size is not the only requirement for uterine involution; the 
uterus must be sloughed off, regenerated, and blood flow reorganized. 
The whole process requires at least 5 weeks (Beal, 19S6). The high 
proportion of relaxin treated heifers not bred may be due to incomplete 
involution and restoration of the uterine integrity, which would lead to 
postpartum anestrus or some other reasons yet undetermined, particularly 
since this was seen only in one breeding season. 
We conclude from these studies that porcine relaxin may be used 
alone or in combination with cloprostenol and dexamethasone for 
facilitating parturition without adversely affecting subsequent 
reproductive function. 
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SUMMARY AND DISCUSSION 
These studies were conducted to determine role of exogenous relaxin 
on the physiology of bovine parturition. In particular, to quantitate 
and qualitatively describe the effects of purified porcine relaxin on 
induction of parturition, pelvic relaxation, cervical dilatation, 
progesterone, estrone, and 17&-estradiol secretion as well as determine 
the effect of relaxin treatment during the prepartum on subsequent 
reproductive fertility. 
In the first two sections of this study, forty-seven beef heifers 
categorized as small (S), medium (M) and large (L) based upon genetic 
composition were assigned at random to one of three treatments on Day 273 
of gestation: vehicle, n = 16; single relaxin (3,000 U), n =• 14; and 
double relaxin (2 x 3,000 U, 12 h apart), n = 17. Each size was repre­
sented in each treatment. Peripheral plasma progesterone (P^) levels, 
pelvic width (PW), height (PH), and cervical dilatation (CD) were 
determined from Day 270 to Day 2 postpartum. Relaxin increased PW, PH, 
and the rate of pelvic growth (cm/day) in all sizes (P<0.05). PW growth 
was 280, 213 and 204% and PH growth was 510, 264 and 204% of the respec­
tive pretreatment rates for S, M and L, respectively. PW growth was 
higher than PH growth in all sizes but maximal in S; relaxin attenuated 
these differences. For S, PW growth was 1.21 and 1.45 of the PW growth 
for M and L, respectively, before treatment and 1.6 and 2.0 after treat­
ment. Postpartum involution of PW was -0.28, -0.36 and -0.5 cm/day and 
for PH was -0.2, -0.27 and -0.29 cm/day in S, M and L, respectively. The 
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correlation between PH and PA decreased with size, CD increased to 5.49, 
6.03 and 5.54 cm in S, M and L, respectively, at 48 h post-treatment. 
Plasma P^ (10.10 ± 0.47 ng/ml) (mean ± SEM) decreased to 6.40, 5.33 and 
5.27 ng/ml by 48 h post-treatment in S, M and L, respectively. Both P^ 
and CD were unrelated to size. Relaxin given twice was more effective 
than once at inducing CD and decreasing P^ in all sizes as well as 
increasing pelvic area in S heifers. Relaxin induced marked earlier 
calving than gel vehicle (P<0.002). The intervals between the 
administration of relaxin or gel and calving were 2*1, 2.5 and 5.3 days 
for heifers given relaxin twice, once and gel vehicle, respectively. The 
duration of gestation was significantly reduced (P<0.002) in relaxin 
treated heifers as compared with control heifers. Relaxin given twice 
was more effective at inducing parturition than a single relaxin 
treatment (P<0.05). Within 24 h plasma P^ levels decreased by 0.0, 6.9 
and 7.1 ng/ml in heifers given gel, relaxin once, and twice, 
respectively. Coincident with the declining levels of P^, increased 
by 450i 1150 and 1700 pg/sl and 17g-Eg by 41, 94 and 150 pg/ml in hsifsrs 
given gel, relaxin once and twice, respectively. Mean deviation of 
cervical dilatation increased by 634, 526 and 11% in heifers given 
relaxin twice, once, and gel vehicle, respectively. Relaxin induced 
maximum pelvic opening between 12 and 36 h after treatment. 
In the third section, we described the effects of administering 
purified porcine relaxin by intramuscular injections or into the cervical 
os on plasma relaxin levels, progesterone, estrone, and 173-estradiol 
level in crossbred beef heifers during late pregnancy. 
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Purified porcine relaxin (3,000 U/mg) was administered 
intramuscularly (RLX-IM; 1 mg, n » 2); and in the cervical os (RLX-OS; 1 
mg, n = 2), on Day 273. Controls received either 0.01 M PBS (PBS; 1 ml, 
IM, n » 2), or 0.01 M GEL-PBS (GEL; 1 ml, OS, n = 2). Blood was sampled 
from a jugular catheter at -12, -6, -1.5, -0.5, 0 (time of treatment), 
0.5 h intervals to 6 h and hourly intervals to 24 h after treatment for 
RIA. Relaxin treated heifers showed an acute elevation in relaxin. In 
contrast with the control heifers, there was a significant (P<0.01) 
depression of peripheral plasma levels of progesterone in relaxin treated 
heifers. Both and E^ were significantly (P<0.05) elevated in relaxin 
treated heifers above the normal increase seen in the control heifers. 
Plasma relaxin level was 4.95, 1.5 and 0.24 ng/ml in RLX-IM, RLX-OS and 
control heifers, respectively. Peripheral plasma relaxin peaked between 
23-31 ng/ml at 1-2.5 h before returning to less than 0.5 ng/ml at 5-12 h 
after treatment. Relaxin administration accounted for 70, 73 and 58% of 
the progesterone, E^ and E^ variability between treatments, respectively. 
A. significant (P<0.01) decrease in progesterone preceded the rise in 
and E^ at 1.5, 2-2.5 and 2-3.5 h, respectively. Maximum progesterone 
deviation from pretreatment mean concentration was -5.43, -3.05 and -0.92 
ng/ml for RLX-IM, RLX-OS and controls. Peak elevation of E^ was 407.3, 
306.5 and 71.5 pg/ml and E^ was 82.2, 35. and 7.8 pg/ml for RLX-IM, RLX-
OS and controls, respectively. 
In the fourth study, the effects of porcine relaxin (RLX; 3,000 
U/mg) with cloprostenol (Clo) or dexamethasone (Dex) on induction of 
parturition, pelvic and cervical dilatation, and the incidence of 
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dystocia were investigated in crossbred beef heifers (n = 101). Clo (500 
yg, IM, n = 30) or Dex (20 mg, IM, n = 30) was given at Day 273, 10 ± 1 d 
before expected parturition (d 283). Heifers were assigned at random 
within Clo and Dex groups to receive RLX (1 mg, n « 5), IM or into the 
cervical os (OS) at 0 h (the time of Clo and Dex treatment) or 24 h 
later. In lieu of RLX, controls received .01 M PBS (1 ml, IM, n = 5) or 
.01 M Gel-PBS (1 ml, OS, n = 5). Eleven and six first calving and 16 and 
9 second calving heifers also received Clo + RLX and Clo + PBS, 
respectively. Radioimmunoassay of daily plasma samples indicated an 
abrupt decrease in progesterone with time (P<.001), from 7.5 ± .50 to 1.0 
± .30 ng/ml (mean ± SE) within 48 h for all groups. The rate of 
progesterone decrease was accelerated (P<.01) in RLX-treated heifers, in 
contrast with Dex and Clo control heifers, 5.3 ± .36 and 2.8 ± .40 ng/ml 
mean decrease in 24 h, respectively. Peripheral plasma progesterone was 
similar (P>.05) in all groups by 48 h after RLX administration. Relaxin 
combined with Clo or Dex condensed the calving period by these heifers by 
reducing the Interval between treatment and calving (33 vs. 55 h: P<-01). 
Pelvic area increased (P<.05) 3.5 ± 1.38, 10.7 ± 1.70, 5.3 ± 1.60 
2 
and 12.6 ± 2.60 cm (mean ± SE) from pretreatment means at 24 h for Clo, 
Clo + RLX, Dex, and Dex + RLX, respectively. Similarly, cervical 
dilatation increased (P<.001) .56, 2.35, .85 and 2.5 cm for Clo, Clo + 
RLX, Dex, Dex + Rl, respectively. Route of administration (IM or OS) and 
time (0 or 24 h) of relaxin treatment affected (P<.05) pelvic area and 
cervical dilatation within 2 h. The incidence and severity of dystocia 
were reduced by relaxin (P<«05), 62 and 35% calving ease and 1.8 and 2.6 
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dystocia score for relaxin and control heifers, respectively. Pelvic and 
cervical dilatation were greater (F<.01) and the incidence of dystocia 
and duration of labor were reduced (P<.01) in relaxin-treated in contrast 
with Clo alone in second as compared with first calving heifers. 
The incidence and duration of retained placenta in Clo and Dex 
groups were reduced by Rl, 23 and 75% and 12 and 24 h for R1 and Clo or 
Dex treated controls, respectively (P<.01). The incidence and duration 
of retained placenta were unrelated to progesterone concentrations 24 h 
before (r = .29) and after (r = .38) parturition. 
Finally, in the fifth section we analyzed the subsequent reproduc­
tive performance during the breeding season to determine if the prepartum 
administration of relaxin would have affected reproductive function. The 
studies showed that after 4 artificial inseminations (AI), 96, 94 and 93% 
of relaxin-treated, vehicle and untreated heifers, respectively, in the 
breeding herd maintained pregnancy to term. Of these, 87, 87 and 85% of 
relaxin-treated, vehicle and untreated heifers were pregnant after 2 A.I, 
respectively. Among small, medium and large heiferS; 1.3» 2=8 and 21=4% 
remained unbred. The interaction of relaxin and frame size was unrelated 
(P>.05), and failure to breed also was unrelated to treatments during the 
first calving season. Overall, 100, 82.9 and 97.0% of small, medium and 
large heifers bred, remained pregnant to term, respectively. When 
combined with cloprostenol or dexamethasone, the reproductive performance 
was similarly unimpaired. We conclude from these studies that purified 
relaxin administered intracervically to the primiparous beef heifers 
during late pregnancy induces premature parturition. Marked shifts of 
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P^, , I7&-E2» pelvic canal and cervical relaxation reflect the 
premature parturition induced by relaxln in cattle* These results 
provide strong evidence that a pharmacological dosage of relaxln Induces 
an acute decrease of progesterone secretion in beef heifers during late 
pregnancy. We suggest that the marked luteolytlc effect of relaxln on 
progesterone secretion could be a direct or indirect action, but the 
mechanisms are yet unknown. Relaxln induced different patterns of growth 
for PW and PH among different frame sizes of heifers. Calving 
difficulties due to inadequate dally growth or insufficient pelvic 
opening can be mediated by relaxln. The combined induction of 
parturition with relaxln and cloprostenol or relaxln have a beneficial 
effect. The incidence of dystocia was reduced due to increased pelvic 
and cervical relaxation and the incidence of retained placenta was 
similarly reduced. We also conclude that relaxln given intracervlcally 
during late pregnancy to primiparous beef heifers to facilitate 
parturition was not deleterious to subsequent postpartum fertility. 
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APPENDIX A. DATA FROM PRIMIPAROUS BEEF HEIFERS USED 
IN STUDY FROM SECTIONS I AND II IN SPRING 1984 
Table A-1. Data 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC 
PHT PWIDTH CDIAM 
BIRTH-
WT 
HCIR-
CUM 
EASE PROG 
BIRTl 
YR 
2 4 550.0 2 -9.0 17.8 16.5 3.2 8.15 82 
2 4 550.0 2 -8.0 - - - 17.8 16.5 3.2 - - - 7.81 82 
2 4 550.0 2 -7.0 - - - 18.0 16.8 4.0 - - - 9.51 82 
2 4 550.0 2 -6.0 - - - 18.0 16.9 3.7 - - - 9.96 82 
2 4 550.0 2 -5.0 - - - 17.5 16.4 4.2 - - - 9.06 82 
2 4 550.0 2 -4.0 - - - 18.0 17.4 4.0 - - - 9.67 82 
. 2 4 550.0 2 -3.0 - - - 18.4 17.5 4.8 - - - 6.51 82 
2 4 550.0 2 -2.5 - - - 18.6 17.0 5.0 - - - - 82 
2 4 550.0 2 -2.0 - - - 18.5 17.6 4.7 - - - 2.54 82 
2 4 550.0 2 -1.5 - - - 18.4 17.5 5.0 - - - - 82 
2 4 550.0 2 . -1.0 - - - 18.5 17.9 5.0 - - - 0.51 82 
2 4 550.0 2 0.0 282 -3 3 18.4 17.0 9.6 39.09 51.50 1 0.85 82 
2 4 550.0 2 0.5 - - - 18.4 17.2 9.2 - - - - 82 
2 4 550.0 2 1.0 - - - 17.4 16.7 6.8 — - - 0.64 82 
2 4 550.0 2 1.5 - - - 17.0 16.4 5.8 - - - - 82 
2 4 550.0 2 2.0 - - - 17.0 16.5 5.2 - - - 0.26 82 
16 4 465.0 2 —8.0 - - - 17.4 16.6 3.0 - - - - 82 
16 4 465.0 2 -7.0 - - - 17.4 16.6 3.0 - - - 10.19 82 
16 4 465.0 2 -6.0 - - - 17.6 16.8 3.5 - - - - 82 
16 4 465.0 2 -5.0 - - - 17.0 16.9 4.0 - - - 9.91 82 
16 4 465.0 2 -4.0 - - - 18.0 17.1 3.8 - - - 9.28 82 
16 4 465.0 2 -3.0 - - - 17.9 16.2 4.8 - - - 10.31 82 
16 4 465.0 2 -2.0 - - - 18.2 17.0 5.0 ' — - - 9.06 82 
16 4 465.0 2 -1.5 - - - 18.0 17.4 5.0 - - - - 82 
16 4 465.0 2 -1.0 - - - 18.1 16.9 5.1 - - - 9.28 82 
16 4 465.0 2 -0.5 - - - 18.0 17.8 6.8 - - - - 82 
16 4 465.0 2 0.0 281 -2 2 18.3 18.0 12.1 31.82 51.00 4 0.79 82 
16 4 465.0 2 0.5 - - - 18.3 17.9 12.1 - - - - 82 
Table A-1. (Continued) 
ID SIZE BODYlfP TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC 
PHT 
16 4 465.0 2 1.0 18.4 
16 4 465.0 2 1.5 - - - 18.2 
16 4 465.0 2 2.0 - - - 18.0 
18 4 434.0 3 -6.0 - - - 16.7 
18 4 434.0 3 -5.0 - - - 17.4 
18 4 434.0 3 -4.0 - - - 17.0 
18 4 434.0 3 -3.0 - - - 17.2 
18 4 434.0 3 -2.0 - - - 17.4 
18 4 434.0 3 —1.0 - - - 17.4 
18 4 434.0 3 -0.5 - - - 19.0 
18 4 434.0 3 0.0 279 -1 -1 18.8 
18 4 434.0 3 0.5 - - - 18.9 
18 4 434.0 3 1.0 - - - 18.8 
18 4 434.0 3 1.5 - - - 18.4 
18 4 434.0 3 2.0 - - - 17.8 
34 6 538.0 3 -9.5 - - - 18.6 
34 6 538.0 3 -8.5 - - - 18.8 
34 6 538.0 3 -7.5 - - - 18.6 
34 6 538.0 3 -6.5 - - - 18.4 
34 6 538.0 3 -5.5 - - - 18.5 
34 6 538.0 3 -4.5 - - - 18.6 
34 6 538.0 3 -4.0 - - - 18.9 
34 6 538.0 3 -3.5 - - - -
34 6 538.0 3 -3.0 - - - 18.9 
34 6 538.0 3 -2.5 - - - 19.1 
34 6 538.0 3 -1.5 - - - 19.4 
34 6 538.0 3 -0.5 - - - 19.0 
34 6 538.0 3 0.0 281 -4.5 4.5 19.4 
•34 6 538.0 3 0.5 - — - 19.4 
PWIDTH CDIAM EASE PROG 
17.2 6.4 - - - 0.03 82 
16.9 5.7 - - - - 82 
16.8 5.4 - - - 0.68 82 
15.5 2.0 - - - 11.32 82 
16.3 2.6 - - - 9.96 82 
16.4 3.1 - - - 8.26 82 
16.5 4.1 - - - - 82 
16.6 3.4 - - - 8.15 82 
16.8 4.1 - - - 7.92 82 
17.4 5.2 - - - 82 
17.8 12.2 38.18 50.00 1 1.02 82 
17.4 8.6 - - - - 82 
17.2 7.2 - - - 0.37 82 
17.6 6.8 - - - - 82 
16.9 4.2 - - - 0.23 82 
17.5 2.9 - - - 9.26 82 
17.3 2.6 - - - 7.31 82 
17.7 3.9 - - - 8.23 82 
17.4 3.8 - - - 6.76 • 82 
17.4 4.1 - - - 7.09 82 
17.5 4.2 - - - 9.27 82 
17.8 5.9 - - - - 82 
- - - - - 3.59 82 
18.0 4.9 - - - - 82 
18.4 5.2 - - - - 82 
18.0 4.7 - - - 5.45 82 
18.3 5.6 - - - 0.62 82 
18.7 9.6 44.55 51.75 3 0.08 82 
19.0 9.0 - - - 0.05 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC 
PHT 
34 6 538.0 3 1.0 19.2 
34 6 538.0 3 1.5 - - - 19.1 
57 6 618.0 3 -6.0 - - - 19.0 
57 6 618.0 3 -5.0 • — - - 19.2 
57 6 618.0 3 -4.0 - - - 19.1 
57 6 618.0 3 -3.0 - - - 19.0 
57 6 618.0 3 -2.0 - - - 19.1 
57 6 618.0 3 -1.5 - - - 19.4 
57 6 618.0 3 -1.0 - - - 19.6 
57 6 618.0 3 -0.5 - - - 19.6 
57 6 618.0 3 0.0 286 -2.0 2.0 19.6 
57 6 618.0 3 0.5 - - - 19.4 
57 6 618.0 3 1.0 - - - 19.4 
57 6 618.0 3 1.5 - - - 19.0 
57 6 618.0 3 2.0 - - - 19.0 
62 2 430.0 4 -4.0 - - - 17.2 
62 2 430.0 4 -3.0 - - - 17.0 
62 2 430.0 4 -1.5 - - - 18.0 
62 2 430.0 4 -1.0 - - - 18.8 
62 2 430.0 4 -0.5 - - - 19.1 
62 2 430.0 4 0.0 267 -1.5 1.5 18.8 
62 2 430.0 4 0.5 - - - 18.9 
62 2 430.0 4 1.0 - - - 18.6 
62 2 430.0 4 1.5 - - - 18.9 
62 2 430.0 4 2.0 - - - 18.1 
62 2 430.0 4 3.0 - - - 18.2 
102 6 550.0 2 -12.5 - - - 18.0 
102 6 550.0 2 -11.5 - - - 18.0 
102 6 550.0 2 -10.5 - - - 17.6 
PWIDTH CDIAM EASE PROG. 
18.4 8.6 - - - - 82 
18.6 6.0 - - - 0.08 82 
17.0 3.0 - - - 12.80 82 
16.9 3.0 - - - 10.47 82 
17.1 3.4 - - - 12.45 82 
17.4 4.1 - - - 8.04 82 
17.2 3.9 - - - 8.04 82 
17.8 6.4 - - - - 82 
18.5 3.9 - - - 2.83 82 
18.5 4.2 - - - - 82 
18.4 11.9 52.73 56.50 3 2.55 82 
18.6 8.6 - - - - 82 
18.2 6.2 - - - 0.06 82 
17.6 4.1 - - - - 82 
17.1 3.8 - - - 0.04 82 
16.0 2.6 - - - 11.89 82 
16.4 3.6 - - - 12.68 82 
17.5 6.6 - - - - 82 
17.8 6.0 - - - 2.33 82 
17.9 6.9 - - - - 82 
17.9 10.4 23.64 44.00 1 2.53 82 
17.8 8.3 - - - - 82 
16.3 7.9 - 0 - 1.69 82 
16.5 7.8 - - - - 82 
16.3 6.5 - - - 0.62 82 
16.3 6.4 - - - 0.45 82 
16.0 2.9 - - - 12.46 82 
16.0 3.0 - - - 12.57 82 
16.2 3.2 - - - 11.09 82 
Table A-1. (Continued) 
ID SIZE BODYWT IRI % % PWIDTH CDIAM EASE PROG. 
102 6 550.0 2 —9*5 - - - 18.4 15.8 3.8 - - - 10.70 82 
102 6 550.0 2 -8.5 - - - 18.6 16.0 4.0 - - - 11.89 82 
102 6 550.0 2 -7.5 - - - 18.5 17.0 4.4 - - - 10.65 82 
102 6 550.0 2 -6.5 - - - 18.2 17.3 4.0 - - - 10.13 82 
102 6 550.0 2 —6.0 - - - 18.0 17.6 4.4 - - - - 82 
102 6 550.0 2 -5.5 - - - 18.1 17.1 4.2 - - - 8.83 82 
102 6 550.0 2 -5.0 - - - 18.0 17.2 4.3 - - - - 82 
102 6 550.0 2 -4.5 - - - 18.2 17.4 4.0 - - - 6.91 82 
102 6 550.0 2 -3.5 - - - 18.4 17.5 4.0 - - - 7.64 82 
102 6 550,0 2 -2.5 - - - 18.4 17.8 4.6 - - - 6.39 82 
102 6 550.0 2 -1.5 - - - 18.2 17.5 4.8 - - - 5.42 82 
102 6 550.0 2 -0.5 - - - 19.5 18.0 4.0 - - - 1.39 82 
102 6 550.0 2 0.0 286 -6.5 6.5 19.6 18.0 8.3 42.72 50.50 4 - 82 
102 6 550.0 2 0.5 - - - 19.6 18.0 7.9 - - - 0.71 82 
102 6 550.0 2 1.0 - - - 19.5 17.9 7.5 - - - - 82 
102 6 550.0 2 1.5 - - - 17.2 17.0 6.9 - - - 0.51 82 
114 2 404.0 3 -6.5 - - - 17.0 16.2 2.5 - - - 10.42 82 
114 2 404.0 3 -5.5 - - - 17.0 16.4 3.6 - - - 11.94 82 
114 2 404.0 3 -4.5 - - - 17.5 16.9 3.6 - - - 11.63 82 
114 2 404.0 3 -3.5 - - - 17.2 16.8 3.8 - - - 10.28 82 
114 2 404.0 3 -2.5 - - - 17.0 16.8 4.2 - - - 12.45 82 
114 2 404.0 3 -2.0 - - - 17.3 17.0 5.9 - - - - 82 
114 2 404.0 3 -1.5 - - 17.0 16.8 4.6 - - - 4.30 82 
114 2 404.0 3 -1.0 - - - 17.2 17.0 4.8 - - - - 82 
114 2 404.0 3 -0.5 - - - 17.6 17.1 5.9 - - - 1.19 82 
114 2 404.0 3 0.0 280 -2.5 2.5 17.8 17.1 12.6 42.73 55.50 4 - 82 
114 2 404.0 3 0.5 - - - 17.8 17.0 8.8 - - - 0.68 82 
114 2 404.0 3 1.0 - - - 17.6 16.9 6.6 - - - - 82 
114 2 404.0 3 1.5 - - - 17.1 16.9 4.1 - - - 0.70 82 
Table A-1. (Continued) 
IDSIZEBODÏBT TET PHT PWIDIH CDI4M EASE PROG. 
120 6 520.0 3 -9.5 - - - 19.0 17.1 3.3 - - - 10.14 82 
120 6 520.0 3 -8.5 - - - 19.1 17.0 3.1 - - - 8.83 82 
120 6 520.0 3 -7.5 - - - 19.1 17.1 3.3 - - - .  9.06 82 
120 6 520.0 3 -6.5 - - - 19.4 17.0 3.7 - - - 10.75 82 
120 6 520.0 3 -5.5 - - - 19.2 17.1 3.1 - - - 12.86 82 
120 6 520.0 3 -4.5 - - - 19.1 17.6 3.1 - - - 11.89 82 
120 6 520.0 3 -3.5 - - - 19.6 17.6 3.4 - - - 12.74 82 
120 6 520.0 3 -3.0 - - - 19.8 18.1 5.1 - - - - 82 
120 6 520.0 3 -2.5 - - - 19.2 18.6 5.3 - - - 7.35 82 
120 6 520.0 3 -2.0 - - - 20.0 19.1 5.6 - - - - 82 
120 6 520.0 3 -1.5 - - - 20.0 19.1 5.2 - - - 2.15 82 
120 6 520.0 3 -0.5 - - - 19.8 19.0 5.6 - - - 1.02 82 
120 6 520.0 3 0.0 282 -3.5 3.5 20.0 19.1 11.2 41.82 47.25 3 - 82 
120 6 520.0 3 0.5 - - - 19.8 18.9 8.4 - - 0.64 82 
120 6 520.0 3 1.0 - - - 19.4 18.0 6.8 - - - - 82 
120 6 520.0 3 1.5 - - - 19.4 18.0 5.2 - - - 0.45 82 
124 4 459.0 2 -10.5 - - - 17.6 16.0 3.9 - - - 10.19 82 
124 4 459.0 2 -9.5 - - - 17.6 16.5 4.0 - - - 11.32 82 
124 4 459.0 2 —8.5 - - - 17.8 16.2 4.2 - - - 11.20 82 
124 4 459.0 2 -7.5 - - - 18.2 17.3 3.9 - - - 9.66 82 
124 4 459.0 2 -6.5 - - - 17.9 17.0 4.1 - - - 9.51 82 
124 4 459.0 2 -5.5 - - - 18.0 17.4 3.9 - - - 9.74 82 
124 4 459.0 2 -4.5 - - - 18.0 17.5 3.6 - - - 9.65 82 
124 4 459.0 2 -4.0 - - - 18.2 17.1 3.7 - - - - 82 
124 4 459.0 2 -3.5 - - - 18.0 17.1 3.5 - - - 10.76 82 
124 4 459.0 2 -3.0 - - - 18.0 17.1 3.6 - - - - 82 
124 4 459.0 2 -2.5 - - - 18.0 17.0 3.7 - - - 6.89 82 
124 4 459.0 2 -1.5 - - - 18.2 18.0 4.0 - - 5.09 82 
124 4 459.0 2 -0.5 - - - 18.6 17.9 4.0 - - - 0.79 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC PHT 
124 4 459.0 2 0.0 284 -4.5 4.5 18.3 
124 4 459.0 2 0.5 - - - 18.1 
124 4 459.0 2 1.0 - - - 18.2 
124 4 459.0 2 1.5 - - - 18.1 
126 2 440.0 2 -9.5 - - - 17.0 
126 2 440.0 2 -8.5 - - - 16.8 
126 2 440.0 2 -7.5 - - - 17.5 
126 2 440.0 2 -6.5 - - - 17.2 
126 2 440.0 2 -5.5 - - - 17.5 
126 2 440.0 2 -4.5 - - - 17.6 
126 2 440.0 2 -3.5 - - - 17.8 
126 2 440.0 2 -3.0 - - - 18.0 
126 2 440.0 2 -2.5 - - - 18.0 
126 2 440.0 2 -2.0 - - - 17.9 
126 2 440.0 2 -1.5 - - - 18.2 
126 2 440.0 2 -0.5 - - - 18.2 
126 2 440.0 2 0.0 282 -3.5 3.5 18.0 
126 2 440.0 2 0.5 - - - 17.9 
126 2 440.0 2 1.0 - - - 17.4 
126 2 440.0 2 1.5 - - - 17.3 
140 2 442.0 2 -21.0 - - - 17.9 
140 2 442.0 2 -20.0 - - - 17.4 
140 2 442.0 2 -19.0 - - - 17.4 
140 2 442.0 2 -18.0 - - - 17.6 
140 2 442.0 2 -17.0 - - - 17.2 
140 2 442.0 2 -16.0 - - - 17.4 
140 2 442.0 2 -15.0 - - - 18.2 
140 2 442.0 2 -14.5 - - - 18.2 
PWIDTH CDIAM EASE PROG, 
18.2 8.9 34.55 - 1 -
17.6 6.0 - - - 0.74 
17.1 5.1 - - - -
17.3 4.8 - - - 0.66 
16.5 3.0 - - - 12.23 
16.0 3.5 - - - 14.16 
16.0 3.5 - - - 10.31 
16.4 3.3 - - - 11.43 
16.4 4.3 - - - 12.00 
16.2 4.7 - - - 8.95 
17.0 4.8 - - - 10.87 
16.9 4.7 - - - -
16.2 4.5 - - - 11.89 
16.7 4.9 - - - -
17.4 6.0 - - - 2.21 
17.4 6.5 - - - 0.25 
17.0 8.9 35.45 42.50 1 -
16.8 5.6 - - - 0.34 
16.6 5.4 - - - -
16.6 5.2 - - - 0.23 
15.2 1.9 - - - -
16.3 1.9 - - - -
16.0 2.0 - - - -
16.1 2.0 - - - -
16.4 2.4 - - - -
16.5 3.0 - - - -
17.0 3.2 - - - 11.53 
17.0 3.3 - - - -
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
EAY-
TRT 
DAY-
TTOC PHT 
140 2 442.0 2 -14.0 18.0 
140 2 442.0 2 -13.5 - - - 18.1 
140 2 442.0 2 -13.0 - - - 18.1 
140 2 442.0 2 -12.0 - - - 18.2 
140 2 442.0 2 -11.0 - - - 18.2 
140 2 442.0 2 -10.0 - - - 18.5 
140 2 442.0 2 -9.0 - - - 18.5 
140 2 442.0 2 —8.0 - - - 18.2 
140 2 442.0 2 -7.0 - - - 18.1 
140 2 442.0 2 -6.0 - - - 18.1 
140 2 442.0 2 -5.0 - - - 18.0 
140 2 442.0 2 -4.0 - - - 18.0 
140 2 442.0 2 -3.0 - - - 18.2 
140 2 442.0 2 -2.0 - - - 18.1 
140 2 442.0 2 -1.0 - - - 18.4 
140 2 442.0 2 0.0 294 -15.0 15.0 18.1 
140 2 442.0 2 0.5 - - - 18.2 
140 2 442.0 2 1.1 - - - 17.9 
140 2 442.0 2 1.5 - - - 17.8 
140 2 442.0 2 2.0 - - - 18.0 
142 6 627.0 2 -14.0 - - - 18.0 
142 6 627.0 2 -13.0 - — - 18.4 
142 6 627.0 2 -12.0 - — - 18.1 
142 6 627.0 2 -11.0 - - - 18.1 
142 6 627.0 2 -10.0 - - - 18.1 
142 6 627.0 2 -9.0 - - - 18.1 
142 6 627.0 2 —8.0 - - - 18.6 
142 6 627.0 2 -7.5 - - - 18.6 
142 6 627.0 2 -7.0 - - - 18.4 
PHIDTH CDIAM EASE PROG, 
17.1 3.4 - - - 10.39 82 
17.4 3.0 - - - - 82 
16.6 3.2 - - - 10.37 82 
17.6 3.0 - - - 10.22 82 
17.6 3.0 - - - 9.38 82 
16.9 3.0 - - - 9.06 82 
17.1 3.5 - - - 9.38 82 
17.1 3.2 - - - 8.60 82 
17.2 3.8 - - - - 82 
17.1 4.2 - - - 8.97 82 
17.0 4.0 - - - - 82 
17.3 3.9 - - - 7.82 82 
17.0 4.0 - - - 7.40 82 
17.1 4.3 - - - 7.48 82 
17.0 4.4 - - - 5.50 82 
17.2 9.8 33.64 45.25 1 0.16 82 
17.3 8.0 - - - - 82 
16.5 7.1 - - - 0.09 82 
16.8 5.3 - - - - 82 
17.0 4.3 - - - 0.05 82 
17.2 2.2 - - - - 82 
17.2 2.6 - - - - 82 
17.0 2.5 - - - - 82 
17.1 2.6 - - - - 82 
17.0 2.5 - - - - 82 
17.3 3.0 - - - 9.04 82 
17.5 3.0 - - - 8.55 82 
17.6 3.2 - - - - 82 
17.4 3.2 - - - 9.30 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
D&Y-
TRT 
DAY-
TTOC PHT 
142 6 627.0 2 -6.5 18.5 
142 6 627.0 2 -6.0 - - 18.4 
142 6 627.0 2 -5.0 - - 18.4 
142 6 627.0 2 -4.0 - - 18.4 
142 6 627.0 2 -3.0 - - 18.4 
142 6 627.0 2 -2.0 - - 18.5 
142 6 627.0 2 -1.0 - - 18.6 
142 6 627,0 2 0.0 282 -3.0 8.0 18.8 
142 6 627.0 2 0.5 - - 18.8 
142 6 627.0 2 1.0 - - 19.0 
142 6 627.0 2 1.5 - - 19.0 
142 6 627.0 2 2.0 - - 18.4 
147 6 404.5 4 -2.0 - - 18.2 
147 6 404.5 4 -1.0 - - 18.5 
147 6 404.5 4 -0.5 - - 19.6 
147 6 404.5 4 0.0 282 -0.5 0.5 19.5 
147 6 404.5 4 0.5 - - 19.1 
147 6 404.5 4 1.0 - - 18.7 
147 6 404.5 4 1.5 - - 18.9 
147 6 404.5 4 2.0 - - 18.6 
162 2 410.9 2 -8.5 - - 16.8 
162 2 410.9 2 -7.5 - - 16.2 
162 2 410.9 2 -6.5 - - 16.5 
162 2 410.9 2 -5.5 - - 17.0 
162 2 410.9 2 -4.5 - - 17.0 
162 2 410.9 2 -3.5 - - 17.2 
162 2 410.9 2 -2.5 - - 16.8 
162 2 410.9 2 -2.0 - - 16.9 
162 2 410.9 2 -1.5 - - 16.8 
162 2 410.9 2 -1.0 - - 16.9 
PWIDTH CDIAM EASE PROG. 
17.6 3.3 - - - - 82 
17.2 3.1 - - - 6.58 82 
17.6 3.1 - - - 6.81 82 
17.4 3.0 - - - 6.58 82 
17.3 3.9 - - - 6.06 82 
17.6 4.2 - - - - 82 
17.6 4.5 - - - 2.02 82 
17.8 10.5 45.45 54.00 1 0.81 82 
17.4 8.3 - - - - 82 
17.3 6.5 - - - 0.39 82 
17.2 6.5 - - - - 82 
16.9 5.1 - - - 0.83 82 
16.0 2.9 - - . - 11.55 82 
16.5 4.0 - - - 11.09 82 
17.6 6.2 - - - - 82 
17.8 12.0 42.73 53.00 3 1.81 82 
17.9 8.9 - - - - 82 
17.1 7.6 - - - 0.45 82 
17.2 4.5 - - - - 82 
17.2 4.2 - - - 0.84 82 
13.5 3.0 - - - 7.93 82 
14.0 3.7 - - - 7.13 82 
15.4 3.0 - - - 4.87 82 
15.4 3.9 - - - 7.64 82 
15.9 3.8 - - - 6.11 82 
15.8 3.6 - - - 7.70 82 
16.0 4.0 - - - 4.98 82 
15.8 4.2 - - - - 82 
15.6 4.1 - - - 82 
15.4 4.0 - - - 6.39 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC PHT 
162 2 410.9 2 -0.5 _ 16.9 
162 2 410.9 2 0.0 281 -2.5 2.5 17.1 
162 2 410.9 2 0.5 - - - 17.0 
162 2 410.9 2 1.0 - - - 16.9 
162 2 410.9 2 1.5 - - - 16.8 
169 6 466.0 4 -2.5 - - - 19.0 
169 6 466.0 4 -1.5 - - - 19.0 
169 6 466.0 4 -1.0 - - - 19.4 
169 6 466.0 4 -0.5 - - - 19.5 
169 6 466.0 4 0.0 279 -1.0 1.0 19.6 
169 6 466.0 4 0.5 - - - 19.6 
169 6 466.0 4 1.0 - - - 19.4 
169 6 466.0 4 1.5 - - - 19.2 
169 6 466.0 4 2.5 - - - 19.0 
170 6 440.0 3 -10.0 - - - 19.0 
170 6 440.0 3 -9.0 - - - 19.0 
170 6 440.0 3 -8.0 - - - 19.1 
170 6 440.0 3 -7.0 - - - 19.6 
170 6 440.0 3 -6.0 - - - -
170 6 440.0 3 -5.0 - - - 19.4 
170 6 440.0 3 -4.0 - - - 19.3 
170 6 440.0 3 -3.5 - - - 19.4 
170 6 440.0 3 -3.0 - - - 20.0 
170 6 440.0 3 -2.5 - - - 20.0 
170 6 440.0 3 -2.0 - - - 19.2 
170 6 440.0 3 -1.0 - - - 19.1 
170 6 440.0 3 0.0 283 -4.0 4.0 -
170 6 440.0 3 0.5 - - - 19.1 
170 6 440.0 3 1.0 - - - 19.2 
170 6 440.0 3 1.5 - — - 19.1 
PWIDTH CDIAM EASE PROG. 
15.5 3.9 - - - - 82 
16.0 8.4 32.73 46.75 2 0.94 82 
16.1 7.5 - - - - 82 
15.9 6.6 - - - 0.67 82 
15.9 6.0 - - - 0.60 82 
17.0 3.8 - - - 7.64 82 
17.2 3.8 - - - 10.47 82 
17.6 5.8 - - - - 82 
18.2 6.8 - - - 0.65 82 
18.3 11.8 45.45 51.5 3 - 82 
18.4 10.6 - - - 0.62 82 
18.4 8.5 - - - - 82 
18.5 7.8 - - - 0.49 82 
17.8 6.4 - - - 0.40 82 
16.5 2.6 - - - - 82 
17.5 2.9 - - - - 82 
17.0 2.8 - - 11.89 82 
17.1 3.1 - - - 9.26 82 
- - - - - - 82 
17.5 3.6 - - - 8.49 82 
17.4 4.1 - - - 8.49 82 
18.1 6.1 - - - - 82 
19.5 5.8 - - - 3.81 82 
19.5 4.3 - - - - 82 
18.5 4.2 - - - 2.91 82 
18.6 4.3 - - - 1.68 82 
- - 46.36 - 2 0.79 82 
18.6 11.3 - - - - 82 
18.4 8.0 - - - 0.59 82 
18.0 7.1 - - - - 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT % PHT PWIDTH CDIAM EASE PROG. 
170 6 440.0 3 2.0 - - - 18.9 17.1 5.5 - - - 0.27 82 
187 4 427.0 3 -8.5 - - - 17.0 17.0 2.6 - - - 15.68 82 
187 4 427.0 3 -7.8 - - - 17.4 16.6 3.1 - - - - 82 
187 4 427.0 3 -6.5 - - - 17.2 16.8 3.6 - - - 13.66 82 
187 4 427.0 3 -5.5 - - - 17.4 17.0 3.7 - - - 15.18 82 
187 4 427.0 3 -4.5 - - - 17.6 17.5 3.7 - - - 13.66 82 
187 4 427.0 3 -3.5 - - - 17.4 17.0 3.9 - - - 13.41 82 
187 4 427.0 3 -2.5 - - - 17.6 17.0 4.1 - - - 15.68 82 
187 4 427.0 3 -1.5 - - - 17.6 17.1 3.9 - - - 14.28 82 
187 4 427.0 3 -1.0 - - - 18.4 18.1 4.8 - - - - 82 
187 4 427.0 3 -0.5 - - - 19.6 18.0 6.1 - - - 0.81 82 
187 4 427.0 3 0.0 282 -1.5 1.5 19.4 18.0 11.6 41.82 53.0 3 — 82 
187 4 427.0 3 0.5 - - - 19.5 18.1 10.2 - - - 0.56 82 
187 4 427.0 3 1.5 - - - 19.0 17.6 7.1 - - - - 82 
187 4 427.0 3 1.5 - - - 18.0 17.0 4.5 - - - 0.45 82 
192 2 400.0 4 -4.5 - - - 17.1 16.4 2.0 - - - 8.34 82 
192 2 400.0 4 -3.5 - - - 17.4 16.8 2.8 - - - 10.62 82 
192 2 400.0 4 -2.5 - - - 17.8 16.6 3.8 - - - 10.36 82 
192 2 400.0 4 -2.0 - - - 17.8 17.1 4.1 - - - - 82 
192 2 400.0 4 -1.5 - - - 18.0 17.8 6.2 - - - 9.71 82 
192 2 400.0 4 -1.0 - - - 18.8 17.4 5.8 - - - - 82 
192 2 400.0 4 -0.5 - - - 18.9 18.2 6.3 - - - 1.26 82 
192 2 400.0 4 0.0 282 -2.0 2.0 19.3 18.0 11.5 30.91 48.0 2 - 82 
192 2 400.0 4 0.5 - - - 19.1 18.0 10.5 - - - 0.86 82 
192 2 400.0 4 1.0 - - - 19.0 17.4 8.2 - - - - 82 
192 2 400.0 4 1.5 - - - 18.6 17.0 6.9 - - - 0.53 82 
192 2 400.0 4 2.0 - - - 18.4 17.2 6.5 - - - - 82 
192 2 400.0 4 2.5 - - - 18.6 17.0 5.9 - - - - 82 
206 4 540.0 3 -8.0 - - - 18.6 17.0 2.6 - - - 8.61 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC PHT 
206 4 540.0 3 -7.0 _ _ _ 18.8 
206 4 540.0 3 -6.0 - - - 19.0 
206 4 540.0 3 -5.0 - - - 19.0 
206 4 540.0 3 -4.0 - - - 19.1 
206 4 540.0 3 -3.0 - - - 19.1 
206 4 540.0 3 -2.0 - - - 19.1 
206 4 540.0 3 -1.5 - - - 19.6 
206 4 540.0 3 -1.0 - - - 19.6 
206 4 540.0 3 -0.5 - - - 19.4 
206 4 540.0 3 0.0 278 -2.0 2.0 19.6 
206 4 540.0 3 0.5 - - - 19.5 
206 4 540.0 3 1.0 - - - 19.4 
206 4 540.0 3 1.5 - - - 19.0 
206 4 540.0 3 2.0 - - - 18.8 
214 2 392.0 4 -11.0 - - - 16.4 
214 2 392.0 4 -10.0 - - - 16.8 
214 2 392.0 4 -9.0 - - - 17.2 
214 2 392.0 4 -8.0 - - - 17.3 
214 2 392.0 4 -7.0 - - - 17.1 
214 2 392.0 4 -6.0 - - - 17.6 
214 2 392.0 4 -5.0 - - - 17.6 
214 2 392.0 4 -4.0 - - - 17.2 
214 2 392.0 4 -3.0 - - - 17.6 
214 2 392.0 4 -2.0 - - - 17.4 
214 2 392.0 4 -1.5 - - - 18.0 
214 2 392.0 4 -1.0 - - - 18.5 
214 2 392.0 4 -0.5 - - - 18.4 
214 2 392.0 4 0.0 282 -1.5 1.5 18.5 
214 2 392.0 4 0.5 - - - 18.5 
214 2 392 4 1.0 - - - 18.6 
PWIDTH CDIAM EASE PROG, 
17.1 3.4 - - - -
17.0 4.0 - - - 9.26 
17.0 3.6 - - - 10.49 
17.2 3.8 - - - 10.85 
17.1 4.2 - - - 10.65 
17.1 4.0 - - - 10.24 
17.8 5.9 - - - -
18.4 4.8 - - - 2.43 
19.0 4.5 - - - -
18.5 10.5 49.09 54.0 3 2.02 
18.4 8.5 - - - -
18.6 7.6 - - - 1.92 
18.0 5.6 - - - -
17.4 4.1 - - - 0.86 
16.0 3.0 - - - 10.76 
16.5 2.9 - - - 8.49 
16.1. 3.1 - - - 8.21 
16.2 3.1 - - - 11.89 
16.4 3.1 - - - 10.47 
16.0 2.9 - - - 12.45 
15.8 2.9 - - - -
15.9 2.9 - - - 11.04 
16.4 3.9 - . - - 11.04 
16.5 4.5 - - - 11.09 
16.6 6.3 - - - -
17.0 6.7 - - - 5.04 
16.7 6.9 - - - -
17.8 12.0 35.45 45.0 3 1,47 
16.9 11.2 - - - -
17.4 10.8 - - - 1.02 
82 
82 
82 
82 
82 
82 
82 
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82 
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82 
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82 
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Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC PHT 
214 2 392.0 4 1.5 18.4 
214 2 392 4 2.0 - - - 18.4 
220 6 579.0 2 -14.0 - - - 18.9 
220 6 579.0 2 -13.0 - - - 19.0 
220 6 579 2 -12.0 - - - 19.0 
220 6 579.0 2 -11.0 - - - 19.2 
220 6 579.0 2 -10.0 - - - 19.1 
220 6 579.0 2 -9.0 - - - 19.1 
220 6 579.0 2 —8.0 - - - 19.2 
220 6 579.0 2 -7.5 - - - 19.1 
220 6 579.0 2 -7.0 - - - 19.5 
220 6 579.0 2 -6.5 - - - 19.6 
220 6 579.0 2 -6.0 - - - 19.3 
220 6 579.0 2 -5.0 - - - 19.2 
220 6 579.0 2 -4.0 - - - 19.4 
220 6 579.0 2 -3.0 - - - 19.2 
220 6 579.0 2 -2.0 - - - 19.4 
220 6 579.0 2 -1.0 - - - 19.6 
220 • 6 579.0 2 0.0 284 -3.0 8.0 19.3 
220 6 579.0 2 0.5 - - - 18.9 
226 6 579.0 2 1.0 - - - 18.8 
220 6 579.0 2 1.5 - - - 18.9 
220 6 579.0 2 2.0 - - - 19.0 
221 6 509.0 4 -2.0 - - - 18.0 
221 6 509.0 4 -1.0 - - - 18.2 
221 6 509.0 4 -0.5 - - - 19.0 
221 6 509.0 4 0.0 273 -0.5 0.5 19.3 
221 6 509.0 4 0.5 - - - 19.2 
221 6 509.0 4 1.0 - - - 19.3 
PWIDTH CDIAM "çJJ" EASE PROG. 
17.2 10.6 - - - - 82 
17.1 6.5 - - - 1.19 82 
17.5 2.2 - - - - 82 
17.0 3.3 - - - - 82 
17.2 3.0 . - - - - 82 
17.6 3.1 - - - - 82 
17.4 3.2 - - - - 82 
17.0 3.3 - - - - 82 
17.4 3.2 - - - 11.61 82 
17.2 3.1 - - - - 82 
17.4 3.0 - - 11.21 82 
17.5 5.3 - - - 82 
17.0 3.3 - - - 9.34 82 
17.3 3.2 - - - 9.91 82 
17.4 3.1 - - — 7.81 82 
17.1 3.2 - - - 9.97 82 
17.2 4.0 - - - 11.72 82 
17.6 4.9 - - - 6.79 82 
17.6 8.9 44.55 49.0 3 2.04 82 
17.8 7.2 - - - - 82 
17.8 6.5 - - - 1.18 82 
17.9 6.5 - - - - 82 
17.0 4.4 - - - 0.85 82 
17.0 3.2 - - - 11.66 82 
17.6 4.1 - - - 9.06 82 
17.8 5.9 - - - - 82 
19.0 12.6 33.64 52.5 4 1.92 82 
19.0 11.5 - - - - 82 
19.0 11.6 - - - 0.46 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TiRT 
DAY-
TTOC PHT 
221 6 509.0 4 1.5 _ 19.3 
221 6 509.0 4 2.0 - - 19.0 
229 2 462.0 1 -6.0 - - 18.6 
229 2 462.0 1 -5.0 - - 18.8 
237 6 459.0 3 -6.5 - - 18.0 
237 6 459.0 3 -5.5 - - 18.0 
237 6 459.0 3 -4.5 - - 18.0 
237 6 459.0 3 -3.5 - - 18.0 
237 6 459.0 3 -2.5 - - 18.6 
237 6 459.0 3 -2.0 - - 18.4 
237 6 459.0 3 -1.5 - - 18.9 
237 6 459.0 3 -1.0 - - 18.5 
237 6 459.0 3 -0.5 - - 18.6 
237 6 459.0 3 0.0 277 -2.5 2.5 -
237 6 459.0 3 0.5 - - 18.2 
237 6 459.0 3 1.0 - - 18.0 
237 6 459.0 3 1.5 - - 18.1 
249 4 457.0 2 -13.0 - - 17.0 
249 4 457.0 2 -12.0 - - 17.0 
249 4 457.0 2 -11.0 - - 17.0 
249 4 457.0 2 -10.0 - - 17.5 
249 4 457.0 2 -9.0 - - 18.0 
249 4 457.0 2 —8.0 - - 18.0 
249 4 457.0 2 -7.0 - - 17.8 
249 4 457.0 2 -6.5 - • - 17.8 
249 4 457.0 2 -6.0 - - 18.5 
249 4 457.0 2 -5.5 - - 18.2 
249 4 457.0 2 -5.0 - - 18.2 
249 4 457.0 2 -4.0 - - 18.5 
PWIDTH CDIAM C^IR- gaSE PROG. 
18.3 8.0 - - - - 82 
17.2 4.0 - - - 0.44 82 
17.5 3.4 - - - 11.24 82 
17.3 3.5 - - - 12.91 82 
17.4 3.0 - - - 8.18 82 
17.2 3.8 - - - 8.73 82 
17.0 3.6 - - - 9.90 82 
17.2 3.9 - - - 10.71 82 
17.6 4.1 - - - 11.90 82 
17.6 5.1 - - - - 82 
18.5 5.2 - - - 2.46 82 
18.4 6.9 - - - - 82 
18.0 6.9 - - - 0.95 82 
- - 38.18 52.75 3 - 82 
18.0 6.8 - - - 0.41 82 
18.0 5.4 - - - - 82 
17.6 4.5 - - - 0.53 82 
15.5 3.5 - - - - 82 
16.0 3.6 - - - 7.36 82 
16.0 3.2 - - - 10.65 82 
16.4 3.6 - - - 9.63 82 
16.5 4.0 - .  - - 11.21 82 
16.5 4.8 - - - 7.10 82 
17.4 5.1 - - - 6.80 82 
17.4 4.9 - - - - 82 
17.0 4.9 - - - 7.85 82 
16.9 5.0 - - - - 82 
17.5 4.8 - - - 6.80 82 
17.8 5.8 - - - 7.40 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC PHT 
249 4 457.0 2 -3.0 18.2 
249 4 457.0 2 -2.0 - - - -
249 4 457.0 2 -1.0 - - - -
249 4 457.0 2 0.0 285 -7.0 7.0 18.1 
249 4 457.0 2 0.5 - - - 18.2 
249 4 457.0 2 1.0 - - - 18.2 
249 4 457.0 2 1.5 - - - 18.2 
249 4 457.0 2 2.0 - - - 18.0 
256 2 455.8 2 -6.0 - - - 18.0 
256 2 455.8 2 -5.0 - - - 18.0 
256 2 455.8 2 -4.0 - - - 18.0 
256 2 455.8 2 -3.0 - - - 17.9 
256 2 455.8 2 -2.5 - - - 18.0 
256 2 455.8 2 -2.0 - - - 18.0 
256 2 455.8 2 -1.5 - - - 18.1 
256 2 455.8 2 -1.0 - - - 18.1 
256 2 455.8 2 0.0 - -3.0 3.0 18.2 
256 2 455.8 2 0.5 - - - 18.4 
256 2 455.8 2 1.0 - - - 18.4 
256 2 455.8 2 1.5 - - - 18.0 
256 2 455.8 2 2.0 - - - 18.0 
258 6 570.0 2 -6.0 - - - 18.0 
.258 6 570.0 2 -5.0 - - - 18.0 
258 6 570.0 2 -4.0 - - - 18.2 
258 6 570.0 2 -3.5 - - - 18.6 
258 6 570.0 2 -3.0 - - - 17.8 
258 6 570.0 2 -2.05 - - - 18.5 
258 6 570.0 2 -2.0 - - - 18.6 
258 6 570.0 2 -1.0 - - - 18.4 
PWIDTH CDIAM EASE PROG, 
17.5 5.6 8.50 
17.0 12.1 32.72 41.25 4 0.28 
17.0 8.2 - - - -
17.0 8.1 - - - 0.33 
16.8 6.3 - - - -
16.8 6.0 - - - 0.24 
16.4 2.6 - - - 11.21 
16.0 3.2 - - - 10.64 
16.4 3.5 - - - 10.64 
16.5 4.0 - - - 7.13 
16.4 4.0 - - - -
16.6 4.1 - - - 6.79 
16.4 4.2 - - - -
16.8 4.3 - - - 3.06 
17.0 4.9 31.82 45.5 1 -
17.1 10.5 - - - 1.81 
17.1 8.6 - - - -
17.1 6.4 - - - 0.57 
16.9 4.2 - - - -
16.0 2.8 - - - 11.21 
17.0 3.4 - - - 11.21 
17.2 4.1 - - - 9.63 
17.3 4.3 - - - -
17.2 4.9 - - - 11.32 
17.4 4.7 - - - -
17.4 4.8 - - - 12.46 
17.6 5.1 - - - 11.22 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC PHT 
258 6 570.0 2 0.0 279 -4.0 4.0 18.6 
258 6 570.0 2 0.5 - - - 18.4 
258 6 570.0 2 1.0 - - - 17.8 
258 6 570.0 2 1.5 - - - 17.6 
258 6 570.0 2 2.0 - - - 17.9 
283 6 509.0 2 -11.0 - - - 17.4 
283 6 509.0 2 -10.0 - - - 17.4 
283 6 509.0 2 -9.0 - - - 17.6 
283 6 509.0 2 -8.0 - - - 17.0 
283 6 509.0 2 -7.0 - - - 18.0 
283 6 509.0 2 -6.0 - - - 17.9 
283 6 509.0 2 -5.0 - - - 18.2 
283 6 509.0 2 -4.5 - - — 18.2 
283 6 509.0 2 -4.0 - - - 18.0 
283 6 509.0 2 -3.5 - - - 18.4 
283 6 509.0 2 -3.0 - - - 18.9 
283 6 509.0 2 -2.0 - - - 19.0 
283 6 509.0 2 -1.0 - - - 19.6 
283 6 509.0 2 0.0 284 -5.0 5.0 -
283 6 509.0 2 0.5 - - - 19.2 
283 6 509.0 2 1.0 - - - 19.2 
283 6 509.0 2 1.5 - - - 19.0 
283 6 509.0 2 2.0 - - - 18.0 
286 6 460.0 2 -10.5 - - - 17.8 
286 6 460.0 2 -9.5 - - - 17.6 
286 6 460.0 2 -8.5 - - - 17.4 
286 6 460.0 2 -7.5 - - - 18.0 
286 6 460.0 2 -6.5 - - - 17.6 
286 6 460.0 2 -5.5 - - - 17.8 
286 6 460.0 2 -4.5 - - - 18.0 
PWIDTH CDIAM EASE PROG. 
17.8 10.1 38.18 52.0 1 2.20 82 
17.9 7.1 - - - - 82 
16.6 6.4 - - - 0.85 82 
16.4 5.8 - - - - 82 
16.4 4.1 - - - 0.36 82 
16.6 2.6 - - - 7.47 82 
16.6 3.0 - - - 8.04 82 
16.8 3.5 - - - 12.46 82 
16.9 4.0 - - - 9.39 82 
17.1 3.8 - - - 7.24 82 
16.2 4.8 - - - 8.21 82 
17.0 5.0 - - - 10.64 82 
17.0 5.0 - - - - 82 
17.0 4.7 - - - 10.19 82 
17.5 5.0 - - - - 82 
17.8 5.3 - - - - 82 
18.0 5.3 - - - - 82 
18.0 5.2 - - - 9.85 82 
- - 49.09 54.5 4 1.86 82 
17.9 6.9 - - - - 82 
17.8 6.4 - - - 0.26 82 
17.4 5.9 - - - - 82 
17.0 4.5 - - - 0.26 82 
16.2 2.8 - - - 8.61 82 
16.2 3.0 - - - 6.23 82 
16.8 3.0 - - - 6.68 82 
16.8 3.5 - - - 5.94 82 
16.5 3.5 - - - 6.51 82 
17.5 4.2 - - - 8.83 82 
17.6 4.3 - - - 6.45 82 
Table A-1. (Continued) 
lOSIZEBODCTI m ™ PWIDIH CDIiM EASE PROG. "Jf" 
286 6 460.0 . 2 -4.0 - - — 18.0 17.6 4.5 - - - 82 
286 6 460.0 2 -3.5 - - — 17.8 17.4 4.6 - - - - 82 
286 6 460.0 2 -3.0 - - - 18.0 17.6 4:8 - - - - 82 
286 6 460.0 2 -2.5 - - - 18.6 17.8 4.3 - - - 6.45 82 
286 6 460.0 2 -1.5 - - - 18.6 17.5 4.9 - - - 5.66 82 
286 6 460.0 2 -0.5 - - - 18.0 17.2 5.1 - - - 1.36 82 
286 6 460.0 2 0.0 283 -4.5 4.5 18.6 17.4 11.5 39.09 51.50 1 - 82 
286 6 460.0 2 0.5 - - - 17.9 17.2 10.5 - - - 1.30 82 
286 6 460.0 2 1.0 - - - 17.8 16.8 6.0 - - - - 82 
286 6 460.0 2 1.5 - - - 17.6 16.8 5.8 - - - 0.62 82 
289 2 420.0 3 -7.5 - - — 17.1 16.3 3.4 - - - 10.23 82 
289 2 420.0 3 -6.5 - - - 16.8 16.4 3.2 - - - 10.76 82 
289 2 420.0 3 -5.5 - - — 17.1 16.6 3.4 - - - 9.63 82 
289 2 420.0 3 -4.5 - - - 17.2 16.8 3.2 - - - 9.06 82 
289 2 420.0 3 -3.5 - - - 17.1 16.4 3.3 - - - 6.79 82 
289 2 420.0 3 -2.5 - - - 17.5 16.7 3.7 - - - 6.79 82 
289 2 420.0 3 -1.5 - — - 17.6 16.5 3.9 - - - 6.93 82 
289 2 420.0 3 -1.0 - - - 18.4 17.6 6.9 - - - - 82 
289 2 420.0 3 -0.5 - - - 18.2 17.8 5.4 - - - 0.96 82 
289 2 420.0 3 0.0 284 -1.5 1.5 18.4 17.8 9.5 34.55 49.5 3 - 82 
289 2 420.0 3 0.5 - - - - - - - - - 0.65 82 
289 2 420.0 3 1.0 - - - 18.4 17.6 6.2 - - - - 82 
289 2 420.0 3 1.5 - - - 18.1 17.0 4.2 - - - 0.84 82 
291 6 502.0 4 -10.5 - - - 18.1 17.5 1.9 - - - 10.62 82 
291 6 502.0 4 -9.5 - - - 18.3 17.4 2.0 - - - 9.86 82 
291 6 502.0 4 -8.5 - - - 18.3 17.5 2.4 - - - 10.62 82 
291 6 502.0 4 -7.5 - - - 18.2 17.4 3.0 - - - 10.74 82 
291 6 502.0 4 -6.5 - - - 18.4 17.0 3.2 - - - 8.84 82 
291 6 502.0 4 -5.5 - - - 18.4 17.2 4.0 - - - - 82 
291 6 502.0 4 -4.5 - - - 18.3 17.0 3.8 - - - 9.35 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC PHT 
291 6 502.0 4 -4.0 _ 18.6 
291 6 502.0 4 -3.5 - - - 18.9 
291 6 502.0 4 -3.0 - - - 19.0 
291 6 502.0 4 -2.5 - - - -
291 6 502.0 4 -2.0 - - - 19.2 
291 6 502.0 4 -1.5 - - - 19.1 
291 6 502.0 4 -0.5 - - - 19.0 
291 6 502.0 4 0.0 - -4.0 4.0 19.6 
291 6 502.0 4 0.5 - - - 19.0 
291 6 502.0 4 1.0 - - - 19.1 
291 6 502.0 4 1.5 - - - 19.2 
294 4 458.0 4 -7.5 - - - 18.7 
294 4 458.0 4 —6.5 - - - 18.5 
294 4 458.0 4 -5.5 - - - 18.4 
294 4 458.0 4 -4.5 - - — 18.0 
294 4 458.0 4 -3.5 - - - 18.1 
294 4 458.0 4 -2.5 - - - 18.0 
294 4 458.0 4 -2.0 - - — 19.6 
294 4 458.0 4 -1.5 - - - 19.4 
294 4 458.0 4 -1.0 - - - 19.8 
294 4 458.0 4 -0.5 - - - 19.8 
294 4 458.0 4 0.0 280 -2.0 2.0 19.8 
294 4 458.0 4 0.5 - - - 19.6 
294 4 458.0 4 1.0 - - - 19.5 
294 4 458.0 4 1.5 - - - 19.4 
298 4 452.0 2 -10.5 - - - 17.6 
298 2 452.0 2 -9.5 - - - 17.4 
298 2 452.0 2 -8.5 - - - 17.5 
298 . 2 452.0 2 -7.5 - — - 17.4 
298 2 452.0 2 -6.5 - - - -
PWIDTH CDIAM EASE PROG, 
17.4 6.3 - - - - 82 
18.2 6.2 - - - 2.83 82 
18.3 6.5 - - - - 82 
- 6.2 - - - 1.21 82 
18.6 6.2 - - - - 82 
18.6 5.5 - - - 0.86 82 
18.5 5.6 - - - 0.30 82 
18.7 12.6 46.36 56.00 3 - 82 
18.2 10.6 - - - 0.40 82 
18.1 7.6 - - - - 82 
18.0 6.8 - - - 0.25 82 
17.4 2.2 - - - 10.78 82 
17.0 2.4 - - - - 82 
17.0 2.9 - - - - 82 
17.0 3.1 - - - 6.95 82 
17.5 3.0 • - - - 6.54 82 
17.0 3.9 - - - 7.65 82 
17.8 4.2 - - - - 82 
17.8 5.3 - - - 0.35 82 
17.6 5.8 - - - - 82 
17.4 5.8 - - - 2.60 82 
17.6 12.0 37.27 46.64 1 - 82 
17.9 11.6 - - - 0.22 82 
17.6 11.0 - - - - 82 
17.6 6.8 - - - 0.45 82 
15.0 2.5 - - - 11.23 82 
15.4 2.5 - - - - 82 
15.5 2.5 - - - 14.35 82 
15.7 2.9 - - - 11.16 82 
— — — — 
- 10.76 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
EAY-
TRT 
DAY-
TTOC PHT 
298 2 452.0 2 -5.5 _ 16.8 
298 2 452.0 2 -4.5 - - - 16.3 
298 2 452.0 2 -4.0 - - - 16.5 
298 2 452.0 2 -3.5 - - - 17.2 
298 2 452.0 2 -3.0 - - - 17.1 
298 2 452.0 2 -2.5 - - - 16.8 
298 2 452.0 2 -1.5 - - - 17.0 
298 2 452.0 2 -0.5 - - - 17.1 
298 2 452.0 2 0.0 284 -4.5 4.5 17.2 
298 2 452.0 2 0.5 - - - 17.1 
298 2 452.0 2 1.0 - - - 17.0 
298 2 452.0 2 1.5 - - - 17.2 
309 4 472.0 2 -9.5 - - - 18.0 
309 4 472.0 2 -8.5 - - - 18.0 
309 4 472.0 2 -7.5 - - - 17.8 
309 4 472.0 2 -6.5 - - - 17.9 
309 4 472.0 2 -5.5 - - - 18.0 
309 4 472.0 2 -4.5 - - - 18.5 
309 4 472.0 2 -3.5 - - - 18.5 
309 4 472.0 2 -3.0 - - - 18.3 
309 4 472.0 2 -2.5 - - - 18.5 
309 4 472.0 2 —2.0 - - - 18.4 
309 4 472.Ô 2 -1.5 - - - 18.0 
309 4 472.0 2 -0.5 - - - 17.9 
309 4 472.0 2 0.0 283 -3.5 3.5 18.0 
309 4 472.0 2 0.5 - - - 17.9 
309 4 472.0 2 1.0 - - - 18.0 
309 4 472.0 2 1.5 - - - 17.8 
320 6 456.0 3 -5.5 - - - 18.1 
PWIDTH CDIAM EASE PROG, 
15.8 2.8 1- - - 8.78 82 
15.5 2.8 - - - 9.34 82 
15.8 3.0 - ... - 9.06 82 
15.5 3.2 - - - - 82 
15.6 3.1 - - - 8.38 82 
16.8 3.1 - - - 82 
15.2 4.1 - - - 5.50 82 
15.8 4.5 - - - 0.63 82 
16.0 10.1 33.63 49.75 1 - 82 
15.9 8.2 - - - 0.80 82 
16.0 7.3 - - - - 82 
16.0 5.4 - - - 0.45 82 
16.5 3.2 - - - 10.19 82 
16.0 3.0 - - - 9.51 82 
15.9 4.0 - - - 9.91 82 
17.0 4.2 - - 8.83 82 
16.4 4.0 - - - 10.76 82 
17.0 4.2 - - - 9.06 82 
16.8 4.6 - - - 10.87 82 
16.4 4.3 - - - - 82 
16.7 4.5 - - - 9.23 82 
16.7 4.4 - - - - 82 
17.2 4.3 - - - 7.08 82 
16.8 4.9 - - - 0.82 82 
17.1 8.6 38.18 42.75 4 - 82 
16.8 7.4 - - - 0.71 82 
16.6 6.9 - - - - 82 
16.4 5.8 - - - 0.62 82 
17.6 3.3 - - - 9.91 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC PHT 
320 6 456.0 3 -4.5 18.0 
320 6 456.0 3 -3.5 - - - 18.4 
320 6 456.0 3 -3.0 - - - 19.1 
320 6 456.0 3 -2.5 - - - 18.9 
320 6 456.0 3 -2.0 - - - 19.1 
320 6 456.0 3 -1.5 - - - 18.5 
320 6 456.0 3 —0.5 - - - 19.5 
320 6 456.0 3 0.0 278 -3.5 3.5 19.4 
320 6 456.0 3 0.5 - - - 19.3 
320 6 456.0 3 1.0 - - - 19.2 
320 6 456.0 3 1.5 - - — 18.9 
324 4 465.0 4 -5.0 - - - 18.6 
324 4 465.0 4 -4.0 - - - 18.5 
324 4 465.0 4 -3.0 - - - 18.6 
324 4 465.0 4 -2.0 - - - 18.4 
324 4 465.0 4 -1.0 - - - 18.5 
324 4 465.0 4 -0.5 - - - 20.0 
324 4 465.0 4 0.0 279 -0.5 0.5 19.4 
324 4 465.0 4 0.5 - - - 19.5 
324 4 465.0 4 1.0 - - - 19.6 
324 4 465.0 4 1.5 - - - 19.6 
324 4 465.0 4 2.0 - - - 19.4 
326 4 450.0 4 -7.5 - - - 17.5 
326 4 450.0 4 -6.5 - - - 17.1 
326 4 450.0 4 -5.5 - - - 17.4 
326 4 450.0 4 -4.5 - - - 17.6 
326 4 450.0 4 -3.5 - - - 17.6 
326 4 450.0 4 -2.5 - - - 17.4 
326 4 450.0 4 -1.5 - - - 17.4 
PWIDTH CDIAM EASE PROG. 
17.2 4.2 - - - 8.72 
17.6 3.8 - - - 9.29 
18.0 6.1 - - Wn -
18.9 6.1 - - - 0.76 
18.4 5.0 - - - -
18.1 4.8 - - - 1.36 
18.0 6.1 - - - 0.38 
18.4 8.6 43.64 47.25 3 -
18.2 7.0 - - - 0.15 
18.2 6.6 - - - -
17.9 5.8 - - - 0.14 
16.3 3.1 - - - 9.63 
17.0 3.6 - - - 11.32 
16.9 4.4 - - - 11.21 
17.2 4.1 - - - 9.85 
17.2 4.1 - - - 9.06 
18.6 6.1 - - - -
18.2 12.5 45.45 48.00 3 3.51 
18.0 10.8 - - - -
18.0 10.9 - - - 1.41 
17.9 10.0 - - - -
17.8 8.2 - - - 0.68 
16.2 3.0 - - - 8.78 
16.4 3.6 - - - 11.32 
16.3 3.4 - - - 12.34 
16.5 3.6 - - - 11.43 
16.4 3.5 - - - 11.04 
16.5 3.8 - - - 11.32 
16.3 3.6 - - - 11.82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
82 
Table A-1. (Continued) 
I» SIZE BODYWT TET % PHI PMIDIH CDIM »%%%- EASE PROG. %=' 
326 4 450.0 4 -1.0 - - - 17.8 16.7 5.5 - - - - 82 
326 4 450.0 4 -0.5 - - - 18.0 17.2 6.4 - - - 0.82 82 
326 4 450.0 4 0.0 281 -1.0 1.0 18.0 17.0 10.2 40.00 52.00 3 - 82 
326 4 450.0 4 0.5 - - - 18.0 16.9 8.2 - - - 0.62 82 
326 4 450.0 4 1.0 - - - 18.1 16.9 6.9 - - - - 82 
326 4 450.0 4 1.5 - - - 17.9 16.6 5.2 - - - 0.55 82 
327 6 459.0 4 -14.0 - - - 17.4 16.9 2.9 - - - 8.27 82 
327 6 459.0 4 -13.0 - - - 18.1 16.4 2.9 - - - 8.78 82 
327 6 459.0 4 -12.0 - - - 18.0 17.2 2.6 - - - 9.63 82 
327 6 459.0 4 -11.0 - - - 18.0 17.5 2.5 - - - 11.66 82 
327 6 459.0 4 -10.0 - - - 18.2 17.5 2.7 - - - - 82 
327 6 459.0 4 -9.0 - - - 18.1 17.5 2.8 - - - 11.44 82 
327 6 459.0 4 -8.0 T - - 18.4 17.3 3.5 - - - 8.49 82 
327 6 459.0 4 -7.5 - - - 19.2 17.4 5.8 - - - - 82 
327 6 459.0 4 -7.0 - - - 19.0 17.9 6.3 - - - 5.04 82 
327 6 459.0 4 -6.5 - - - 19.0 17.8 6.6 - - - - 82 
327 6 459.0 4 —6.0 - - - 19.0 17.5 3.0 - - - 5.66 82 
327 6 459.0 4 -5.0 - - - 19.5 17.5 4.2 - - - 5.53 82 
327 6 459.0 4 -4.0 - - - 19.5 18.0 4.0 - - - 5.62 82 
327 6 459.0 4 -3.0 - - - 19.0 17.5 4.2 - - - 7.02 82 
327 6 459.0 4 -2.0 - - - 18.5 17.5 4.6 - - - 5.95 82 
327 6 459.0 4 -1.0 - - - - - - - - - - 82 
327 6 459.0 4 0.0 - -8.0 8.0 18.6 17.4 10.6 38.18 51.50 3 0.85 82 
327 6 459.0 4 0.5 - - - 18.4 17.2 10.2 - - - - 82 
327 6 459.0 4 1.0 - - - 18.5 17.0 9.4 - - - 0.78 82 
327 6 459.0 4 1.5 - - - 18.6 17.1 6.0 - - - - 82 
327 6 459.0 4 2.0 - - - 18.9 16.9 4.0 - - - 0.83 82 
329 6 440.0 4 -3.5 - - - 17.8 17.0 3.1 - - - 11.02 82 
329 6 440.0 4 -2.5 - - - 18.0 17.5 3.5 - - - 9.35 82 
329 6 440.0 4 -1.5 - - - 18.1 17.2 4.2 - - - 11.09 82 
Table A-1. (Continued) 
IDSIZEBODÏMT TET % % PHI PWIDTH CDIAM BASE PROG. 
329 6 440.0 4 -1.0 - - - 19.2 17.4 6.3 - - - - 82 
329 6 440.0 4 -0.5 - - - 19.4 18.2 6.4 - - - 1.53 82 
329 6 440.0 4 0.0 276 -1.0 1.0 19.4 19.1 12.2 37.27 53.00 1 - 82 
329 6 440.0 4 0.5 - - - 19.0 18.0 7.9 - - - 1.33 82 
329 6 440.0 4 1.0 - - - 19.0 17.9 7.4 - - - - 82 
329 6 440.0 4 1.5 - - - 19.0 18.0 6.8 - - - 0.39 82 
339 2 418.0 4 -4.5 - - - 17.0 15.8 1.8 - - - 8.34 82 
339 2 418.0 4 -3.5 - - - 17.4 16.0 2.8 - - - 7.93 82 
339 2 418.0 4 -2.5 - - - 17.5 15.9 4.1 - - - 8.90 82 
339 2 418.0 4 -1.5 - - - 17.4 15.5 4.1 - - - 9.04 82 
339 2 418.0 4 -1.0 - - - 18.2 16.0 6.9 - - - - 82 
339 2 418.0 4 0.5 - - - 18.5 16.4 6.6 - - - 4.17 82 
339 2 418.0 4 0.0 278 -1.0 1.0 18.6 17.0 12.1 30.91 44.75 1 - 82 
339 2 418.0 4 0.5 - - - 18.7 17.5 11.6 - - - 0.26 82 
339 2 418.0 4 1.0 - - - 18.1 17.1 9.1 - - - - 82 
339 2 418.0 4 1.5 - - - 18.1 17.0 7.1 - - - 0.03 82 
360 4 548.0 4 -12.0 - - - 18.0 18.0 2.5 - - - - 11.89 82 
360 4 548.0 4 -11.0 - - - 17.9 18.0 3.0 - - - 14.15 82 
360 4 548.0 4 -10.0 - - - 18.0 18.0 2.8 - - - - 82 
360 4 548.0 4 -9.0 - - - 18.2 18.2 3.1 - - - 12.45 82 
360 4 548.0 4 —8.0 - - - 18.1 17.9 3.2 - - - 9.06 82 
360 4 548.0 4 -7.0 - - - 18.5 18.0 3.5 - - - 11.04 82 
360 4 548.0 4 -6.0 - - - 18.0 17.6 4.1 - - - 9.06 82 
360 4 548.0 4 -5.5 - - - 19.0 19.0 6.5 - - - - 82 
360 4 548.0 4 -5.0 - - - 19.9 19.2 6.2 - - - 1.58 82 
360 4 548.0 4 -4.5 - - - 19.8 19.1 6.3 - - - - 82 
360 4 548.0 4 -4.0 - - - 19.5 19.0 5.7 - - - 2.94 82 
360 4 548.0 4 -3.0 - - - 19.4 19.1 5.0 - - - 0.91 82 
360 4 548.0 4 -2.0 - — - 19.0 18.5 4.8 - - - 0.47 82 
Table A-1. (Continued) 
ID SIZE BODYWT IRT PWIDTH CDI4M EASE PROG. "™-
360 4 548.0 4 -1.0 - - - 19.5 19.0 5.1 - - - 0.01 82 
360 4 548.0 4 0.0 - -5.5 5.5 19.1 19.0 11.2 41.82 53.25 4 0.01 82 
360 4 548.0 4 0.5 - - - 19.2 18.4 7.3 - - - - 82 
360 4 548.0 4 1.0 - - - 18.9 18.2 7.1 - - - 0.01 82 
360 4 548.0 4 1.5 - - - 18.5 18.2 7.0 - - - - 82 
360 4 548.0 4 2.0 - - - 18.4 18.6 6.9 * - - - 0.01 82 
360 4 548.0 4 3.0 - - - 18.5 18.0 4.4 - - - 0.01 82 
365 4 468.0 4 -9.5 - - - 17.8 16.7 2.9 - - - 14.15 82 
365 4 468.0 4 -8.5 - - - 18.0 17.1 3.7 - - - 15.28 82 
365 4 468.0 4 -7.5 - - - 17.9 16.8 3.0 — - - 14.16 82 
365 4 468.0 4 -6.5 - - - 17.8 16.8 3.1 - - - 15.28 82 
365 4 468.0 4 -5.5 - - - 17.9 16.8 3.1 — - - - 82 
365 4 468.0 4 -4.5 - - - 18.0 17.0 3.2 - - - 14.15 82 
365 4 468.0 4 -3.5 - - - 18.0 17.4 3.1 - - - 15.28 82 
365 4 468.0 4 -2.5 - - - 17.8 17.2 3.2 - - - 12.17 82 
365 4 468.0 4 -2.0 - - - 17.8 17.4 5.4 - - - - 82 
365 4 468.0 4 -1.5 - - - 18.0 18.1 6.8 - - - 7.08 82 
365 4 468.0 4 -1.0 - - - 19.4 18.0 6.7 - - - - 82 
365 4 468.0 4 -0.5 - - - 19.0 18.4 6.5 - - - 2.03 82 
365 4 468.0 4 0.0 284 -2.0 2.0 19.0 18.4 12.5 36.36 60.00 3 - 82 
365 4 468.0 4 0.5 - - - 19.2 18.5 10.8 - - - 1.64 82 
365 4 468.0 4 1.0 - - - 19.2 18.1 7.2 - - - - 82 
365 4 468.0 4 1.5 - - - 19.0 17.0 6.9 - - - 1.19 82 
371 2 530.0 4 -9.0 - - - 17.9 16.5 3.8 - - - 11.61 82 
371 2 530.0 4 -8.0 - - - 17.9 16.9 3.8 - - - 11.04 82 
371 2 530.0 4 -7.0 - - - 17.8 17.0 4.0 - - - 10.76 82 
371 2 530.0 4 -6.0 - - - 17.2 17.0 3.9 - - - 10.65 82 
371 2 530.0 4 -5.0 - - - 17.9 16.9 3.9 - - - 8.49 82 
371 2 530.0 4 -4.0 - - - 17.9 17.2 3.8 - - - 9.91 82 
Table A-1. (Continued) 
ID SIZE BODYWT TRT 
DAY-
PREG 
DAY-
PART 
DAY-
TRT 
DAY-
TTOC PHT 
371 2 530.0 4 -3.0 17.6 
371 2 530.0 4 -2.5 - - - 18.2 
371 2 530.0 4 -2.0 - - - 19.5 
371 2 530.0 4 -1.5 - - - 19.8 
371 2 530.0 4 -1.0 - - - 19.2 
371 2 530.0 4 0.0 279 -2.5 2.5 19.4 
371 2 530.0 4 0.5 - - - 19.4 
371 2 530.0 4 1.0 - - - 19.2 
371 2 530.0 4 1.5 - - - 19.1 
371 2 530.0 4 2.0 - - - 19.0 
376 2 460.0 3 -3.0 - - - 16.9 
376 2 460.0 3 -2.0 - - - 16.8 
376 2 460.0 3 -1.0 - - - 16.5 
376 2 460.0 3 -0.5 - - - 17.6 
376 2 460.0 3 0.0 276 -1.0 1.0 17.6 
376 2 460.0 3 0.5 - - - 17.6 
376 2 460.0 3 1.0 - - - 17.6 
376 2 460.0 3 1.5 - - - 17.8 
376 2 460.0 3 2.0 - - - 17.6 
376 2 460.0 3 3.0 - - - 17.3 
387 4 483.0 3 -9.5 - - - 17.9 
387 4 483.0 3 -8.5 - - - 18.0 
387 4 483.0 3 -7.5 - - - 18.2 
387 4 483.0 3 -6.5 - - - 18.1 
387 4 483.0 3 -5.5 - - - 17.9 
387 4 483.0 3 -3.5 - - - 18.1 
387 4 483.0 3 -3.0 - - - 18.7 
387 4 483.0 3 -2.5 - - - 19.4 
387 4 483.0 3 -2.0 - - - 19.2 
387 4 483.0 3 -1.5 - - - 19.1 
PWIDTH CDIAM EASE PROG, 
17.1 3.9 - - - 11.61 82 
18.0 6.1 - - - 82 
18.2 5.9 - - - 4.76 82 
18.2 5.8 - - - - 82 
18.0 6.6 - - - 1.24 82 
18.2 11.3 36.36 44.63 3 1.75 82 
18.1 10.2 - - - - 82 
18.4 7.1 - - - 0.74 82 
17.9 6.5 - - - - 82 
17.9 6.0 - - - 0.53 82 
14.5 2.9 - - - 11.32 82 
15.8 3.8 - - - 8.72 82 
15.4 3.9 - - - 7.93 82 
16.5 6.2 - - - - 82 
16.8 11.8 30.00 50.50 1 1.58 82 
17.0 8.8 - - - - 82 
16.6 6.0 - - - 0.62 82 
16.7 4.6 - - - - 82 
16.5 4.0 - - - 0.45 82 
15.8 4.0 - - - - 82 
16.6 3.0 - - - 11.16 82 
17.0 3.6 - - - 10.12 82 
17.1 3.5 - - - 9.94 82 
16.5 3.8 - - - 11.89 82 
16.8 3.7 - - - 10.76 82 
17.0 4.2 - - - 11.27 82 
17.3 6.2 - - - - 82 
17.8 5.3 - - - 8.74 82 
17.9 5.6 - - - - 82 
17.7 5.0 - - - 6.63 82 
Table A-1. (Continued) 
IDSIZEBODÏWI IRT % PHI PHIDTH CDIAM EASE PROG. 
387 4 483.0 3 -0.5 - - - 19.1 17.2 5.8 - - - 0.99 82 
387 4 483.0 3 0.0 280 -•3. 5 3.5 18.9 18.0 11.5 37.27 46.25 3 - 82 
387 4 483.0 3 0.5 - - - 18.6 17.2 8.1 - - - 0.92 82 
387 4 483.0 3 1.0 - - - 18.2 17.1 6.0 - - - - 82 
387 4 483.0 3 2.5 - - - 18.0 16.8 5.0 - - - 0.74 82 
387 4 483.0 3 3.5 - - - 18.1 16.7 4.9 - - - - 82 
396 6 405.0 4 -4.5 - - - 17.8 16.4 2.8 - - - 12.79 82 
396 6 405.0 4 -3.5 - - - 17.9 16.8 3.2 - - - 12.11 82 
396 6 405.0 4 -2.5 - - - 18.1 16.9 3.8 - - - 12.45 82 
396 6 405.0 4 -1.5 - - - 18.1 16.7 4.0 - - - 9.29 82 
396 6 405.0 4 -1.0 - - - 18.4 17.8 5.8 - - - - 82 
396 6 405.0 4 -0.5 - - - 18.5 17.5 6.5 - - - 0.76 82 
396 6 405.0 4 0.0 281 -1. 0 1.0 18.5 17.8 12.2 32.00 42.00 1 - 82 
396 6 405.0 4 0.5 - - - 18.1 17.2 8.4 - - - 1.58 82 
396 6 405.0 4 1.0 - - - 18.0 17.3 6.1 - - - 82 
396 6 405.0 4 1.5 -- - - 18.2 17.4 5.6 - - - 0.70 82 
396 6 405.0 4 2.0 - - - 18.2 17.1 4.5 - - - - 82 
396 6 405.0 4 2.5 - - - 18.0 17.2 4.8 - - - 0.55 82 
406 6 442.0 4 -3.0 — - - 17.6 16.9 3.2 - - - 9.06 82 
408 6 442.0 4 -2.0 - - - 17.3 16.5 4.1 - - - 7.08 82 
408 6 442.0 4 -1.0 - - - 17.2 16.6 4.2 - - - 6.23 82 
408 6 442.0 4 -0.5 - - - 18.4 17.8 6.5 - - - - 82 
408 6 442.0 4 0.0 276 -0. 5 0.5 18.5 18.0 11.9 30.00 43.00 1 0.43 82 
408 6 442.0 4 0.5 - - - 18.4 17.9 10.8 - - - - 82 
408 6 442.0 4 1.0 - - - 18.6 17.8 8.6 - - - 0.57 82 
408 6 442.0 4 1.5 - - - 18.5 17.6 8.9 - - - - 82 
408 6 442.0 4 2.0 - - - 18.6 17.2 6.4 - - - 0.36 82 
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APPENDIX B. PERIPHERAL PLASMA ESTRONE AND 176-ESTRADIOL 
LEVELS FOR PRIMIPAROUS BEEF HEIFERS IN SECTION II 
Table B-1. Data 
)BS TRT ID DAY El E2 
1 2 309 -4.5 1.83 168.45 
2 2 309 -3.5 2.05 179.86 
3 2 309 -2.5 2.89 228.98 
4 2 309 -1.5 3.81 333.09 
5 2 309 -0.5 5.27 432.48 
6 2 309 0.5 0.49 64.97 
7 2 309 1.5 0.06 20.61 
8 2 102 -5.0 2.09 218.68 
9 2 102 -4.5 2.46 295.74 
10 2 102 -3.5 2.89 330.49 
11 2 102 -2.5 3.13 337.31 
12 2 102 -1.5 3.33 436.87 
13 2 102 -0.5 4.72 523.35 
14 2 102 0.5 1.16 83.35 
15 2 102 1.5 0.09 54.97 
16 2 298 -4.5 1.83 180.00 
17 2 298 -3.5 2.09 207.48 
18 2 298 -2.5 2.43 292.05 
19 2 298 -1.5 3.43 336.67 
20 2 298 -0.5 4.85 464.96 
21 2 298 0.5 1.42 68.42 
22 2 298 1.5 Û.Û9 48.98 
23 2 124 -5.0 1.68 197.42 
24 2 124 -4.5 2.19 250.55 
25 2 124 -3.5 2.63 314.62 
26 2 124 -2.5 3.18 372.56 
27 2 124 —1.5 4.08 394.19 
28 2 124 -0.5 5.31 466.91 
29 2 124 0.5 1.27 105.04 
30 2 124 1.5 0.09 32.75 
31 2 283 -5.0 1.95 179.14 
32 2 283 -4.0 2.66 215.59 
33 2 283 -3.0 3.14 290-39 
34 2 283 -2.0 3.61 330.00 
35 2 283 -1.0 4.91 473.49 
36 2 283 0.0 1.48 120.45 
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Table B-1. (Continued) 
OBS TRT ID DAY El E2 
37 2 283 1.0 0.14 81.49 
38 2 283 2.0 0.08 43.45 
39 2 126 -4.5 1.87 190.00 
40 2 126 -3.5 2.06 205.64 
41 2 126 -2.5 2.66 231.66 
42 2 126 -1.5 3.14 310.48 
43 2 126 -0.5 4.62 463.36 
44 2 126 0.5 1.14 103.55 
45 2 126 1.5 0.08 43.45 
46 2 2 -4.0 1.86 181.22 
47 2 2 -3.0 2.43 201.48 
48 2 2 —2.0 3.02 368.03 
49 2 2 -1.0 5.29 496.86 
50 2 2 0.0 1.29 109.60 
51 2 2 1.0 0.94 68.40 
52 2 2 2.0 0.06 53.83 
53 3 289 -3.5 1.81 184.91 
54 3 289 -2.5 2.35 226.23 
55 3 289 -1.5 3.24 302.45 
56 3 289 -0.5 4.07 395.39 
57 3 289 0.5 0.70 86.99 
58 3 289 1.5 0.09 32.16 
59 3 206 -5.0 2.04 169.06 
60 3 206 -4.0 2.27 223.64 
61 3 206 -3.0 2.82 252.25 
62 3 206 —2.0 3.26 329.53 
63 3 206 -1.0 4.24 470.54 
64 3 206 0.0 0,88 108.79 
65 3 206 1.0 0.06 26.77 
66 3 114 -4.5 1.87 140.60 
67 3 114 -3.5 1.98 192.12 
68 3 114 -2.5 2.52 241.65 
69 3 114 -1.5 3.28 340.52 
70 3 114 -0.5 4.34 472.55 
71 3 114 0.5 0.99 92.97 
72 3 114 1.5 0.09 22.02 
73 3 387 -4.5 1.68 184.65 
74 3 387 -3.5 1.86 238.44 
75 3 387 -2.5 2.41 308.91 
76 3 387 -1.5 3.80 386.74 
77 3 387 -0.5 0.98 88.74 
78 3 387 0.5 0.35 62.96 
79 3 387 1.5 0.08 29.40 
80 3 120 -5.0 1.45 162.04 
81 3 120 -4.5 2.03 201.17 
216 
Table B-1. (Continued) 
OBS TRT ID DAY El E2 
82 3 120 -3.5 2.48 238.21 
83 3 120 -2.5 2.65 259.24 
84 3 120 -1.5 4.65 412.46 
85 3 120 -0.5 1.23 112.46 
86 3 120 0.5 0.05 68.02 
87 3 237 -4.5 1.84 146.82 
88 3 237 -3.5 2.23 174.08 
89 3 237 -2.5 2.81 226.53 
90 3 237 -1.5 4.47 429.18 
91 3 237 -0.5 1.42 298.02 
92 3 237 0.5 0.21 98.74 
93 3 237 1.5 0.07 69.21 
94 3 57 -5.0 * 1.77 171.94 
95 3 57 -4.0 1.92 218.78 
96 3 57 -3.0 2.00 272.49 
97 3 57 -2.0 2.15 297.19 
98 3 57 -1.0 3.68 335.01 
99 3 57 0.0 0.56 89.93 
100 3 57 1.0 0.06 21.82 
101 4 294 -4.5 1.49 207.68 
102 4 294 -3.5 2.08 252.38 
103 4 294 -2.5 2.96 284.53 
104 4 294 -1.5 4.36 433.01 
105 4 294 -0.5 1.40 185.77 
106 4 294 0.5 0.26 96.10 
107 4 294 1.5 0.05 21.22 
108 4 214 -5.0 1.71 218.73 
109 4 214 -4,0 2 = 04 218=73 
110 4 214 -3.0 2.23 225.04 
111 4 214 -2.0 2.37 284.97 
112 4 214 -1.0 3.58 417.78 
113 4 214 0.0 0.94 68.06 
114 4 214 1.0 0.08 22.73 
115 4 62 -4.0 1.53 186.50 
116 4 62 -3.0 2.06 221.98 
117 4 62 -2.0 2.53 260.64 
118 4 62 -1.0 4.13 440.23 
119 4 62 0.0 4.86 133.92 
120 4 62 1.0 0.08 53.29 
121 4 62 2.0 0.06 27.67 
122 4 192 -4.5 1.75 190.88 
123 4 192 -3.5 2.12 253.43 
124 4 192 -2.5 2.53 298.55 
125 4 192 -1.5 4.14 445.26 
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Table B-1. (Continued) 
OBS TRT ID DAY El E2 
126 4 192 -0.5 2.42 298.55 
127 4 192 0.5 0.87 98.31 
128 4 192 1.5 0.07 66.94 
129 4 329 -3.5 2.08 210.90 
130 4 329 -2.5 2.44 243.80 
131 4 329 -1.5 3.06 320.57 
132 4 329 -0.5 4.42 450.40 
133 4 329 0.5 1.24 106.31 
134 4 329 1.5 0.22 71.73 
135 4 324 -4.0 1.95 197.51 
136 4 324 -3.0 2.28 237.97 
137 4 324 -2.0 2.57 275.96 
138 4 324 -1.0 2.82 "326.51 
139 4 324 0.0 3.38 448.42 
140 4 324 1.0 1.13 86.07 
141 4 324 2.0 0.09 31.25 
142 4 169 -3.5 1.79 182.40 
143 4 169 -2.5 1.98 211.11 
144 4 169 -1.5 2.33 222.41 
145 4 169 -0.5 3.16 399.22 
146 4 169 0.5 0.72 120.08 
147 4 169 1.5 0.06 68.85 
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APPENDIX C. PERIPHERAL PLASMA RELAXIN, PROGESTERONE, ESTRONE 
AND 176-ESTRADIOL FOR SECTION III 
Table C-1. Data 
>BS ID TRT TIME REL PROG El £2 
1 16 ROS -720 0.125 6.85 767.2 62.50 
2 16 ROS -360 0.300 6.68 718.3 65.40 
3 16 ROS -90 0.200 6.54 725.0 68.50 
4 16 ROS -60 0.125 6.82 712.6 63.40 
5 16 ROS -30 0.125 6.73 720.0 69.50 
6 16 ROS 0 0.125 6.41 768.0 63.50 
7 16 ROS 30 1.500 6.51 748.5 68.50 
8 16 ROS 60 21.000 6.32 803.8 75.40 
9 16 ROS 90 20.000 5.11 884.1 69.80 
10 16 ROS 120 15.500 4.32 860.8 70.30 
11 16 ROS 150 9.750 3.20 969.0 68.60 
12 16 ROS 180 8.500 4.61 981.2 69.50 
13 16 ROS 210 12.500 4.15 874.0 71.40 
14 16 ROS 240 - 4.00 922.8 80.20 
15 16 ROS 270 13.000 4.36 881.8 71.70 
16 16 ROS 300 3.500 4.41 1072.0 79.70 
17 16 ROS 330 7.250 4.63 1011.0 75.40 
18 16 ROS 360 12.000 4.35 1240.0 90.60 
19 16 ROS 420 10.600 4.83 1301.0 109.50 
20 16 ROS 480 2.250 5.01 1210.0 111. 60 
21 16 ROS 540 2.050 4.86 1074.0 99.70 
22 16 ROS 600 2.020 4.95 1088.0 88.40 
23 16 ROS 660 0.900 5.31 1249.0 98.80 
24 16 ROS 720 0.750 5.13 1108.0 -
25 16 ROS 780 - 5.03 1335.0 109.50 
26 16 ROS 840 0.680 4.89 1542.0 87.20 
27 16 ROS 900 0.490 4.75 1345.0 69.50 
28 16 ROS 960 0.600 4.69 1381.0 78.20 
29 16 ROS 1020 0.490 5.00 1025.0 63.50 
30 16 ROS 1080 0.200 4.93 1069.0 61.30 
31 16 ROS 1140 0.220 5.14 1001.0 59.60 
32 16 ROS 1200 0.200 5.02 1021.0 61.70 
33 16 ROS 1260 0.125 4.94 1102.0 88.60 
34 16 ROS 1320 0.125 4.86 1206.0 100.10 
35 16 ROS 1380 0.210 4.71 1198.0 89.40 
36 16 ROS 1440 0.180 4.36 1201.0 101.20 
c-1. 
ID 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
398 
44 
44 
44 
44 
44 
219 
(Continued) 
TRT TIME REL PROG El E2 
ROS -720 0.125 8.21 795.6 89.50 
ROS -360 0.125 8.91 780.0 86.00 
ROS -90 0.125 8.00 826.0 81.60 
ROS —60 0.125 7.81 801.5 79.50 
ROS -30 0.125 8.63 810.0 80.40 
ROS 0 0.125 8.11 803.0 82.60 
ROS 30 1.500 7.91 807.0 82.00 
ROS 60 40.000 8.45 819.0 81.50 
ROS 90 16.200 6.04 880.4 82.10 
ROS 120 14.500 5.17 892.3 86.50 
ROS 150 0.750 5.64 864.5 84.20 
ROS 180 0.900 5.69 831.9 85.30 
ROS 210 13.000 5.96 829.4 84.60 
ROS 240 5.000 6.32 868.7 90.20 
ROS 270 9.500 6.10 873.5 90.80 
ROS 300 0.800 4.94 862.8 88.60 
ROS 330 8.500 5.32 900.0 100.00 
ROS 360 0.800 4.85 911.0 98.00 
ROS 420 5.000 5.13 931.0 97.00 
ROS 480 0.750 6.81 928.0 110.00 
ROS 540 0.950 6.37 933.0 113.00 
ROS 600 0.850 6.15 941.0 104.20 
ROS 660 0.930 5.91 923.0 116.00 
ROS 720 0.620 5.82 934.0 119.00 
ROS 780 0.490 5.61 944.0 121.10 
ROS 840 0.330 6.31 901.0 101.00 
RGS 900 0.450 6.45 889.0 98.80 
ROS 960 0.520 6.20 862.0 99.00 
ROS 1020 0.620 6.81 873.0 89.40 
ROS 1080 0.350 6.27 880.0 88.30 
ROS 1140 0.410 5.39 890.5 90.0 
ROS 1200 0.420 5.47 889.4 87.80 
ROS 1260 0.610 6.21 870.0 90.00 
ROS 1320 0.520 6.08 902.0 92.00 
ROS 1380 0.540 4.71 906.0 88.30 
ROS 1440 0.480 6.21 899.0 93.00 
RIM -720 0.200 7.08 642.5 61.50 
RIM -360 0.210 7.94 684.3 69.50 
RIM -90 0.125 7.21 636.2 66.40 
RIM -60 0.125 6.92 675.1 65.40 
RIM -30 0.185 6.98 704.5 63.40 
RIM 0 0.198 7.32 698.5 60.20 
RIM 30 — 7.12 712.3 63.40 
•1. 
ID 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
44 
33 
33 
33 
33 
33 
33 
33 
33 
33 
33 
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(Continued) 
TRT TIME REL PROG El E2 
RIM 60 9.500 7.00 734.7 70.10 
RIM 90 10.000 6.85 795.4 76.30 
RIM 120 14.650 6.01 982.6 79.40 
RIM 150 25.210 5.75 992.5 79.20 
RIM 180 29.000 4.12 1100.0 83.60 
RIM 210 14.860 3.69 1212.0 89.70 
RIM 240 12.110 3.20 1008.0 90.30 
RIM 270 0.910 3.21 1147.0 89.40 
RIM 300 0.650 3.84 1248.0 92.20 
RIM 330 0.610 5.32 1341.0 104.70 
RIM 360 — 4.85 1104.0 114.00 
RIM 420 0.810 5.13 1194.0 114.10 
RIM 480 0.750 5.81 1034.0 106.40 
RIM 540 0.750 5.37 1038.0 98.40 
RIM 600 0.700 6.15 1014.0 103.60 
RIM 660 0.125 5.91 977.2 107.70 
RIM 720 0.400 5.82 1041.0 100.70 
RIM 780 0.125 5.61 1004.0 101.00 
RIM 840 0.125 5.31 991.0 98.70 
RIM 900 0.150 6.25 989.1 102.00 
RIM 960 0.180 6.20 962.0 99.40 
RIM 1020 0.125 5.81 973.0 98.20 
RIM 1080 0.200 5.39 980.0 93.70 
RIM 1140 0.190 5.27 990.0 90.30 
RIM 1200 0.125 5.47 989.0 102.00 
RIM 1260 0.125 5.21 1020.0 103.40 
RIM 1320 0.125 5.08 1003.0 96.50 
RIM 1380 0.125 5.91 1009.0 94.10 
RIM 1440 0.125 5.21 1013.0 98.20 
RIM -720 0.125 10.14 514.8 44.00 
RIM -360 0.140 9.86 561.0 40.70 
RIM -90 0.150 10.07 542.1 48.30 
RIM 060 0.180 9.92 549.0 46.30 
RIM -30 0.125 9.81 518.3 44.10 
RIM 0 0.125 9.20 542.1 48.20 
RIM 30 4.950 9.68 517.5 40.30 
RIM 60 15.000 9.74 541.7 48.20 
RIM 90 14.500 6.81 530.1 53.60 
RIM 120 20.500 5.36 580.5 59.40 
RIM 150 21.000 4.10 592.3 72.30 
RIM 180 17.500 3.68 611.4 86.50 
RIM 210 — 3.41 680.9 108.40 
RIM 240 13.500 3.01 664.7 130.60 
RIM 270 — 3.44 690.8 141.50 
ID 
33 
33 
33 
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360 
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(Continued) 
TRT TIME REL PROG El E2 
RIM 300 _ 3.69 632.3 136.80 
RIM 330 - 2.74 681.9 131.60 
RIM 360 13.500 3.08 753.0 160.10 
RIM 420 5.500 2.64 803.4 172.10 
GEL -720 0.250 5.61 682.5 73.20 
GEL -360 0.220 6.21 698.4 69.30 
GEL -90 0.180 6.31 671.6 78.65 
GEL —60 0.180 5.41 690.8 75.30 
GEL -30 0.310 5.01 665.4 78.50 
GEL 0 0.310 5.49 678.6 78.90 
GEL 30 0.280 5.88 681.1 80.60 
GEL 60 0.330 6.01 692.1 76.20 
GEL 90 0.210 6.32 693.4 70.25 
GEL 120 0.310 5.81 645.6 80.61 
GEL 150 0.190 5.65 672.8 74.43 
GEL 180 0.250 6.11 644.4 72.80 
GEL 210 0.390 5.34 674.7 78.20 
GEL 240 0.410 5.66 719.7 71.60 
GEL 270 0.610 5.94 731.3 78.89 
GEL 300 0.480 6.13 700.3 79.00 
GEL 330 0.200 5.89 741.4 77.70 
GEL 360 0.220 5.64 738.8 70.12 
GEL 420 0.220 6.04 714.4 74.61 
GEL 480 0.250 5.92 731.5 78.43 
GEL 540 0.250 5.86 721.4 81.41 
GEL 600 0.250 5.37 796.6 79.30 
GEL 660 0.125 5.48 789.4 79.90 
GEL 720 0.250 5.42 744.1 81.12 
GEL 780 0.125 5.41 761.8 77.60 
GEL 840 0.125 5.83 812.4 74.70 
GEL 900 0.125 5.86 791.9 83.20 
GEL 960 0.125 5.79 800.3 83.20 
GEL 1020 0.125 5.32 756.7 78.60 
GEL 1080 0.225 5.74 781.4 80.30 
GEL 1140 0.225 5.41 800.9 81.40 
GEL 1200 0.125 5.29 782.1 73.40 
GEL 1260 0.125 5.38 791.3 80.40 
GEL 1320 0.125 5.47 745.6 73.40 
GEL 1380 0.125 5.44 783.1 79.40 
GEL 1440 0.125 5.39 804.4 77.40 
GEL -720 0.125 9.42 682.5 83.80 
GEL -360 0.125 10.21 682.5 87.60 
GEL -90 0.125 9.14 662.7 71.40 
GEL —60 0.125 9.08 644.4 68.70 
222 
Table C-1. (Continued) 
OBS ID TRT TIME REL PROG El E2 
168 224 GEL -30 0.125 9.96 691.8 65.30 
169 224 GEL 0 0.125 10.36 682.5 65.30 
170 224 GEL 30 0.125 9.45 661.4 68.50 
171 224 GEL 60 0.125 9.17 639.6 70.10 
172 224 GEL 90 0.125 8.94 664.5 72.40 
173 224 GEL 120 0.125 9.36 637.1 73.60 
174 224 GEL 150 0.125 8.64 671.8 79.80 
175 224 GEL 180 0.125 8.79 650.0 75.50 
176 224 GEL 210 0.125 9.36 668.7 76.70 
177 224 GEL 240 0.125 9.24 686.8 78.30 
178 224 GEL 300 0.125 8.76 710.1 77.40 
179 224 GEL 330 0.125 8.76 715.6 78.30 
180 224 GEL 360 0.125 8.16 693.6 78.30 
181 224 GEL 420 0.125 8.83 680.4 71.32 
182 224 GEL 480 0.125 8.24 708.6 70.44 
183 224 GEL 540 0.125 8.67 723.8 70.62 
184 224 GEL 600 . 0.125 8.23 721.5 76.37 
185 224 GEL 660 0.125 8.69 714.7 78.90 
186 224 GEL 720 0.125 8.11 701.1 73.36 
187 224 GEL 780 0.125 8.08 709.6 72.43 
188 224 GEL 840 0.125 8.37 720.7 71.70 
189 224 GEL 900 0.125 8.26 700.9 76.80 
190 224 GEL 960 0.125 8.05 711.3 73.30 
191 224 GEL 1020 0.125 8.13 704.5 79.90 
,192 224 GEL 1080 0.125 8.21 698.6 76.60 
193 224 GEL 1140 0.125 8.43 702.4 70.78 
194 224 GEL 1200 0.125 8.61 712.3 73.90 
195 224 GEL 1260 0.125 8.53 729.1 74.22 
196 224 GEL 1320 0.125 8.34 720.7 72.40 
197 224 GEL 1380 0.125 8.02 702.6 78.52 
198 224 GEL 1440 0.125 8.43 711.9 73.30 
199 155 PBS -720 0.125 8.38 838.3 89.60 
200 155 PBS -360 0.125 8.30 798.4 81.70 
201 155 PBS -90 0.125 7.94 790.5 85.40 
202 155 PBS -60 0.125 8.67 813.7 88.50 
203 155 PBS -30 0.125 8.92 817.3 81.30 
204 155 PBS 0 0.125 8.32 832.4 82.20 
205 155 PBS 30 0.125 8.63 828.4 89.60 
206 155 PBS 60 0.125 8.11 801.1 89.80 
207 155 PBS 90 0.125 7.94 811.3 89.40 
208 155 PBS 120 - 7.66 898.1 82.41 
209 155 PBS 150 0.250 8.16 820.6 80.50 
210 155 PBS 180 0.160 8.06 808.9 89.61 
211 155 PBS 210 0.150 7.99 832.2 83.42 
223 
Table C-1. (Continued) 
OBS ID TRT TIME REL PROG El E2 
212 155 PBS 240 0.150 8.02 839.0 81.30 
213 155 PBS 270 0.150 7.39 826.4 89.40 
214 155 PBS 300 0.125 7.48 864.7 -
215 155 PBS 330 0.125 7.63 883.8 86.34 
216 155 PBS 360 0.125 7.84 872.3 86.80 
217 155 PBS 420 0.125 7.08 867.5 88.61 
218 155 PBS 480 0.125 7.52 884.7 89.52 
219 155 PBS 540 0.125 7.63 881.4 81.40 
220 155 PBS 600 0.125 7.91 899.8 89.30 
221 155 PBS 660 0.125 7.17 871.2 87.44 
222 155 PBS 720 0.125 7.28 871.5 83.22 
223 155 PBS 780 0.125 7.49 896.2 86.30 
224 155 PBS 840 0.125 7.63 891.3 86.40 
225 155 PBS 900 0.125 7.40 893.8 90.90 
226 • 155 PBS 960 0.125 7.36 883.5 93.31 
227 155 PBS 1020 0.125 7.86 890.9 88.10 
228 155 PBS 1080 0.125 7.80 904.1 86.40 
229 155 PBS 1140 0.125 7.92 889.7 89.30 
230 155 PBS 1200 0.125 7.34 897.5 86.40 
231 155 PBS 1260 0.125 7.34 891.5 88.70 
232 155 PBS 1320 0.125 7.64 900.3 82.20 
233 155 PBS 1380 0.125 7.87 886.4 85.40 
234 155 PBS 1440 0.125 7.20 897.2 89.10 
235 325 PBS -720 0.180 6.95 801.3 72.80 
236 325 PBS -360 0.125 6.33 831.5 78.60 
237 325 PBS -90 0.155 5.92 827.4 79.40 
238 325 PBS -60 0.155 5.64 816.6 82.50 
239 325 F55 -30 0.150 6.30 530.9 80.83 
240 325 PBS 0 0.300 6.14 811.4 84.40 
241 325 PBS 30 0.450 5.73 832.6 89.53 
242 325 PBS 60 0.500 5.86 820.8 90.10 
243 325 PBS 90 0.900 6.11 834.5 90.60 
244 325 PBS 120 0.750 6.04 899.1 89.20 
245 325 PBS 150 0.500 5.81 862.1 81.90 
246 325 PBS 180 0.800 5.77 890.7 89.60 
247 325 PBS 210 0.600 5.49 820.2 83.40 
248 325 PBS 240 - 5.69 846.7 81.31 
249 325 PBS 270 0.200 6.14 856.8 89.20 
250 325 PBS 300 0.250 6.00 881.1 87.21 
251 325 PBS 330 0.450 6.21 844.2 93.91 
252 325 PBS 360 0.400 5.89 864.3 91.90 
253 325 PBS 420 0.310 5.81 863.1 88.30 
254 325 PBS 480 0.310 5.93 871.2 91.30 
255 325 PBS 540 0.280 6.00 908.4 89.30 
224 
Table C-1. (Continued) 
OBS ID TRT TIME REL PROG El E2 
256 325 PBS 600 0.250 5.88 896.7 88.10 
257 325 PBS 660 0.125 5.74 879.9 93.60 
258 325 PBS 720 0.125 5.95 900.2 87.60 
259 325 PBS 780 0.125 6.11 891.7 93.40 
260 325 PBS 840 0.140 6.03 875.7 88.50 
261 325 PBS 900 0.150 5.84 893.2 89.22 
262 325 PBS 960 0.320 5.71 901.4 90.43 
263 325 PBS 1020 0.160 5.77 906.5 87.41 
264 325 PBS 1080 0.125 5.83 908.7 96.40 
265 325 PBS 1140 0.160 5.49 890.8 91.33 
266 325 PBS 1200 0.170 5.94 914.3 86.32 
267 325 PBS 1260 0.125 5.68 873.5 87.30 
268 325 PBS 1320 0.190 5.78 894.6 87.42 
269 325 PBS 1380 0.130 5.95 901.7 92.60 
270 325 PBS 1440 0.140 5.72 880.7 84.70 
225 
APPENDIX D. DATA FROM PRIMIPAROUS HEIFERS USED IN 
SECTION IV, SPRING 1985 
Table D-1. Data 
OBS ID TRT DPREG CD PH PW PRG DPART 
1 339 D1 273 1.4 16.0 15.0 6.71 276 
2 339 D1 274 2.2 16.5 15.0 6.84 276 
3 339 D1 275 2.7 17.0 15.0 6.47 276 
4 339 D1 276 3.7 17.5 15.0 0.92 276 
5 339 D1 278 4.5 17.6 15.0 0.61 276 
6 339 D1 277 6.8 18.0 15.0 0.34 276 
7 253 D1 273 3.0 17.2 16.0 7.91 276 
8 253 D1 274 3.1 17.3 16.0 7.08 276 
9 253 D1 275 3.2 17.8 16.0 7.22 276 
10 253 D1 276 4.7 18.2 16.0 1.84 276 
11 253 D1 277 5.0 18.5 16.0 0.28 276 
12 253 D1 278 4.2 18.0 16.0 0.19 276 
13 93 D1 272 2.8 17.6 16.2 8.39 274 
14 93 D1 273 3.0 18.0 16.2 8.64 274 
15 93 D1 274 4.8 18.6 16.2 4.11 274 
16 93 D1 275 5.5 18.8 16.2 0.81 274 
17 93 D1 276 4.2 18.6 16.2 0.25 274 
18 49 D1 270 2.4 18.0 16.6 7.38 275 
19 49 D1 271 2.6 18.1 16.6 7.52 275 
20 49 D1 272 2.8 18.0 16.6 7.11 275 
21 49 D1 273 2.8 18.0 16.6 7.46 275 
22 49 D1 274 4.8 18.4 16.6 3.85 275 
23 49 D1 275 6.8 18.6 16.6 0.85 275 
24 49 D1 276 4.2 18.4 16.6 0.32 275 
25 49 D1 277 4.0 18.2 16.6 0.26 275 
26 190 D1 272 2.6 16.2 15.4 8.54 275 
27 190 D1 273 2.8 16.3 15.4 8.06 275 
28 190 D1 274 3.0 16.3 15.4 8.41 275 
29 190 D1 275 3.2 16.5 15.4 7.91 275 
EASE PSENT DDC DREL VALDC VALREL RET RTIME 
275 275 19.33 19.33 1 2 
275 275 19.33 19.33 1 2 
275 275 19.33 19.33 1 2 
275 275 19.33 19.33 1 2 
275 275 19.33 19.33 1 2 
275 275 19.33 19.33 1 2 
275 275 22.75 22.75 1 6 
275 275 22.75 22.75 1 6 
275 275 22.75 22.75 1 6 
275 275 22.75 22.75 1 6 
275 275 22.75 22.75 1 6 
275 275 22.75 22.75 1 6 
273 273 25.50 25.50 1 1 
273 273 25.50 25.50 1 1 
273 273 25.50 25.50 1 1 
273 273 25.50 25.50 1 1 
273 273 25.50 25.50 1 1 
273 273 51.63 51.63 2 48 
273 273 51.63 51.63 2 48 
273 273 51.63 51.63 2 48 
273 273 51.63 51.63 2 48 
273 273 51.63 51.63 2 48 
273 273 51.63 51.63 2 48 
273 273 51.63 51.63 2 48 
273 273 51.63 51.63 2 48 
275 275 8.58 8.58 1 2 
275 275 8.58 8.58 1 2 
275 275 8.58 8.58 1 2 
275 275 8.58 8.58 1 2 
N 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRG DPART DYST EASE PSENT DDC DREL VALDC VALREL RET RTIME 
30 190 D1 276 6.5 17.0 15.4 0.97 275 1 275 275 8.58 8.58 2 
31 190 D1 277 5.2 16.8 15.4 0.41 275 1 275 275 8.58 8.58 2 
32 203 D2 271 2.5 16.4 14.0 8.06 274 1 273 273 24.68 24.68 11 
33 203 D2 272 2.7 16.5 14.0 8.32 274 1 273 273 24.68 24.68 11 
34 203 D2 273 2.9 16.5 14.0 8.13 274 1 273 273 24.68 24.68 11 
35 203 D2 274 4.1 16.9 14.0 2.16 274 1 273 273 24.68 24.68 11 
36 203 D2 275 5.6 17.0 14.0 0.67 274 1 273 273 24,68 24.68 11 
37 203 D2 276 5.0 16.8 14.0 0.38 274 1 273 273 24.68 24.68 11 
38 374 D2 273 2.1 17.0 16.0 6.28 276 1 275 275 30,20 30.20 36 
39 374 D2 274 1.9 17.3 16.0 6.37 276 1 275 275 30.20 30.20 36 
40 374 D2 275 2.2 17.5 16.0 6.41 276 1 275 275 30.20 30.20 36 
41 374 D2 276 4.9 18.2 16.0 3.22 276 1 275 275 30.20 30.20 36 
42 374 D2 277 5.6 18.0 16.0 0.84 276 1 275 275 30.20 30.20 36 
43 374 D2 278 5.2 17.8 16.0 0.33 276 1 275 275 30.20 30.20 36 
44 257 D2 272 1.9 17.0 16.6 7.16 275 1 274 274 17.50 17.50 6 
45 257 D2 273 2.2 17.4 16.6 7.20 275 1 274 274 17.50 17.50 6 
46 257 D2 274 2.6 17.6 16.6 7.20 275 1 274 274 17.50 17.50 6 
47 257 D2 275 6.0 19.0 16.6 2.61 275 1 274 274 17.50 17.50 6 
48 257 D2 276 4.9 18.7 16.6 0.73 275 1 274 274 17.50 17.50 6 
49 257 D2 277 4.8 18.8 16.6 0.42 275 1 274 274 17.50 17.50 6 
50 30 D2 272 1.8 17.2 14.2 6.84 273 2 273 273 9.50 9.50 6 
51 30 D2 273 2.2 17.0 14.2 6.91 273 2 273 273 9.50 9.50 6 
52 30 D2 274 6.8 17.8 14.2 1.62 273 2 273 273 9.50 9.50 6 
53 30 D2 275 6.5 17.8 14.2 0.31 273 2 273 273 9.50 9.50 6 
54 30 D2 276 5.2 17.4 14.2 0.24 273 2 273 273 9.50 9.50 6 
55 407 D2 273 2.0 17.0 15.3 7.38 276 1 275 275 28.50 28.50 3 
56 407 D2 274 2.7 17.0 15.3 7.06 276 1 275 275 28.50 28.50 3 
57 407 D2 275 3.0 17.3 15.3 7.48 276 1 275 275 28.50 28.50 3 
58 407 02 276 4.0 17.8 15.3 3.44 276 1 275 275 28.50 28.50 3 
59 407 D2 277 5.2 17.9 15.3 0.84 276 1 275 275 28.50 28.50 3 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRG DPART DYST EASE PSENT DDC DREL VALDC VALREL RET RTIME 
60 407 D2 278 5.5 18.0 15.3 0.25 276 1 1 1 275 275 28.50 28.50 3 
61 56 D3 273 2.0 17.0 15.5 8.16 277 1 1 1 275 276 50.27 28.60 6 
62 56 D3 274 2.2 17.2 15.5 8.08 277 1 1 1 275 276 50.27 28.60 6 
63 56 D3 275 2.6 17.4 15.5 8.47 277 1 1 1 275 276 50.27 28.60 6 
64 56 D3 276 3.5 17.8 15.5 2.41 277 1 1 1 275 276 50.27 28.60 6 
65 56 D3 277 6.5 18.0 15.5 0.84 277 1 1 1 275 276 50.27 28.60 6 
66 56 D3 278 5.0 18.0 15.5 0.37 277 1 1 1 275 276 50.27 28.60 6 
67 56 D3 279 4.6 17.9 15.5 0.28 277 1 1 1. 275 276 50.27 28.60 6 
68 148 D3 273 1.9 16.5 15.3 7.19 276 1 1 1 275 276 36.00 14.00 1 
69 148 D3 274 2.0 16.8 15.3 6.38 276 1 1 1 275 276 36.00 14.00 1 
70 148 D3 275 2.2 16.5 15.3 6.24 276 1 1 1 275 276 36.00 14.00 1 
71 148 D3 276 2 6 16.8 15.3 2.91 276 1 1 1 275 276 36.00 14.00 1 
72 148 D3 277 7.0 17.9 15.3 0.39 276 1 1 1 275 276 36.00 14.00 1 
73 148 D3 278 5.9 17.0 15.3 0.26 276 1 1 1 275 276 36.00 14.00 1 
74 356 D3 270 2.7 18.1 16.0 7.02 274 1 1 1 273 274 38.60 14.50 6 
75 356 D3 271 3.0 18.6 16.0 6.98 274 1 1 1 273 274 38.60 14.50 6 
76 356 D3 272 3.3 18.8 16.0 6.54 274 1 1 1 273 274 38.60 14.50 6 
77 356 D3 273 3.5 18.8 16.0 6.28 274 1 1 1 273 274 38.60 14.50 6 
78 356 D3 274 4.7 19.2 16.0 4.81 274 1 1 1 273 274 38.60 14.50 6 
79 356 D3 275 5.9 19.4 16.0 1.28 274 1 1 1 273 274 38.60 14.50 6 
80 356 D3 276 4.0 18.8 16.0 0.51 274 1 273 274 38.60 14.50 6 
81 112 D3 271 1.6 18.2 17.6 8.21 275 4 1 1 273 274 44.50 19.00 3 
82 112 D3 272 1.7 18.4 17.6 8.16 275 4 1 1 273 274 44.50 19.00 3 
83 112 D3 273 2.1 18.6 17.6 8.08 275 4 1 1 273 274 44.50 19.00 3 
84 112 D3 274 3.0 18.8 17.6 7.91 275 4 1 1 273 274 44.50 19.00 3 
85 112 D3 275 6.3 19.2 17.6 5.08 275 4 1 1 273 274 44.50 19.00 3 
86 112 D3 276 5.4 19.1 17.6 2.04 275 4 1 1 273 274 44.50 19.00 3 
87 112 D3 277 5.0 18.8 17.6 0.62 275 4 1 1 273 274 44.50 19.00 3 
88 74 D4 273 2.6 17.0 16.0 0.36 275 1 1 1 274 275 35.30 10.00 1 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRG DPART DYS' 
89 74 D4 274 2.8 17.2 16.0 6.80 275 1 
90 74 D4 275 3.4 17.6 16.0 6.85 275 1 
91 74 D4 276 6.3 17.6 16.0 5.11 275 1 
92 74 D4 277 5.2 17.2 16.0 1.83 275 1 
93 304 D4 270 2.2 17.8 16.9 0.46 275 2 
94 304 D4 271 2.6 17.8 16.9 7.24 275 2 
95 304 D4 272 3.0 18.0 16.9 7.11 275 2 
96 304 D4 273 3.0 18.2 16.9 7.26 275 2 
97 304 D4 274 3.2 18.4 16.9 7.06 275 2 
98 304 D4 275 5.5 18.8 16.9 5.91 275 2 
99 304 D4 276 6.9 18.8 16.9 0.72 275 2 
100 304 D4 277 5.0 18.4 16.9 0.65 275 2 
101 308 D4 271 1.9 17.0 15.6 7.64 275 1 
102 308 D4 272 2.0 17.2 15.6 7.03 275 1 
103 308 D4 273 2.2 17.6 15.6 6.81 275 1 
104 308 D4 274 2.6 17.6 15.6 5.24 275 1 
105 308 D4 275 4.6 18.0 15.6 1.93 275 1 
106 308 D4 276 5.8 18.2 15.6 0.68 275 1 
107 308 D4 277 3.9 18.0 15.6 0.36 275 1 
108 131 D4 273 2.7 18.3 16.8 7.44 277 1 
109 131 D4 274 2.9 18.4 16.8 7.24 277 1 
110 131 D4 275 3.1 18.6 16.8 7.61 277 1 
111 131 D4 276 3.6 18.7 16.8 4.96 277 1 
112 131 D4 277 5.6 19.1 16.8 1.26 277 1 
113 131 D4 278 5.0 19.0 16.8 0.72 277 1 
114 131 D4 279 4.1 18.9 16.8 0.29 277 1 
115 58 D4 273 2.0 17.5 15.0 6.93 276 1 
116 58 D4 274 2.2 17.6 15.0 7.00 276 1 
117 58 D4 275 2.3 17.6 15.0 6.84 276 1 
118 58 D4 276 2.8 17.6 15.0 3.07 276 1 
119 58 D4 277 5.5 18.0 15.0 1.14 276 1 
ISE PSENT DDC DREL VALDC VALREL RET RTIME 
27,4 275 35.30 10.00 1 1 
274 275 35.30 10.00 1 1 
274 275 35.30 10.00 1 1 
274 275 35.30 10.00 1 1 
273 274 52.10 28.00 1 16 
273 274 52.10 28.00 1 16 
273 274 52.10 28.00 1 16 
273 274 52.10 28.00 1 16 
273 274 52.10 28.00 1 16 
273 274 52.10 28.00 1 16 
273 274 52.10 28.00 1 16 
273 274 52.10 28.00 1 16 
273 274 48.30 25.50 1 20 
273 274 48.30 25.50 1 20 
273 274 48.30 25.50 1 20 
273 274 48.30 25.50 1 20 
273 274 48.30 25.50 1 20 
273 274 48.30 25.50 1 20 
273 274 48.30 25.50 1 20 
275 276 48.00 23.50 1 6 
275 276 48.00 23.50 1 6 
275 276 48.00 23.50 1 6 
275 276 48.00 23.50 1 6 
275 276 48.00 23.50 1 6 
275 276 48.00 23.50 1 6 
275 276 48.00 23.50 1 6 
275 276 34.00 1.00 - 60 
275 276 34.00 1.00 - 60 
275 276 34.00 1.00 - 60 
275 276 34.00 1.00 - 60 
275 276 34.00 1.00 - 60 
i\j 
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VO 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRG DPART 
120 58 D4 278 5. 2 18.0 15.0 0.43 276 
121 58 D4 279 3. 9 17.9 15.0 0.26 276 
122 75 D4 273 1. 8 17.6 16.0 8.31 276 
123 75 D4 274 2. 4 17.6 16.0 8.04 276 
124 75 D4 275 2. 4 17.6 16.0 8.12 276 
125 75 D4 276 3. 8 17.5 16.0 6.09 276 
126 75 D4 277 6. 2 18.0 16.0 0.98 276 
127 75 D4 278 5. 2 17.8 16.0 0.54 276 
128 100 D5 271 2. 2 18.1 16.6 8.22 275 
129 100 D5 272 2. 6 18.1 16.6 8.47 275 
130 100 D5 273 2. 9 18.2 16.6 8.31 275 
131 100 D5 274 3. 1 18.2 16.6 5.07 275 
132 100 D5 275 5. 0 18.4 16.6 2.38 275 
133 100 D5 276 4. 8 18.4 16.6 0.89 275 
134 100 D5 277 4. 8 18.3 16.6 0.34 275 
135 142 D5 273 2. 5 17.5 16.û 7.08 277 
136 142 D5 274 2. 9 17.8 16.0 6.94 277 
137 142 D5 275 2. 6 17.8 16.0 6.83 277 
138 142 D5 276 2. 8 18.4 16.0 4.11 277 
139 142 D5 277 3. 2 18.8 16.0 1.26 277 
140 142 D5 278 4. 9 18.6 16.0 0.37 277 
141 142 D5 279 4. 0 18.0 16.0 0.29 277 
142 115 D5 268 2. 1 18.5 16.8 9.42 275 
143 115 D5 269 2. 3 18.6 16.8 9.16 275 
144 115 D5 270 2. 4 18.6 16.8 9.00 275 
145 115 D5 271 2. 6 18.8 16.8 9.11 275 
146 115 D5 272 2. 8 18.9 16.8 9.05 275 
147 115 D5 273 3. 0 19.0 16.8 8.79 275 
148 115 D5 274 3. 5 19.0 16.8 5.10 275 
149 115 D5 275 6. 9 19.0 16.8 0.89 275 
PSENT DDC DREL VALDC VALREL RET RTIME 
1 275 276 34.00 1.00 - 60 
1 275 276 34.00 1.00 - 60 
1 275 276 37.50 11.33 1 4 
1 275 276 37.50 11.33 1 4 
1 275 276 37.50 11.33 1 4 
1 275 276 37.50 11.33 1 4 
1 275 276 37.50 11.33 1 4 
1 275 276 37.50 11.33 1 4 
1 273 274 48.00 24.00 2 28 
1 273 274 48.00 24.00 2 28 
1 273 274 48.00 24.00 2 28 
1 273 274 48.00 24.00 2 28 
1 273 274 48.00 24.00 2 28 
1 273 274 48.00 24.00 2 28 
1 273 274 48.00 24.00 2 28 
1 275 276 50.60 23.30 3 0 
1 275 276 50.60 23.30 3 0 
1 275 276 50.60 23.30 3 0 
1 275 276 50.60 23.30 3 0 
1 275 276 50.60 23.30 3 0 
1 275 276 50.60 23.30 3 0 
1 275 276 50.60 23.30 3 0 
1 273 274 48.50 23.00 2 48 
1 273 274 48.50 23.00 2 48 
1 273 274 48.50 23.00 2 48 
1 273 274 48.50 23.00 2 48 
1 273 274 48.50 23.00 2 48 
1 273 274 48.50 23.00 2 48 
1 273 274 48.50 23.00 2 48 
1 273 274 48.50 23.00 2 48 
Table D-1. . (Continued) 
OBS ID TRT DPREG CD PH PW PRG DPART DYS' 
150 115 D5 276 5.8 18.9 16.8 0.34 275 4 
151 115 D5 277 5.1 18.7 16.8 0.31 275 4 
152 370 D5 271 2.4 16.8 15.4 6.34 275 1 
153 370 D5 272 2.8 17.0 15.4 6.58 275 1 
154 370 D5 273 3.0 17.2 15.4 6.49 275 1 
155 370 D5 274 3.5 17.6 15.4 3.60 275 1 
156 370 D5 275 3.9 18.0 15.4 1.37 275 1 
157 370 D5 276 6.0 18.0 15.4 0.67 275 1 
158 370 D5 277 4.6 18.0 15.4 0.28 275 
159 171 D6 273 2.2 17.9 16.0 7.29 276 5 
160 171 D6 274 2.2 17.8 16.0 7.58 276 5 
161 171 D6 275 2.4 17.9 16.0 5.11 276 5 
162 171 D6 276 2.8 17.8 16.0 1.38 276 5 
163 171 D6 277 5.2 18.0 16.0 0.78 276 5 
164 171 D6 278 5.0 18.0 16.0 0.33 276 5 
165 275 D6 273 2.0 17.6 15.5 6.49 277 4 
166 275 D6 274 2.3 18.0 15.5 6.83 277 4 
167 275 D6 275 2.0 18.3 15.5 6.38 277 4 
168 275 D6 276 3.0 18.5 15.5 5.00 277 4 
169 275 D6 277 4.0 19.0 15.5 1.81 277 4 
170 275 D6 278 6.9 18.9 15.5 0.67 277 4 
171 275 D6 279 6.0 18.9 15.5 0.29 277 4 
172 387 D6 273 2.2 17.5 16.4 7.41 277 4 
173 387 D6 274 2.1 17.6 16.4 7.03 277 4 
174 387 D6 275 2.7 17.8 16.4 6.94 277 4 
175 387 D6 276 3.5 17.8 16.4 4.32 277 4 
176 387 D6 277 4.2 18.2 16.4 1.97 277 4 
177 387 D6 278 6.9 18.5 16.4 0.96 277 4 
178 387 D6 279 5.0 18.1 16.4 0.26 277 4 
EASE PSENT DDC DREL VALDC VALREL RET RTIME 
2 1 273 274 48.50 23.00 2 48 
2 1 273 274 48.50 23.00 2 48 
1 1 273 274 51.00 27.75 1 
1 1 273 274 51.00 27.75 1 
1 1 273 274 51.00 27.75 1 
1 1 273 274 51.00 27.75 1 
1 1 273 274 51.00 27.75 1 
1 1 273 274 51.00 27.75 1 
1 1 273 274 51.00 27.75 1 
2 2 274 275 48.00 24.00 2 48 
2 2 274 275 48.00 24.00 2 48 
2 2 274 275 48.00 24.00 2 48 
2 2 274 275 48.00 24.00 2 48 
2 2 274 275 48.00 24.00 2 48 
2 2 274 275 48.00 24.00 2 48 
2 2 275 276 52.25 28.25 2 48 
2 2 275 276 52.25 28.25 2 48 
2 2 275 276 52.25 28.25 2 48 
2 2 275 276 52.25 28.25 2 48 
2 2 275 276 52.25 28.25 2 48 
2 2 275 276 52.25 28.25 2 48 
2 2 275 276 52.25 28.25 2 48 
2 1 275 276 54.66 32.45 2 48 
2 1 275 276 54.66 32.45 2 48 
2 1 275 276 54.66 32.45 2 48 
2 1 275 276 54.66 32.45 2 48 
2 1 275 276 54.66 32.45 2 48 
2 1 275 276 54.66 32.45 2 48 
2 1 275 276 54.66 32.45 2 48 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRC DPAR: 
179 377 D6 270 2.0 18.0 16.6 9.43 277 
180 377 D6 271 2.1 18.0 16.6 9.38 277 
181 377 D6 272 2.2 18.0 16.6 9.06 277 
182 377 D6 273 2.6 18.2 16.6 9.21 277 
183 377 D6 274 3.0 18.2 16.6 6.94 277 
184 377 D6 275 3.5 18.3 16.6 4.93 277 
185 377 D6 276 3.7 18.6 16.6 2.61 277 
186 377 D6 277 5.1 18.2 16.6 1.06 277 
187 377 D6 278 4.4 18.1 16.6 0.29 277 
188 377 D6 279 4.3 18.1 LB.6 0.26 277 
189 13 D6 273 2.6 17.5 15.5 7.82 280 
190 13 D6 274 2.7 17.8 15.5 7.69 280 
191 13 D6 275 2.7 17.9 15.5 7.15 280 
192 13 D6 276 3.6 18.0 15.5 6.11 280 
193 13 D6 277 3.9 18.0 15.5 4.35 280 
194 13 D6 278 3.8 18.2 15.5 2.01 280 
195 13 D6 279 3.3 18.3 15.5 1.32 280 
196 13 D6 280 - - 15.5 0.94 280 
197 13 D6 281 6.1 18.3 15.5 0.41 280 
198 13 D6 282 4.8 18.1 15.5 0.27 280 
199 7 Cl 273 2.0 16.0 14.5 7.36 276 
200 7 Cl 274 2.6 16.2 14.5 7.50 276 
201 7 Cl 275 2.8 16.3 14.5 7.28 276 
202 7 Cl 276 7.0 16.8 14.5 2.06 276 
203 7 Cl 277 5.5 17.0 14.5 0.81 276 
204 368 Cl 271 2.2 17.8 16.1 7.93 274 
205 368 Cl 272 2.6 17.7 16.1 8.04 274 
206 368 Cl 273 3.0 18.4 16.1 8.21 274 
207 368 Cl 274 4.2 18.8 16.1 2.15 274 
208 368 Cl 275 5.5 18.8 16.1 0.67 274 
PSENT DDC DREL VALDC VALREL RET RTIME 
273 274 93.00 68.10 - 48 
273 274 93.00 68.10 - 48 
273 274 93.00 68.10 - 48 
273 274 93.00 68.10 - 48 
273 274 93.00 68.10 - 48 
273 274 93.00 68.10 - 48 
273 274 93.00 68.10 - 48 
273 274 93.00 68.10 - 48 
273 274 93.00 68.10 - 48 
273 274 93.00 68.10 - 48 
275 276 - - - 6 
275 275 - - - 6 
275 276 - - - 6 
275 276 - - - 6 
275 276 - - - 6 
275 276 - - - 6 
275 276 - - - 6 
275 276 - - - 6 
275 276 - - - 6 
275 276 - - - 6 
275 275 24.33 24.33 1 3 
275 275 24.33 24.33 1 3 
275 275 24.33 24.33 1 3 
275 275 24.33 24.33 1 3 
275 275 24.33 24.33 1 3 
274 274 28.20 28.20 1 6 
274 274 28.20 28.20 1 6 
274 274 28.20 28.20 1 6 
274 274 28.20 28.20 1 6 
274 274 28.20 28.20 1 6 
M 
w to 
Table D-1, (Continued) 
OBS ID TRT DPREG CD PH PW PRG DPAR^  
209 368 Cl 276 5.0 18.2 16.1 0.94 274 
210 216 Cl 273 2.1 18.2 17.0 8.71 276 
211 216 Cl 274 2.2 18.4 17.0 8.45 276 
212 216 Cl 275 2.4 18.6 17.0 8.17 276 
213 216 Cl 276 4.9 18.9 17.0 2.18 276 
214 216 Cl 277 6.5 18.8 17.0 0.96 276 
215 216 Cl 278 6.3 18.8 17.0 0.52 276 
216 192 Cl 273 2.1 18.0 16.0 7.06 277 
217 192 Cl 274 2.3 18.1 16.0 6.95 277 
218 192 Cl 275 2.5 18.2 16.0 6.83 277 
219 192 Cl 276 4.6 18.5 16.0 2.96 277 
220 192 Cl 277 6.8 18.9 16.0 0.84 277 
221 192 Cl 278 6.0 18.8 16.0 0.62 277 
222 192 Cl 279 5.1 18.6 16.0 0.41 277 
223 134 Cl 273 2.4 18.0 16.5 9.11 275 
224 134 Cl 274 2.1 18.1 16.5 8.46 275 
225 134 Cl 275 2.7 18.3 16.5 2.34 275 
226 134 Cl 276 5.1 18.6 16.5 0.76 275 
227 134 Cl 277 6.9 18.8 16.5 0.91 275 
228 134 Cl 278 6.0 18.8 16.5 0.55 275 
229 196 C2 273 2.2 16.5 14.8 9.06 276 
230 196 C2 274 2.6 16.9 14.8 8.61 276 
231 196 C2 275 3.0 17.0 14.8 8.42 276 
232 196 C2 276 3.8 18.0 14.8 1.89 276 
233 196 C2 277 5.8 18.1 14.8 0.37 276 
234 196 C2 278 5.8 18.2 14.8 0.31 276 
235 20 C2 273 2.6 16.4 16.0 7.24 275 
236 20 C2 274 2.9 16.9 16.0 7.56 275 
237 20 C2 275 3.2 17.0 16.0 6.87 275 
238 20 C2 276 4.8 17.5 16.0 0.88 275 
EASE PSENT DDC DREL VALDC VALREL RET RTIME 
1 274 274 28.20 28.20 1 6 
2 275 275 29.20 29.20 2 36 
2 275 275 29.20 29.20 2 36 
2 275 275 29.20 29.20 2 36 
2 275 275 29.20 29.20 2 36 
2 275 275 29.20 29.20 2 36 
2 275 275 29.20 29.20 2 36 
2 275 275 37.50 37.50 2 48 
2 275 275 37.50 37.50 2 48 
2 275 275 37.50 37.50 2 48 
2 275 275 37.50 37.50 2 48 
2 275 275 37.50 37.50 2 48 
2 275 275 37.50 37.50 2 48 
2 275 275 37.50 37.50 2 48 
275 275 9.00 9.00 1 6 
275 275 9.00 9.00 1 6 
275 275 9.00 9.00 1 6 
275 275 9.00 9.00 1 6 
275 275 9.00 9.00 1 6 
275 275 9.00 9.00 1 6 
275 275 25.00 25.00 1 2 
275 275 25.00 25.00 1 2 
275 275 25.00 25.00 1 2 
275 275 25.00 25.00 1 2 
275 275 25.00 25.00 1 2 
275 275 25.00 25.00 1 2 
275 275 11.00 11.00 1 6 
275 275 11.00 11.00 1 6 
275 275 11.00 11.00 1 6 
275 275 11.00 11.00 1 6 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRC DPAR^  
239 20 C2 277 5.2 17.6 16.0 0.62 275 
240 45 C2 269 2.6 17.4 16.0 8.31 274 
241 45 C2 270 2.8 17.6 16.0 8.01 274 
242 45 C2 271 2.8 17.5 16.0 8.12 274 
243 45 C2 272 3.0 17.7 16.0 7.98 274 
244 45 C2 273 3.2 17.7 16.0 8.01 274 
245 45 C2 274 4.6 18.4 16.0 7.46 274 
246 45 C2 275 5.4 19.0 16.0 1.27 274 
247 45 C2 276 5.0 18.6 16.0 0.85 274 
248 188 C2 271 2.6 16.0 14.2 7.45 275 
249 188 C2 272 2.5 15.9 14.2 7.14 275 
250 188 C2 273 3.0 16.2 14.2 7.28 275 
251 188 C2 274 2.9 16.3 14.2 6.86 275 
252 188 C2 275 6.8 17.0 14.2 1.21 275 
253 188 C2 276 4.8 17.0 14.2 0.64 275 
254 188 02 277 3.8 16.8 14.2 0.52 275 
255 207 C2 275 2.1 16.5 15.5 7.36 277 
256 207 02 276 2.2 16.8 15.5 3.96 277 
257 207 02 277 4.8 17.2 15.5 1.11 277 
258 207 02 278 6.7 17.1 15.5 0.35 277 
259 207 02 279 5.0 17.0 15.5 0.41 277 
260 88 03 273 2.2 15.9 14.3 7.15 276 
261 88 03 274 2.8 15.9 14.3 6.93 276 
262 88 03 275 2.6 16.2 14.3 4.10 276 
263 88 03 276 3.7 16.9 14.3 1.02 276 
264 88 03 277 6.5 17.0 14.3 0.59 276 
265 88 03 278 6.0 16.8 14.3 0.36 276 
266 254 03 272 2.1 17.8 15.8 8.69 275 
267 254 03 273 2.3 18.0 15.8 8.94 275 
268 254 03 274 2.8 18.1 15.8 5.61 275 
DYST EASE PSENT DdC DREL VALDC VALREL RET RTIME 
1 275 275 11.00 11.00 6 
1 274 274 28.00 28.00 2 
1 274 274 28.00 28.00 2 
1 274 274 28.00 28.00 2 
1 274 274 28.00 28.00 2 
1 274 274 28.00 28.00 2 
1 274 274 28.00 28.00 2 
1 274 274 28.00 28.00 2 
1 274 274 28.00 28.00 2 
2 274 274 - - 6 
2 274 274 - - 6 
2 274 274 - - 6 
2 274 274 - - 6 
2 274 274 - - 6 
2 274 274 - - 6 
2 274 274 - - 6 
1 275 275 37.00 37.00 4 
1 275 275 37.00 37.00 4 
1 275 275 37.00 37.00 4 
1 275 275 37.00 37.00 4 
1 275 275 37.00 37.00 4 
1 274 275 42.00 9.00 12 
1 274 275 42.00 9.00 12 
1 274 275 42.00 9.00 12 
1 274 275 42.00 9.00 12 
1 274 275 42.00 9.00 12 
1 274 275 42.00 9.00 12 
2 1 273 274 39.75 16.00 12 
2 1 273 274 39.75 16.00 12 
2 1 273 274 39.75 16.00 12 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRG DPART DYS' 
269 254 C3 275 6.4 18.6 15.8 1.21 275 2 
270 254 03 276 5.2 18.1 15.8 0.65 275 2 
271 254 03 277 4.1 18.0 15.8 0.21 275 2 
272 329 03 273 1.8 16.5 14.5 8.02 277 4 
273 329 03 274 1.8 16.5 14.5 7.64 277 4 
274 329 03 275 1.9 15.8 14.5 7.91 277 4 
275 329 03 276 2.6 16.8 14.5 4.96 277 4 
276 329 03 277 4.5 17.3 14.5 0.96 277 4 
277 329 C3 278 6.4 17.3 14.5 0.52 277 4 
278 329 03 279 5.2 17.0 14.5 0.22 277 4 
279 201 C3 273 2.4 17.0 15.0 6.91 277 4 
280 201 C3 274 2.5 17.1 15.0 6.58 277 4 
281 201 03 275 2.7 17.1 15.0 6.44 277 4 
282 201 03 276 3.2 17.4 15.0 3.41 277 4 
283 201 C3 277 4.5 17.4 15.0 1.21 277 4 
284 201 C3 278 5.1 17.6 15.0 0.63 277 4 
285 201 C3 279 4.8 17.3 15.0 0.43 277 4 
286 201 C3 280 4.0 17.3 15.0 0.27 277 4 
287 269 C3 273 2.6 17.8 16.0 7.21 277 4 
288 269 C3 274 2.9 17.8 16.0 6.98 277 4 
289 269 C3 275 3.1 18.0 16.0 7.10 277 4 
290 269 C3 276 3.0 18.0 16.0 4.21 277 4 
291 269 C3 277 6.2 18.4 16.0 1.85 277 4 
292 268 03 278 5.0 18.2 16.0 0.81 277 4 
293 268 C3 279 4.3 18.1 16.0 0.43 277 4 
294 117 04 273 2.7 18.8 16.8 7.04 277 4 
295 117 04 274 3.0 19.0 16.8 7.18 277 4 
296 117 04 275 3.5 18.9 16.8 7.12 277 4 
297 117 04 276 3.3 18.8 16.8 3.96 277 4 
298 117 04 277 5.2 18.8 16.8 1.68 277 4 
299 117 04 278 5.8 18.8 16.8 0.89 277 4 
EASE PSENT DDC DREL VALDC VALREL RET RTIME 
1 273 274 39.75 16.00 1 12 
1 273 274 39.75 16.00 1 12 
1 273 274 39.75 16.00 1 12 
2 275 276 37.50 13.50 2 34 
2 275 276 37.50 13.50 2 34 
2 275 276 37.50 13.50 2 34 
2 275 276 37.50 13.50 2 34 
2 275 276 37.50 13.50 2 34 
2 275 276 37.50 13.50 2 34 
2 275 276 37.50 13.50 2 34 
2 275 276 46.50 25.00 2 48 
2 275 276 46.50 25.00 2 48 
2 275 276 46.50 25.00 2 48 
2 275 276 46.50 25.00 2 48 
2 275 276 46.50 25.00 2 48 
2 275 276 46.50 25.00 2 48 
2 275 276 46.50 25.00 2 48 
2 275 276 46.50 25.00 2 48 
2 275 276 42.00 13.30 1 4 
2 275 276 42.00 13.30 1 4 
2 275 276 42.00 13.30 1 4 
2 275 276 42.00 13.30 1 4 
2 275 276 42.00 13.30 1 4 
2 275 276 42.00 13.30 1 4 
2 275 276 42.00 13.30 1 4 
2 275 276 37.00 15.00 1 6 
2 275 276 37.00 15.00 1 6 
2 275 276 37.00 15.00 1 6 
2 275 276 37.00 15.00 1 6 
2 275 276 37.00 15.00 1 6 
2 275 276 37.00 15.00 1 6 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRC DPART DYS1 
300 117 C4 279 4.0 18.9 16.8 0.26 277 4 
301 302 C4 273 2.5 17.2 16.3 6.94 275 1 
302 302 C4 274 2.6 17.3 16.3 4.08 275 1 
303 302 C4 275 3.1 17.4 16.3 1.36 275 1 
304 302 C4 276 6.8 17.8 16.3 0.52 275 1 
305 302 C4 277 5.6 17.6 16.3 0.48 275 1 
306 302 C4 278 3.8 17.4 16.3 0.32 275 1 
307 4 C4 270 2.2 17.2 16.4 8.67 275 4 
308 4 C4 271 2.5 17.5 16.4 8.09 275 4 
309 4 C4 272 2.9 17.8 16.4 8.16 275 4 
310 4 C4 273 3.0 17.8 16.4 8.53 275 4 
311 4 C4 274 3.7 18.0 16.4 5.17 275 4 
312 4 C4 275 6.2 18.2 16.4 1.36 275 4 
313 4 C4 276 5.3 18.0 16.4 0.52 275 4 
314 4 C4 277 4.8 18.0 16.4 0.48 275 4 
315 120 C4 273 2.5 17.4 16.5 8.26 277 4 
316 120 C4 274 2.7 17.6 16.5 8.41 277 4 
317 120 C4 275 2.6 17.8 16.5 6.03 277 4 
318 120 C4 276 4.8 18.0 16.5 3.16 277 4 
319 120 C4 277 3.1 18.3 16.5 1.27 277 4 
320 120 C4 278 6.5 18.6 16.5 0.68 277 4 
321 120 C4 279 5.0 18.4 16.5 0.25 277 4 
322 281 C4 273 3.0 18.0 17.2 8.26 276 1 
.323 281 C4 274 3.5 18.2 17.2 8.41 276 1 
324 281 C4 275 3.6 18.2 17.2 3.16 276 1 
325 281 C4 276 6.4 18.4 17.2 1.21 276 1 
326 281 C4 277 5.8 18.6 17.2 0.68 276 1 
327 281 C4 278 5.0 18.6 17.2 0.41 276 1 
328 357 C5 273 2.2 15.9 13.5 9.01 276 5 
329 357 C5 274 2.9 16.4 13.5 9.16 276 5 
330 357 C5 275 3.6 16.8 13.5 6.38 276 5 
EASE PSENT DDC OREL VALDC VALREL RET RTIME 
1 1 275 276 37.00 15.00 1 6 
1 1 273 274 44.86 20.86 1 6 
1 1 273 274 44.86 20.86 1 6 
1 1 273 274 44.86 20.86 1 6 
1 1 273 274 44.86 20.86 1 6 
1 1 273 274 44.86 20.86 1 6 
1 1 273 274 44.86 20.86 1 6 
2 1 273 274 43.00 20.00 2 48 
2 1 273 274 43.00 20.00 2 48 
2 1 273 274 43.00 20.00 2 48 
2 1 273 274 43.00 20.00 2 48 
2 1 273 274 43.00 20.00 2 48 
2 1 273 274 43.00 20.00 2 48 
2 1 273 274 43.00 20.00 2 • 48 
2 1 273 274 43.00 20.00 2 48 
2 1 275 276 46.75 21.50 2 24 
2 1 275 276 46.75 21.50 2 24 
2 1 275 276 46.75 21.50 2 24 
2 1 275 276 46.75 21.50 2 24 
2 1 275 276 46.75 21.50 2 24 
2 1 275 276 46.75 21.50 2 24 
2 1 275 276 46.75 21.50 2 24 
274 275 38.60 14.18 1 3 
1 274 275 38.60 14.18 1 3 
1 274 275 38.60 14.18 1 3 
1 274 275 38.60 14.18 1 3 
1 274 275 38.60 14.18 1 3 
1 274 275 38.60 14.18 1 3 
2 2 274 275 44.00 20.16 2 36 
2 2 274 275 44.00 20.16 2 36 
2 2 274 275 44.00 20.16 2 36 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRG DPAR: 
331 357 C5 276 3.8 16.6 13.5 1.17 276 
332 357 C5 277 - - 13.5 0.61 276 
333 357 C5 278 4.0 17.0 13.5 0.30 276 
334 288 C5 273 1.8 15.8 14.0 8.25 277 
335 288 C5 274 1.9 16.0 14.0 8.20 277 
336 288 C5 275 2.3 15.9 14.0 6.71 277 
337 288 C5 276 2.7 16.0 14.0 4.09 277 
338 288 C5 277 4.8 16.3 14.0 1.74 277 
339 288 C5 278 5.0 16.0 14.0 0.54 277 
340 37 C5 273 2.7 18.0 17.1 6.49 276 
341 37 C5 274 2.9 18.2 17.1 6.00 276 
342 37 C5 275 3.4 18.3 17.1 3.98 276 
343 37 C5 276 4.0 18.6 17.1 1.86 276 
344 37 C5 277 4.7 18.6 17.1 0.99 276 
345 37 C5 278 4.9 18.3 17.1 0.42 276 
346 37 C5 279 3.6 18.3 17.1 0.28 276 
347 123 C5 268 2.1 18.2 17.5 10.20 274 
348 123 C5 269 2.1 18.2 17.5 9.86 274 
349 123 C5 270 2.3 18.3 17.5 9.78 274 
350 123 C5 271 2.4 18.5 17.5 9.61 274 
351 123 C5 272 2.4 18.4 17.5 9.32 274 
352 123 C5 273 2.6 18.5 17.5 6.14 274 
353 123 C5 274 3.2 18.6 17.5 2.64 274 
354 123 C5 275 5.0 18.6 17.5 1.47 274 
355 123 C5 276 4.1 18.5 17.5 0.64 274 
356 57 C5 273 2.5 18.0 17.2 7.04 277 
357 57 C5 274 2.4 18.1 17.2 7.18 277 
358 57 C5 275 2.4 18.3 17.2 6.98 277 
359 57 C5 276 3.2 18.5 17.2 4.32 277 
360 57 C5 277 5.4 18.6 17.2 1.27 277 
361 57 C5 278 5.0 18.5 17.2 0.81 277 
EASE PSENT DDC DREL VALDC VALREL RET RTIME 
2 2 274 275 44.00 20.16 2 36 
2 2 274 275 44.00 20.16 2 36 
2 2 274 275 44.00 20.16 2 36 
2 2 274 275 73.25 48.25 2 36 
2 2 274 275 73.25 48.25 2 36 
2 2 274 275 73.25 48.25 2 36 
2 2 274 275 73.25 48.25 2 36 
2 2 274 275 73.25 48.25 2 36 
2 2 274 275 73.25 48.25 2 36 
1 274 275 57.50 33.33 1 6 
1 274 275 57.50 33.33 1 6 
1 274 275 57.50 33.33 1 6 
1 274 275 57.50 33.33 1 6 
1 274 275 57.50 33.33 1 6 
1 274 275 57.50 33.33 1 6 
1 274 275 57.50 33.33 1 6 
1 272 273 60.50 35.66 1 12 
1 272 273 60.50 35.66 1 12 
1 272 273 60.50 35.66 1 12 
1 272 273 60.50 35.66 1 12 
1 272 273 60.50 35.66 1 12 
1 272 273 60.50 35.66 1 12 
1 272 273 60.50 35.66 1 12 
1 272 273 60.50 35.66 1 12 
1 272 273 60.50 35.66 1 12 
1 275 276 43.33 21.00 1 16 
1 275 276 43.33 21.00 1 16 
1 275 276 43.33 21.00 1 16 
1 275 276 43.33 21.00 1 16 
1 275 276 43.33 21.00 1 16 
1 275 276 43.33 21.00 1 16 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRC DPART DYS^  
362 57 C5 279 4.7 18.4 17.2 0.27 277 1 
363 195 C6 272 2.3 17.2 16.4 8.69 276 4 
364 195 C6 273 2.6 17.3 16.4 8.71 276 4 
365 195 C6 274 2.7 17.5 16.4 6.04 276 4 
366 195 C6 275 3.2 17.8 16.4 4.37 276 4 
367 195 C6 276 6.2 18.0 16.4 1.19 276 4 
368 195 C6 277 4.1 18.0 16.4 0.65 276 4 
369 195 C6 278 3.9 17.9 16.4 0.30 276 4 
370 121 06 271 2.3 16.8 15.01 9.63 274 4 
371 121 C6 272 2.2 16.8 15.0 8.14 274 4 
372 121 C6 273 2.9 17.0 15.01 5.70 274 4 
373 121 C6 274 5.2 17.2 15. Cl 1.46 274 4 
374 121 C6 275 4.4 17.1 15.0) 0.89 274 4 
375 185 06 273 2.3 18.4 16.01 6.92 277 1 
376 185 06 274 2.5 18.5 16.0' 7.01 277 1 
377 185 06 275 2.8 18.2 16.01 6.87 277 1 
378 185 06 276 3.6 18.5 16.0 3.89 277 1 
379 185 06 277 - - 16.0 1.19 277 1 
380 185 06 278 6.7 18.7 16.0 0.72 277 1 
381 185 06 279 5.8 18.7 16.0 0.30 277 1 
382 129 06 270 2.9 18.8 17.6 8.32 275 4 
383 129 06 271 3.0 18.8 17.6 8.19 275 4 
384 129 06 272 3.2 19.0 17.6 8.65 275 4 
385 129 06 273 3.3 19.0 17.6 8.00 275 4 
386 129 06 274 3.3 19.1 17.6 6.43 275 4 
387 129 06 275 3.8 19.2 17.6 2.01 275 4 
388 129 06 276 5.6 19.2 17.6 1.00 275 4 
389 129 06 277 5.0 19.0 17.6 0.31 275 4 
390 373 06 271 2.0 18.2 17.5 7.21 275 4 
EASE PSENT DDC DREL VALDC VALREL RET RTIME 
1 275 276 43.33 21.00 1 16 
1 273 274 73.00 49.00 2 48 
2 273 274 73.00 49.00 2 48 
2 273 274 73.00 49.00 2 48 
2 273 274 73.00 49.00 2 48 
2 273 274 73.00 49.00 2 48 
2 273 274 73.00 49.00 2 48 
2 273 274 73.00 49.00 2 48 
2 271 272 56.16 32.52 2 48 
2 271 272 56.16 32.52 2 48 
2 271 272 56.16 32.52 2 48 
2 271 272 56.16 32.52 2 48 
2 271 272 56.16 32.52 2 48 
275 276 55.10 32.25 2 48 
275 276 55.10 32.25 3 48 
275 276 55.10 32.25 3 48 
275 276 55.10 32.25 2 48 
275 276 55.10 32.25 2 48 
275 276 55.10 32.25 2 48 
2 275 276 55.10 32.25 2 48 
2 273 274 61.00 39.00 2 48 
2 273 274 61.00 39.00 2 48 
2 273 274 61.00 39.00 2 48 
2 273 274 61.00 39.00 2 48 
2 273 274 61.00 39.00 2 48 
2 273 274 61.00 39.00 2 48 
2 273 274 61.00 39.00 2 48 
2 . 273 274 61.00 39.00 2 48 
2 273 274 45.50 20.36 2 48 
Table D-1. (Continued) 
OBS ID TRT DPREG CD PH PW PRG DPART DYST EASE PSENT DDC DREL VALDC VALREL RET RTIME 
391 373 C6 272 2.3 18.0 17.5 7.36 275 4 2 273 274 45.50 20.36 2 48 
392 373 C6 273 2.7 18.2 17.5 7.18 275 4 2 273 274 45.50 20.36 2 48 
393 373 C6 273 3.5 18.0 17.5 4.68 275 4 2 273 274 45.50 20.36 2 48 
394 373 C6 275 4.5 18.2 17.5 1.24 275 4 2 273 274 45.50 20.36 2 48 
395 373 C6 276 6.2 18.3 17.5 0.76 275 4 2 273 274 45.50 20.36 2 48 
396 373 C6 277 5.4 18.0 17.5 0.25 275 4 2 273 274 45.50 20.36 2 48 
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Table E-1. (Continued) 
OBS BYR SIZ ID FB SB TB LB CONDÂTE 
36 83 2 208 175 181 — — 0 
37 83 2 224 196 - — - 0 
38 83 2 234 182 - - - 118 
39 83 2 240 190 - — - 119 
40 83 2 241 186 - - - 0 
41 83 2 245 188 - — - 118 
42 83 2 282 175 — - - 117 
43 83 2 288 213 — - - 0 
44 83 2 320 189 - - - 118 
45 83 2 325 172 197 208 - 0 
46 83 2 326 195 - — - 0 
47 83 2 329 174 183 — - 118 
48 83 2 333 180 - — - 118 
49 83 2 339 174 - - - 117 
50 83 2 352 — - - - 0 
51 83 2 357 187 - - - . 118 
52 83 2 359 179 - - - 117 
53 83 2 360 185 - - - 118 
54 83 2 374 182 202 - - 120 
55 83 2 378 195 - - - 119 
56 83 2 398 188 - - - 118 
57 83 4 8 177 - - - 117 
58 83 4 13 185 — - - 0 
59 83 4 36 '173 - - - 117 
60 83 4 49 186 - - - 118 
61 83 4 52 182 — - - 118 
62 83 4 70 171 - - - 117 
63 53 4 74 185 - - - 118 
64 83 4 79 190 - - - 119 
65 83 4 93 174 — - - 117 
66 83 4 100 176 - — - 117 
67 83 4 116 171 - - - 117 
68 83 4 117 185 - - - 118 
69 83 4 121 181 - - - 118 
70 83 4 134 191 - - - 119 
71 83 4 142 - - - - 0 
72 83 4 149 189 - - - 118 
73 83 4 152 209 - - - 120 
74 83 4 156 177 - - - 117 
75 83 4 171 182 - - - 118 
76 83 4 185 174 - - - 117 
77 83 4 190 192 - - - 0 
78 83 4 191 178 - - - 117 
79 83 4 195 198 - - - 0 
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Table E-1. (Continued) 
OBS BYR SIZ ID FB SB TB LB COUDAT 
80 83 4 196 178 117 
81 83 4 201 191 - - - 0 
82 83 4 239 - - - - 0 
83 83 4 248 - - - - 0 
84 83 4 254 172 173 192 212 0 
85 83 4 269 185 - - - 118 
86 83 4 274 192 - - - 119 
87 83 4 306 200 201 - - 120 
88 83 4 308 175 - - - 117 
89 83 4 310 - - - - 0 
90 83 4 312 178 - - - 117 
91 83 4 330 177 - - - 117 
92 83 4 366 182 210 - - 121 
93 83 4 370 189 - - - 118 
94 83 4 372 177 - - - 117 
95 83 4 377 191 - - - 119 
96 83 4 381 178 211 - - 0 
97 83 4 389 181 203 - - 0 
98 83 4 402 189 - - - 118 
99 83 4 404 176 - - - 117 
100 83 4 407 208 - - - 120 
101 83 6 4 198 - - - 119 
102 83 6 17 185 - - - 118 
103 83 6 37 175 - - - 117 
104 83 6 57 187 - - - 118 
105 83 6 105 181 - - - 118 
106 83 6 112 186 - - - 118 
107 83 6 115 181 - - - 118 
108 83 6 120 186 - - - 118 
109 83 6 123 172 - - - 117 
110 83 6 129 188 - - - 118 
111 83 6 131 179 180 208 - 0 
112 83 6 163 203 - - - 0 
113 83 6 192 191 - - - 119 
114 83 6 199 209 - - - 120 
115 83 6 213 175 193 211 212 121 
116 83 6 214 181 199 - - 0 
117 83 6 216 181 188 211 - 0 
118 83 6 253 172 192 - - 119 
119 83 6 257 190 212 — - 121 
120 83 6 275 187 - - - 118 
121 83 6 281 185 - - - 118 
122 83 6 302 185 - - - 118 
123 83 6 304 188 - - - 118 
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Table E-1. (Continued) 
OBS BYR SIZ ID FB SB TB LB CONDATE 
124 83 6 317 189 - - - 0 
125 83 6 356 190 - - 119 
126 83 6 362 175 - - - 117 
127 83 6 368 197 - 0 
128 83 6 373 188 - - 118 
129 83 6 387 192 - - - 119 
130 83 6 390 - - - - 0 
OBS BYR SIZ I LB CONDATE 
1 82 2 1.17818E+16 208 120 
2 82 2 10181 - 118 
3 82 2 14175 - 117 
4 82 2 26206 - 120 
5 82 2 37178179 - 117 
6 82 2 42189 - 118 
7 82 2 43184 - 118 
8 82 2 47178 - 117 
9 82 2 62179 - 117 
10 82 2 71191212 - 121 
11 82 2 84187198 - 119 
12 82 2 86189 - 118 
13 82 2 108176 - 117 
14 82 2 114191199210 - 121 
15 82 2 116208209 - 120 
16 82 2 117178188197 - 119 
17 82 2 126180181201 - 120 
18 82 2 139186 - 118 
19 82 2 140 - 0 
20 82 2 153208 - 20 
21 82 2 156173 - 117 
22 82 2 162209 - 120 
23 82 2 177 - 0 
24 82 2 192197 - 119 
25 82 2 204178 - 117 
26 82 2 211213 - 121 
27 82 2 214178 - 117 
28 82 2 229201 — 20 
29 82 2 234197 - 119 
30 82 2 250182 - 118 
31 82 2 256183 - 118 
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Table E-1. (Continued) 
OBS BYR SIZ I LB CONDÂTE 
32 82 2 272190 - 119 
33 82 2 289176191191 - 119 
34 82 2 298176 - 117 
35 82 2 322 - 1 
36 82 2 339 - 0 
37 82 2 368176195 - 19 
38 82 2 370172 - 117 
39 82 2 371 - 0 
40 82 2 376172 - 117 
41 82 2 383187209 - 120 
42 82 2 407186205206 - 120 
43 82 2 414200200 - 120 
44 82 2 423177 - 117 
45 82 4 2185 - 118 
46 82 4 5188189 - 18 
47 82 4 16173 - 117 
48 82 4 18198 - 119 
49 82 4 41176 - 17 
50 82 4 45184 - 118 
51 82 4 60188 - 118 
52 82 4 97177 - 117 
53 82 4 124197 - 119 
54 82 4 138177 - 117 
55 82 4 141185186 - 118 
56 82 4 163193214 - 21 
57 82 4 187178198 - 119 
58 82 4 189175 - 117 
59 82 4 201175 - 117 
60 82 4 210173 - 117 
61 82 4 217187 - 118 
62 82 4 231190209210 - 121 
63 82 4 242188 - 118 
64 82 4 249201 - 120 
65 82 4 268206 - 120 
66 82 4 276200 - 20 
67 82 4 294181 - 118 
68 82 4 309196 - 119 
69 82 4 324206 - 120 
70 82 4 326173195 - 119 
71 82 4 330185206 - 120 
72 82 4 332176184 - 118 
73 82 4 342194 - 119 
74 82 4 358175 - 117 
75 82 4 360182 - 118 
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Table E-1. (Continued) 
OBS BYR SIZ I LB CONDATE 
76 82 4 365190 - 119 
77 82 4 382173 - 117 
78 82 4 385 - 0 
79 82 4 387179 - 17 
80 82 4 398175 - 117 
81 82 6 6177 - 117 
82 82 6 7184 - 118 
83 82 6 20197198 — 119 
84 82 6 32177 - 117 
85 82 6 34186 - 118 
86 82 6 50191213 - 121 
87 82 6 52201 - 120 
88 82 6 57193 - 119 
89 82 6 72178186 - 118 
90 82 6 102187206 - 20 
91 82 6 120 - 1 
92 82 6 142175 - 117 
93 82 6 147189 - 118 
94 82 6 166188 - 118 
95 82 6 169 - 0 
96 82 6 170191212 - 121 
97 82 6 188186 - 18 
98 82 6 205187 - 18 
99 82 6 206 - 0 
100 82 6 220187 - 118 
101 82 6 221180188 - 118 
102 82 6 235 - 0 
Q KJ fim V 
104 82 6 258189 - 118 
105 82 6 283202 - 20 
106 82 6 286181 - 118 
107 82 6 290185 - 118 
108 82 6 291 - 0 
109 82 6 296190214 - 121 
110 82 6 307 - 0 
111 82 6 320195 - 119 
112 82 6 327 - 0 
113 82 6 329177 - 117 
114 82 6 361179 - 117 
115 82 6 369180 - 18 
116 82 6 372177198 - 119 
117 82 6 388 - 0 
118 82 6 392187 - 118 
119 82 6 396189 - 118 
Table E-1. (Continued) 
246 
OBS BYR SIZ I LE CONDATE 
120 82 6 406188 - 118 
121 82 6 408202 - 120 
122 82 — 51172179 - 117 
123 83 2 6179200 - 120 
124 83 2 7172 - 117 
125 83 2 16164 - 116 
126 83 2 19176195 - 119 
127 83 2 20180180 - 118 
128 83 2 30181181 - 118 
129 83 2 33164 - 116 
130 83 2 35178 - 117 
131 . 83 2 38178 - 17 
132 83 2 40176177 - 117 
133 83 2 44165 - 116 
134 83 2 45185185 - 118 
135 83 2 50167 - 116 
136 83 2 53175175195 - 119 
137 83 2 56177178 - 117 
138 83 2 58174 - 117 
139 83 2 62167167 - 116 
140 83 2 63169210 - 21 
141 83 2 64173 - 117 
142 83 2 66172190 - 119 
143 83 2 69165 - 16 
144 83 2 71175 - 17 
145 83 2 72170 - 17 
146 83 2 75177 - 117 
147 83 2 76175 - 117 
148 83 2 83176 - 117 
149 83 2 86181 - 18 
150 83 2 88175175 - 117 
151 83 2 97178201 - 120 
152 83 2 101169 - 116 
153 83 2 126170 - 117 
154 83 2 1.32169E+18 206 20 
155 83 2 141184206 - 20 
156 83 2 145172 - 117 
157 83 2 148167 - 116 
158 83 2 151180180 - 118 
159 83 2 155165165 - 116 
160 83 2 168177 - 117 
161 83 2 172180197 - 19 
162 83 2 " 178181 - 118 
163 83 2 179177 - 117 
OBS 
164 
165 
166 
167 
168 
169 
170 
171 
172 
173 
174 
175 
176 
177 
178 
179 
180 
181 
182 
183 
184 
185 
186 
187 
188 
189 
190 
191 
192 
193 
194 
195 
196 
197 
198 
199 
247 
(Continued) 
BYR SIZ I LB CONDATE 
83 2 188182 - 118 
83 2 197194 - 19 
83 2 200183183 - 18 
83 2 203173173191 - 119 
83 2 207178 - 117 
83 2 208169 - 116 
83 2 224165 - 116 
83 2 234184 - 118 
83 2 240169 - 116 
83 2 241180180 - 118 
83 2 245167199 - 119 
83 2 282167 - 116 
83 2 288171171 - 117 
83 2 296197 - 119 
83 2 320189189 - 118 
83 2 325165 - 116 
83 2 326183204 - 120 
83 2 329171 - 117 
83 2 333168 - 116 
83 2 337166198 - 19 
83 2 339170 - 117 
83 2 352207 - 120 
83 2 357179 - 117 
83 2 359192 - 119 
83 2 360164164 - 116 
83 2 374170170 - 117 
83 2 378172 - 117 
S3 2 398164 - 116 
83 4 8179199198 - 119 
83 4 13175175 - 117 
83 4 36208 - 120 
83 4 48172193213 - 21 
83 4 49184184 - 118 
83 4 52175175 - 117 
83 4 70171 - 117 
83 4 74179 - 117 
83 4 79180 - 118 
83 4 93179179 - 117 
83 4 100182 - 118 
83 4 107191210210 - 21 
83 4 113166185204 - 20 
83 4 116165165 - 116 
83 4 117173 - 117 
83 4 121182 - 118 
OBS 
208 
209 
210 
211 
212 
213 
214 
215 
216 
217 
218 
219 
220 
221 
222 
223 
224 
225 
226 
227 
228 
229 
230 
231 
232 
233 
234 
235 
236 
237 
238 
239 
240 
241 
242 
243 
244 
245 
246 
247 
248 
(Continued) 
BYR SIZ I LB CONDATE 
83 4 134177 - 117 
83 4 142171 - 117 
83 4 143177196 - 119 
83 4 144189209 - 20 
83 4 149180180191 - 119 
83 4 152165185 - 118 
83 4 156172212213 - 121 
83 4 171174 - 117 
83 4 185178 - 117 
83 4 190185 — 118 
83 4 191173 - 117 
83 4 195175 - 117 
83 4 196170 - 117 
83 4 201172 - 117 
83 4 226 - 0 
83 4 227176197 - 19 
83 4 238171 - 17 
83 4 239186 - 118 
83 4 248 - 1 
83 4 254181 - 118 
83 4 269171 - 117 
83 4 271169 - 16 
83 4 274167 - 116 
83 4 297184208 - 20 
83 4 305164165 - 116 
83 4 306182203 - 120 
83 4 308164183 - 118 
33 4 310 - 1 
83 4 312177 - 117 
83 4 330192 - 119 
83 4 366164 - 116 
83 4 370166185 - 118 
83 4 372174 - 117 
83 4 377183183 - 118 
83 4 381177 - 117 
83 4 389166 - 116 
83 4 402182206 - 120 
83 4 404164 - 116 
83 4 407170 - 117 
83 6 4184 - 118 
83 6 17169 - 116 
83 6 28177177 - 17 
83 6 37179179 - 117 
83 6 57177 - 117 
OBS 
252 
253 
254 
255 
256 
257 
258 
259 
260 
261 
262 
263 
264 
265 
266 
267 
268 
269 
270 
271 
272 
273 
274 
275 
276 
277 
278 
279 
280 
281 
282 
283 
17 
20 
116 
20 
118 
120 
116 
120 
119 
117 
116 
20 
116 
0 
1 
120 
117 
117 
117 
118 
17 
116 
117 
118 
19 
118 
1 
19 
118 
117 
118 
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(Continued) 
BYR SIZ LB 
83 6 80179179 -
83 6 104204 -
83 6 105169 -
83 6 111206 -
83 6 112173173182 -
83 6 115182200 -
83 6 120166 -
83 6 123169200 -
83 6 129192 -
83 6 131172 -
83 6 163167 -
83 6 170 -
83 6 173189196209 -
83 6 192169169 -
83 6 198 -
83 6 199 -
83 6 213168168208 -
83 6 214175 -
83 6 216175175 -
83 6 253174 -
83 6 257183 -
83 6 266173 -
83 6 275169 -
83 6 281179 -
83 6 302183 -
83 6 303176196 -
83 6 304186 -
83 6 317 -
83 6 338191 -
83 6 356183 -
83 6 362175175 -
83 6 368185 -
83 6 371186 -
83 6 373182 -
83 6 387178178 -
83 6 390204 -
83 6 392 -
83 6 405191 -
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Glossary of terms used in appendices: 
ID 
SIZE 
TRT 
DAYPREG 
DPRE6 
DAYPART 
DPART 
DAYTTOC 
PHT (PH) 
PWIDTH (PW) 
Heifer number (Brand/Ear Tag Number) 
Body frame size: 2 = small; 4 = medium; 6 = large 
Treatment 
Day of pregnancy (0-283) 
Day of pregnancy (0-283) 
Day of parturition 
Day of parturition 
Number of days from treatment to calving (parturition) 
Pelvic height (cm) 
Pelvic width (cm) 
CDIAM (CD) - Cervical diameter (cm) 
BIRTH WT = Birth weight of calf (kg) 
HCIRCUM = Circumference of head of calf (cm) 
EASE = Ease of calving 
FROG " Plasma progesterone concentration in peripheral plasma 
BIRTH YR 
BYR 
OBS 
DAYS 
2^ 
TIME 
DYST 
(ng/al) 
= Birth year of heifer (dam) 
= Birth year of heifer (dam) 
= Numerical observation identification 
= Days from parturition 
Peripheral plasma levels of estrone (ng/ml) 
Peripheral plasma levels of ITB-estradiol (pg/ml) 
= Time in minutes 
= Dystocia 
PSENT 
OREL 
DDC 
VALDC 
VALREL 
RET 
RTIME 
FB 
SB 
TB 
CONDÀTE 
251 
= Type of presentation of fetus 
= Day of relaxin administraiton 
= Day of Dex or Clo administration 
= Interval between Dex or Clo administration and calving 
» Interval between relaxin administration and calving 
= Presence of retained placenta 
= Duration of retained placenta ' 
= First AI 
= Second AI 
= Third AI 
« Conception date 
